ާ␹⚻⛔ᓮቇ⻠ᐳި
㧔1㧕㜞ᰴ␹⚻ᒻᘒቇಽ㊁1㧚⎇ⓥߩ᭎ⷐ
1. ⷞⷡ⊹⾰␹⚻࿁〝ߩ⸃᣿
2. ญ⣧ᗵⷡߣᖱേ♽࿁〝ㅪ⛊ߩ⎇ⓥ
3. ᄢ⣖⊹⾰⊒↢ᯏ᭴ߩ⸃ᨆ
4. ࠬ࠻࡟ࠬߦࠃࠆ␹⚻࿁〝ᄌൻߩ⎇ⓥ
5. 㜞ᰴ⣖ᯏ⢻ࡀ࠶࠻ࡢ࡯ࠢࠍᵴᕈൻߔࠆᣇ╷ߩ㐿⊒
2㧚ฬ★
દ⮮๺ᄦ
ᢎ᝼㧦
ಎᢎ᝼㧦 ਛ᧛ᶈᐘ
⮮↰㓷ᢥ⻠Ꮷ㧦Kazuo Itoh
Hiroyuki Nakamura
Masafumi Fujita

3㧚⎇ⓥᚑᨐߩ⊒⴫⪺ᦠ㧔๺ᢥ㧕
ߥߒ⪺ᦠ㧔᰷ᢥ㧕
1㧕 Watanabe K, Kubo K, Nakamura H, Tachibana A, Kim W, Ono Y, Sasaguri K, Onozuka M.
Involvement if Dysfunctional Mastication in Congnitive System Deficits in the Mouse. In: Onozuka M,
Yen C, eds. Novel Trends in Brain Science. Tokyo: Springer; 2008:115-129.
✚⺑㧔๺ᢥ㧕
ߥߒ✚⺑㧔᰷ᢥ㧕
ߥߒේ⪺㧔๺ᢥ㧕
ߥߒේ⪺㧔᰷ᢥ㧕
1㧕 Nakamura H, Wu R, Watanabe K, Onozuka M, Itoh K. Projections of glutamate decarboxylase positive
and negative cerebellar neurons to the pretectum in the cat. Neurosci Lett. 2006;403:30-34.
2㧕 Fukumitsu H, Ohtsuka M, Murai R, Nakamura H, Itoh K, Furukawa S. Brain-derived neurotrophic
factor participates in determination of neuronal laminar fate in the developing mouse cerebral cortex.
J Neurosci. 2006;26:13218-13230.
3㧕 Hirano Y, Fujita M, Watanabe K, Niwa M, Takahashi T, Kanematsu M, Ido Y, Tomida M, Onozuka M.
Effect of unpleasant loud noise on hippocampal activities during picture encoding: an fMRI study.
Brain Cogn. 2006;61:280-285.
4㧕 Kubo K, Yamada Y, Iinuma M, Iwaku F, Tamura Y, Watanabe K, Nakamura H, Onozuka M. Occlusal
disharmony induces spatial memory impairment and hippocampal neuron degeneration via stress in
SAMP8 mice. Neurosci Lett. 2007;414:188-191.
5㧕 Nakamura H, Chaumon M, Klijn F, Innocenti GM. Dynamic properties of the representation of thevisual field midline in the visual areas 17 and 18 of the ferret (Mustela putorius). Cereb Cortex.
2008;18:1941-1950.

IF 2.019

IF 7.506

IF 1.845

IF 2.092

IF 6.3684㧚⎇ⓥ⾌₪ᓧ⁁ᴫ
1㧕┹੎⊛⾗㊄1㧕 ⎇ⓥઍ⴫⠪㧦⮮↰㓷ᢥ㧘⎇ⓥಽᜂ⠪㧦౗᧻㓷ਯ㧘ട⮮ೣᑝ㧘⮮ේ ๟㧘ਭ଻㊄ᒎ㧧ᢥㇱ⑼ቇ⋭⑼ቇ
⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(B)(2)㧦㜞㦂␠ળߦ߅޿ߡ⠧ᐕᱤ⑼කቇ߇ᜂ߁␠ળ⊛㊀ⷐᕈࠍ⣖⑼ቇ⊛ߦታ⸽ߔࠆ㧧ᐔᚑ 18㧙19 ᐕᐲ㧧20,410 ජ౞(16,900㧦3,510 ජ౞)
2㧕 ⎇ⓥઍ⴫⠪㧦ਛ᧛ᶈᐘ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(C)㧦ⷞⷡ⊹⾰ third tier visual cortex ߩⷞ㊁ౣ⃻ߣࠛ࡝ࠕ඙ಽ㧧ᐔᚑ 18㧙20 ᐕᐲ㧧3,790 ජ౞(1,400㧦1,690㧦700 ජ౞)
3㧕 ⎇ⓥઍ⴫⠪㧦ਛ᧛ᶈᐘ㧧⥄ὼ⑼ቇ⎇ⓥᯏ᭴↢ℂቇ⎇ⓥᚲ ౒ห೑↪⎇ⓥ㧦ࡅ࠻ᄢ⣖⊹⾰ߦ߅ߌࠆ㧟㧙㧙ᰴⷞⷡ⊹⾰ⶄว૕(third tier visual complex)ߩ૏⟎ߣⷞⷡౣ⃻㧧ᐔᚑ 19 ᐕᐲ㧧72 ජ౞4㧕 ⎇ⓥઍ⴫⠪㧦દ⮮๺ᄦ㧧੩ㇺᄢቇ㔤㐳㘃⎇ⓥᚲ ౒ห೑↪⎇ⓥ㧦Ꮐฝᄢ⣖ඨ⃿⊹⾰ߩᯏ⢻ಽൻߩ⿠Ḯࠍតࠆ㧧ᐔᚑ 19 ᐕᐲ㧧32 ජ౞5㧕 ⎇ⓥઍ⴫⠪㧦ਛ᧛ᶈᐘ㧧⥄ὼ⑼ቇ⎇ⓥᯏ᭴↢ℂቇ⎇ⓥᚲ ౒ห೑↪⎇ⓥ㧦⟤ߒߐࠍ್ᢿߔࠆ⣖̆ⷞⷡߣ⡬ⷡߩⶄวೝỗߦࠃࠆ⣖⾮ᵴㇱ૏ߩ⸃᣿㧧ᐔᚑ 20 ᐕᐲ㧧100 ජ౞6㧕 ⎇ⓥઍ⴫⠪㧦દ⮮๺ᄦ, ⎇ⓥಽᜂ⠪㧦ਛ᧛ᶈᐘ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(C)(2)㧦ࠬ࠻࡟ࠬߦࠃࠅᗖ⿠ߐࠇࠆญ⣧ᗵⷡ⇣Ᏹߩ␹⚻ၮ⋚ߩ⸃᣿㧧ᐔᚑ 20㧙22 ᐕᐲ㧧3,700 ජ౞(2,200㧦900㧦
600 ජ౞)7㧕 ⎇ⓥઍ⴫⠪㧦⮮↰㓷ᢥ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⾌⵬ഥ㊄ၮ⋚⎇ⓥ(C)(2)㧦⢻േ⊛ⷞ⡬ⷡ⸥ᙘ࠻࡟࡯࠾ࡦ
ࠣߩ߽ߚࠄߔ⍮⢻ะ਄ലᨐߩᬌ⸽㧧ᐔᚑ 20㧙22 ᐕᐲ㧧3,970 ජ౞(2,470㧦600㧦900 ජ౞)
2㧕ฃ⸤⎇ⓥߥߒ
3㧕౒ห⎇ⓥ
1㧕 ⎇ⓥઍ⴫⠪㧦દ⮮๺ᄦ㧘⎇ⓥಽᜂ⠪㧦ਛ᧛ᶈᐘ㧦㗶࡮ญ⣧ᯏ⢻ߩ␹⚻ᯏ᭴ߩ⸃᣿㧧ᐔᚑ 18㧙20 ᐕᐲ㧧
6,000 ජ౞(2,000㧦2,000㧦2,000 ජ౞)㧦␹ᄹᎹᱤ⑼ᄢቇ
5㧚⊒᣿࡮․⸵಴㗿⁁ᴫߥߒ
6㧚ቇળᵴേ
ߥߒ
7㧚ቇળ᜗ᓙ⻠Ṷ㧘᜗ᓙࠪࡦࡐࠫࠬ࠻㧘ᐳ㐳ਛ᧛ᶈᐘ㧦
1㧕 ╙ 10 ࿁ᣣᧄຏวቇળቇⴚᄢળ(2006 ᐕ 1 ᦬㧘᧲੩㧘․೎⻠Ṷ‫ޟ‬๰ྨེቭߣ⣖ߩ⍮⊛ᯏ⢻‫౒ޠ‬หṶ⠪)8㧚ቇⴚ⾨╬ߩฃ⾨⁁ᴫߥߒ9㧚␠ળᵴേદ⮮๺ᄦ㧦
1㧕 ↢ℂቇ⎇ⓥᚲㆇ༡ᆔຬ(㨪⃻࿷)2㧕 㜞⍮ᄢቇකቇㇱකቇᢎ⢒ࡢ࡯࡚ࠢࠪ࠶ࡊ ࠲ࠬࠢࡈࠜ࡯ࠬ(㨪⃻࿷)10㧚ႎ๔ᦠ
1㧕 દ⮮๺ᄦ㧦Ꮐฝᄢ⣖ඨ⃿⊹⾰ߩᯏ⢻ಽൻߩ⿠Ḯࠍតࠆ㧦੩ㇺᄢቇ㔤㐳㘃⎇ⓥᚲᐕႎ 38㧦21(2008ᐕ 8 ᦬)
2㧕 ਛ᧛ᶈᐘ㧦ࡑࠞࠢࠩ࡞ⷞⷡ⊹⾰ Third tier visual cortex ߩⷞ㊁ౣ⃻ߣࠛ࡝ࠕ඙ಽ㧦੩ㇺᄢቇ㔤㐳㘃⎇ⓥᚲᐕႎ 37㧦136(2007 ᐕ 7 ᦬)
3㧕 ਛ᧛ᶈᐘ㧦ࡑࠞࠢࠩ࡞ਅ㗡㗂ㅪว㊁㧔7 ㊁㧕ߦ߅ߌࠆᄙ㊀ᗵⷡ౉ജ⛔วߩᒻᘒቇ⊛⎇ⓥ㧦੩ㇺᄢቇ㔤㐳㘃⎇ⓥᚲᐕႎ 36㧦115 (2006 ᐕ 7 ᦬)
11㧚ႎ㆏
1㧕 ਛ᧛ᶈᐘ㧦⣖߇਎⇇ࠍ⷗ࠆ઀⚵ߺ㧦ጘ㒂ᣂ⡞(2007 ᐕ 3 ᦬ 27 ᣣ)
12㧚⥄Ꮖ⹏ଔ
⹏ଔᢎ⢒߿ᄢቇㆇ༡ߥߤߦᢎቭߩᄙᄢߥഭജࠍᔅⷐߣߐࠇࠆߎߣࠍ⠨ᘦߔࠆߣ㧘ߘࠇߥࠅߩ⎇ⓥᚑᨐࠍ਄ߍߡ޿ࠆ‫ޕ‬ᄢቇ㒮↢߿․೎දജ⎇ⓥຬߩ࠻࡟࡯࠾ࡦ߽ࠣߘࠇߥࠅߩᚑᨐࠍ਄ߍߡ޿ࠆ‫ޕ‬㧙㧙⃻⁁ߩ໧㗴ὐ෸߮ߘߩኻᔕ╷⎇ⓥ⾌₪ᓧߦᄙᄢߥᤨ㑆ࠍⷐߒߡ޿ࠆ‫ޕ‬౒ห⎇ⓥߦࠃࠆ⎇ⓥ⾌ߩ⏕଻߇ᦸ߹ߒ޿‫ޕ‬੹ᓟߩዷᦸ⣖ߩ௛߈ࠍ⸃ᨆߔࠆߦߪ␹⚻࿁〝ࠍℂ⸃ߔࠆߎߣ߇㊀ⷐߢ޽ࠆ‫ߩ࡯࠲ࠢࡌࠬ࡞ࠖ࠙ޕ‬ዉ౉ߦࠃࠅ㧘⚦⢩࡟ࡌ࡞ߩ␹⚻࿁〝⸃ᨆࠍㅴ߼ߚ޿‫ޕ‬㧙㧙㧔2㧕↢ℂቇಽ㊁1㧚⎇ⓥߩ᭎ⷐ
ᔃ࡮ᓴⅣ↢ℂቇ㧘ⅣႺ↢ℂቇ㧘ቝቮකቇ․ߦ㊀ജකቇಽ㊁ߩ⎇ⓥࠍਥ૕ߣߒ㧘วࠊߖߡᧃ᪳ᓴⅣᡷༀⵝ⟎㐿⊒㧘⿠┙⵬ഥⵝ⟎㐿⊒㧘㔚᳇ೝỗߦࠃࠆ࡝ࡂࡆ࡝ᯏེ㐿⊒㧘ᣂⷙቝቮ᦯㐿⊒ߥߤ․⸵ߦၮߠ޿ߚ‛ㅧࠅࠍⴕߞߡ޿ࠆ‫ޕ‬
2㧚ฬ★
ᢎ᝼㧦
⻠Ꮷ㧦

᫪↰໪ਯ
↰ਛ㇌ᒾ

Hironobu Morita
Kunihiko Tanaka

3㧚⎇ⓥᚑᨐߩ⊒⴫⪺ᦠ㧔๺ᢥ㧕
1㧕 ᫪↰໪ਯ㧚ࡅ࠻߇↢߈ᱷࠆߚ߼ߩ૕ߩߒߊߺ ╙ 2㧧ฬฎደ㧔ਃᕺ␠㧕
㧧2008 ᐕ㧦4㧙17.

⪺ᦠ㧔᰷ᢥ㧕
ߥߒ✚⺑㧔๺ᢥ㧕
1㧕 ᷰㆻ๺ሶ㧘ን↰⟤Ⓞሶ㧘ዊ㊁Ⴆታ㧚⹺⍮ߣญߩᓎഀ㧘ᱤ⇇ዷᦸ ೎ౠ ․೎ડ↹ ญ⣧ᯏ⢻ቇߩᄛ᣿ߌ㧙ญߩᓎഀࠍ⑼ቇߔࠆ 2006 ᐕ㧧107 Ꮞ㧦586㧙589.
2㧕 ᫪↰໪ਯ㧘቟ㇱജ㧘↰ਛ㇌ᒾ㧚ቝቮⅣႺਅߢߩᓴⅣ⺞▵㧙㊀ജᄌൻߦኻߔࠆേ⣂ⴊ࿶ᔕ╵ 㤗㈮ 2008 ᐕ㧧
57 Ꮞ㧦S66㧙S76.
3㧕 ቟ㇱജ㧘↰ਛ㇌ᒾ㧘᫪↰໪ਯ㧚ਅ⢇㕒⣂ⴊⴕേᘒߩ․ᕈ߆ࠄ⷗ߚᷓㇱ㕒⣂ⴊᩖ∝㧘ᣣᧄⴊᩖᱛⴊቇળ⹹
2008 ᐕ㧧19 Ꮞ㧦495㧙500.
✚⺑㧔᰷ᢥ㧕
ߥߒේ⪺㧔๺ᢥ㧕
1㧕 ጊ↰ብዏ㧘᫪↰໪ਯ㧘↰ਛ㇌ᒾ㧘ဈ᧲⋥ⴕ㧚⿠┙േ૞․ᕈߩ⸃ᨆߦၮߠߊ⿠┙⵬ഥⵝ⟎ߩ㐿⊒ ᣣᧄᯏ᪾ቇળ⺰ᢥ㓸㧔C ✬㧕
㧘2008 ᐕ㧧74 Ꮞ㧦154㧙162.
ේ⪺㧔᰷ᢥ㧕
1㧕 Tanaka K, Gotoh MT, Awazu C, Morita H. Roles of vestibular system in controlling arterial pressure inconscious rats during a short period of microgravity. Neurosci Lett. 2006;397:40-43.
2㧕 Morita H, Abe C, Tanaka K, Shiratori M, Oguri M, Shiga T. Neuromuscular electrical stimulation andottoman-type seat effectively improve popliteal venous flow in sitting position. J Physil Sci.
2006;56:183-186.
3㧕 Fujio T, Fujihara H, Shibata M, Yamada S, Onaka T, Tanaka K, Morita H, Dayanithi G, Kawata M,
Murphy D, Ueta Y. Exaggerated response of arginine vasopressin-enhanced green fluorescent protein
fusion gene to salt loading without disturbance of body fluid homeostasis in rats. J Neuroendocrinol,
2006;18:776-785.
4㧕 Hirano, Y, Fujita, M, Watanabe, K, Niwa, M, Takahashi, T, Kanematsu, M, Ido, Y, Tomida, M,
Onozuka, M. Effect of unpleasant loud noise on hippocampal activities during picture encording: an
fMRI study. Brain Cog. 2006;61:280-285.
5㧕 Nakamura, H, Wu, R, Watanabe, K, Onozuka, M. Projections of glutamate decaboxylase positive andnegative cerebellar neurons to the pretectum in the cat. Neurosci Lett. 2006;403:30-34.
6㧕 Tanaka K, Gotoh MT, Awazu C, Morita H. Roles of vestibular system in controlling arterial pressure inconscious rats during a short period of microgravity. Neuroscience Letters. 2006;397:40-43.
7㧕 Morita H, Abe C, Tanaka K, Shiratori M, Oguri M, Shiga T. Neuromuscular electrical stimulation andottoman-type seat effectively improve popliteal venous flow in sitting position. J Physiol Sci.
2006;56:183-186.
8㧕 Morita H, Abe C, Awazu C, Tanaka K. Long-term hypergravity induces plastic alterations investibulo-cardiovascular reflex in conscious rats. Neurosci Lett. 2007;412:201-205.
9㧕 Abe C, Awazu C, Tanaka K, Chen H, Morita H. Two weeks of 3-G load attenuates pressor response to
microgravity in conscious rats. Exp Brain Res. 2007;181:639-646.
10㧕 Abe C, Tanaka K, Awazu C, Morita H. Strong galvanic vestibular stimulation obscures arterialpressure response to gravitational change in conscious rats. J Appl Physiol. 2008;104:34-40.
11㧕 Shinozaki K, Shimizu Y, Shiina T, Morita H, Takewaki T. Relationship between taste-induced㧙㧙

IF 2.085

IF 0.726

IF 2.920

IF 1.148
IF 2.085
IF 2.085

IF 0.726
IF 2.085
IF 2.027
IF 3.632

physiological reflexes and temperature of sweet taste. Physiology & Behavior. 2008;93:1000-1004.
12㧕 Abe C, Tanaka K, Awazu C, Morita H. Impairment of vestibular-mediated cardiovascular response andmotor coordination in rats born and reared under hypergravity. Am J Physiol. 2008;295:R173-R180.
13㧕 Miyazawa S, Shimizu Y, Shiina T, Hirayama H, Morita H, Takewaki T. Central A1-receptor activation
associated with onset of torpor protects the heart against low temperature in the Syrian hamster. Am
J Physiol. 2008;295:R991-R996.
14㧕 Abe C, Tanaka K, Morita H. The vestibular system is integral in regulating plastic alterations in thepressor response to free drop mediated by the nonvestibular system. Neurosci Lett. 2008;445:149-152.

IF 2.445
IF 3.661

IF 3.661
IF 2.0854㧚⎇ⓥ⾌₪ᓧ⁁ᴫ
1㧕┹੎⊛⾗㊄1㧕 ⎇ⓥઍ⴫⠪㧦᫪↰໪ਯ㧧ቝቮⅣႺ೑↪ߦ㑐ߔࠆ౏൐࿾਄⎇ⓥ㧦೨ᐸ㧙േ⣂ⴊ࿶⺞▵♽ߩน႟ᕈߦ㑐ߔࠆၮ␆⊛߅ࠃ߮⥃ᐥ⊛⎇ⓥ㧧ᐔᚑ 17㧙19 ᐕᐲ㧧35,000 ජ౞(13,000㧦11,000㧦11,000 ජ౞)
2㧕 ⎇ⓥઍ⴫⠪㧦↰ਛ㇌ᒾ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(C)㧦㊀ജᄌൻᤨߩᓴⅣ⺞▵ߦ߅ߌࠆౝ
⡊೨ᐸ♽ᯏ⢻ߩ⸃᣿ߣᔕ↪㧧ᐔᚑ 17㧙20 ᐕᐲ㧧2,800 ජ౞(800㧦700㧦800㧦500 ජ౞)
3㧕 ⎇ⓥઍ⴫⠪㧦᫪↰໪ਯ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(C)㧦⿠┙૕ᕈૐਅߦ߅ߌࠆ೨ᐸ♽ߩ㑐ਈ㧧ᐔᚑ 20㧙22 ᐕᐲ㧧(1,690 ජ౞)
4㧕 ⎇ⓥઍ⴫⠪㧦቟ㇱജ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄․೎⎇ⓥຬᅑബ⾌㧦㊀ജⅣႺᄌൻߦኻߔࠆ↢૕ㆡᔕ࡮዁᧪᦬㕙ၮ࿾ߢ↢ᵴߔࠆߚ߼ߦ㧧ᐔᚑ 20㧙21 ᐕᐲ㧧1,600 ජ౞(800㧦800 ජ౞)
5㧕 ⎇ⓥಽᜂ⠪㧦᫪↰໪ਯ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(C)㧦ⷞᐥਅㇱߦ߅ߌࠆ㘩᰼ਛᨔߩ MRI
ߦࠃࠆ 3 ᰴర↹௝ൻߦ㑐ߔࠆ⎇ⓥ㧧ᐔᚑ 20 ᐕᐲ㧧650 ජ౞
2㧕ฃ⸤⎇ⓥ1㧕 ᫪↰໪ਯ㧦ᷓㇱ㕒⣂ⴊᵹㅦᐲࠍჇടߐߖࠆᦨㆡೝỗࡄ࠲࡯ࡦߩ⸃᣿ߣೝỗⵝ⟎ߩ㐿⊒㧧ᐔᚑ 18 ᐕ
ᐲ㧧1,000 ජ౞㧦ࠝࡓࡠࡦࡋ࡞ࠬࠤࠕᩣᑼળ␠
3㧕౒ห⎇ⓥ1㧕 ᫪↰໪ਯ㧦⥄േゞ↪ࠪ࡯࠻ߩ㐳ᤨ㑆⌕ᐳߦ߅ߌࠆ∋ഭߩ⸃᣿㧧ᐔᚑ 18 ᐕᐲ㧧5,250 ජ౞㧦࠻࡛࠲⥄േゞᩣᑼળ␠
2㧕 ᫪↰໪ਯ㧦ゞਔౝⵝຠ߇ੱ૕ߦ෸߷ߔᓇ㗀㧧ᐔᚑ 18 ᐕᐲ㧧710 ජ౞㧦࠻࡛࠲⚜❱ᩣᑼળ␠3㧕 ᫪↰໪ਯ㧦⥄േゞ↪ࠪ࡯࠻ߩ㐳ᤨ㑆⌕ᐳߦ߅ߌࠆ∋ഭߩ⸃᣿㧧ᐔᚑ 19 ᐕᐲ㧧5,500 ජ౞㧦࠻࡛࠲⥄േゞᩣᑼળ␠
4㧕 ᫪↰໪ਯ㧦ゞਔౝⵝຠ߇ੱ૕ߦ෸߷ߔᓇ㗀㧧ᐔᚑ 19 ᐕᐲ㧧836 ජ౞㧦࠻࡛࠲⚜❱ᩣᑼળ␠5㧕 ᫪↰໪ਯ㧦ࠗࡦࡊ࡜ࡦ࠻ᴦ≮ߦ↪޿ࠆ⿥㖸ᵄࠍ೑↪ߒߚⵝ⟎㐿⊒㧧ᐔᚑ 19 ᐕᐲ㧧740 ජ౞㧦ਣཅᎿᬺᩣᑼળ␠
6㧕 ᫪↰໪ਯ㧦ᐔᚑ 19 ᐕᐲᰴ਎ઍవ┵ቝቮ᦯ⷐ⚛ᛛⴚ㧔ࠣࡠ࡯ࡉ㧕ߩ⎇ⓥ㧧ᐔᚑ 19 ᐕᐲ㧧595,160 ౞㧦⁛┙ⴕ᡽ᴺੱቝቮ⥶ⓨ⎇ⓥ㐿⊒ᯏ᭴
7㧕 ᫪↰໪ਯ㧦⥄ὼ⑼ቇ⎇ⓥᯏ᭴↢ℂቇ⎇ⓥᚲ౒ห೑↪⎇ⓥ㧧ᐔᚑ 20 ᐕᐲ㧧600 ජ౞㧦⥄ὼ⑼ቇ⎇ⓥᯏ
᭴8㧕 ᫪↰໪ਯ㧦⥄േゞ↪ࠪ࡯࠻ߩ㐳ᤨ㑆⌕ᐳߦ߅ߌࠆ∋ഭߩ⸃᣿㧧ᐔᚑ 20 ᐕᐲ㧧5,500 ජ౞㧦࠻࡛࠲⥄േゞᩣᑼળ␠
9㧕 ᫪↰໪ਯ㧦ゞਔౝⵝຠ߇ੱ૕ߦ෸߷ߔᓇ㗀㧧ᐔᚑ 20 ᐕᐲ㧧935 ජ౞㧦࠻࡛࠲⚜❱ᩣᑼળ␠
5㧚⊒᣿࡮․⸵಴㗿⁁ᴫ
1㧕 ጊ↰ብዏ㧘᫪↰໪ਯ㧘↰ਛ㇌ᒾ㧦⿠┙⵬ഥⵝ⟎㧧ᐔᚑ 18 ᐕᐲ
2㧕 ဈ᧲⋥ⴕ㧘ᚑἑື຦㧘⮮Ꮞ๋ᦶ㧘቟⮮ᢅᒄ㧘᧛਄᣿ብ㧘ጊ↰ብዏ㧘᫪↰໪ਯ㧘↰ਛ㇌ᒾ㧘᧲ᐣ⽕㧦ᐳ㕙㚟േᣂᯏ᭴㧧ᐔᚑ 19 ᐕᐲ
3㧕 ዊᩙᚑੱ㧘᫪↰໪ਯ㧘↰ਛ㇌ᒾ㧘቟ㇱജ㧦ࡈ࠶࠻࡟ࠬ࠻ⵝ⟎㧧ᐔᚑ 20 ᐕᐲ
4㧕 ဈ᧲⋥ⴕ㧘ጊ↰ብዏ㧘᫪↰໪ਯ㧘↰ਛ㇌ᒾ㧘᧲ᐣ⽕㧦⿠┙⵬ഥⵝ⟎ߩ㚟േᣇᑼ㧧ᐔᚑ 20 ᐕᐲ
6㧚ቇળᵴേ
1㧕ቇળᓎຬ᫪↰໪ਯ㧦
1㧕 ᣣᧄ∛ᘒ↢ℂቇળℂ੐(㨪⃻࿷)㧙㧙2㧕 ᣣᧄ↢ℂቇળ⹏⼏ຬ(㨪⃻࿷)3㧕 ᣣᧄቝቮ⥶ⓨⅣႺකቇળ⹏⼏ຬ(ᐔᚑ 19 ᐕᐲ㨪⃻࿷)
4㧕 ᣣᧄ⥄ᓞ␹⚻ቇળ⹏⼏ຬ(㨪⃻࿷)↰ਛ㇌ᒾ㧦1㧕 ᣣᧄ∛ᘒ↢ℂቇળ⹏⼏ຬ(㨪⃻࿷)2㧕 ᣣᧄ↢ℂቇળ⹏⼏ຬ(㨪⃻࿷)3㧕 ᣣᧄቝቮ⥶ⓨⅣႺකቇળ⹏⼏ຬ(ᐔᚑ 19 ᐕᐲ㨪⃻࿷)2㧕ቇળ㐿௅
ߥߒ
3㧕ቇⴚ㔀⹹
ߥߒ
7㧚ቇળ᜗ᓙ⻠Ṷ㧘᜗ᓙࠪࡦࡐࠫࠬ࠻㧘ᐳ㐳᫪↰໪ਯ㧦
1㧕 International Society for Gravitational Physiology(ᐔᚑ 18 ᐕ 4 ᦬㧘Osaka㧘Invited Symposium:
Role of the vestibular system in arterial pressure response to gravitational stress; ᐳ㐳㧘Ṷ⠪)
2㧕 International Congress of Pathophysiology (ᐔᚑ 18 ᐕ 6 ᦬㧘Beijing㧘Invited Symposium: Role ofthe vestibular system in cardiovascular responses to gravitational stress; Ṷ⠪)3㧕 ╙ 52 ࿁ᣣᧄቝቮ⥶ⓨⅣႺකቇળᄢળ(ᐔᚑ 18 ᐕ 11 ᦬㧘☨ሶ㧘ᢎ⢒⻠Ṷ‫ޟ‬㊀ജᄌൻᤨߩⴊ࿶⺞▵ߦ߅ߌࠆ೨ᐸ♽ߩᓎഀߣߘߩน႟ᕈ‫ޠ‬Ṷ⠪)
4㧕 International Space Medicine Symposium in Sapporo(ᐔᚑ 19 ᐕ 2 ᦬㧘Sapporo, Plastic alterationof vestibulo-cardiovascular system induced by different gravitational environment; Ṷ⠪)
5㧕 ╙ 84 ࿁ᣣᧄ↢ℂቇળᄢળ(ᐔᚑ 19 ᐕ 3 ᦬㧘Osaka㧘Feedforward arterial pressure control by thevestibular system; Ṷ⠪)
6㧕 ╙ 18 ࿁ᣣᧄ∛ᘒ↢ℂቇળᄢળ(ᐔᚑ 20 ᐕ 1 ᦬㧘␹ᚭ㧘ࠬ࠻࡟ࠬ⎇ⓥߩᣂዷ㐿㧙∛ᘒ↢ℂቇ⊛ⷞὐ߆ࠄߩࠕࡊࡠ࡯࠴‫ޟ‬㊀ജࠬ࠻࡟ࠬߦኻߔࠆᓴⅣ⺞▵㧙೨ᐸ♽ߩᓎഀߣߘߩน႟ᕈ‫ޠ‬ᐳ㐳㧘Ṷ⠪)7㧕 ╙ 85 ࿁ᣣᧄ↢ℂቇળᄢળ(ᐔᚑ 20 ᐕ 3 ᦬㧘Tokyo, Approach to whole body-New stream to study
autonomic nervous and neuroendocrine system: Autonomic control of arterial pressure during
gravitational stress; ᐳ㐳㧘Ṷ⠪)8㧕 ╙ 85 ࿁ᣣᧄ↢ℂቇળᄢળ(ᐔᚑ 20 ᐕ 3 ᦬㧘᧲੩㧘ᢎ⢒ᆔຬળࠪࡦࡐࠫ࠙ࡓ ↢ℂቇળࡕ࠺࡞⻠⟵‫ޟ‬ᔃ࡮ᓴⅣ♽‫ޠ‬Ṷ⠪)9㧕 ╙ 85 ࿁ᣣᧄ↢ℂቇળᄢળ(ᐔᚑ 20 ᐕ 3 ᦬㧘Tokyo, Pathophysiology of deep venous thrombosis andits prophylaxis: Property of lower limbs venous hemodynamics and risk for deep veinthrombosis; ᐳ㐳㧘Ṷ⠪)10㧕 ᣣᧄ㤗㈮⑼ቇળ╙ 55 ࿁ቇⴚ㓸ળ(ᐔᚑ 20 ᐕ 6 ᦬㧘ᮮᵿ㧘ᢎ⢒⻠Ṷ‫ޟ‬ቝቮⓨ㑆ߣᓴⅣ↢ℂ㧙㊀ജᄌൻߦኻߔࠆᔕ╵‫ޠ‬Ṷ⠪)↰ਛ㇌ᒾ㧦
1㧕 International Congress of Pathophysiology(ᐔᚑ 18 ᐕ 6 ᦬, Beijing, Symposium: Correlation
Between Compliance and high frequency centroid of pressure waveform in the abdominal aorta.;Ṷ⠪)2㧕 ᒻߩ⑼ቇળ ᒻࠪࡘ࡯࡟ 2006(ᐔᚑ 18 ᐕ 9 ᦬ ጘ㒂㧘᜗ᓙ⻠Ṷ‫ޟ‬⡊ߣⴊ࿶ߣቝቮකቇ‫ޠ‬Ṷ⠪)8㧚ቇⴚ⾨╬ߩฃ⾨⁁ᴫ1㧕 ቟ㇱജ㧦ᣣᧄ∛ᘒ↢ℂቇળᅑബ⾨(ᐔᚑ 20 ᐕᐲ)
9㧚␠ળᵴേ᫪↰໪ਯ㧦
1㧕 ᣣᧄቇⴚᝄ⥝ળ⑼ቇ⎇ⓥ⾌ᆔຬળኾ㐷ᆔຬ(ᐔᚑ 18 ᐕᐲ㧘ᐔᚑ 20 ᐕᐲ)
2㧕 ࠰࡞࠻ࠨࠗࠛࡦࠬ⎇ⓥ⽷࿅⎇ⓥㆇ༡ክ⼏ળᆔຬ(㨪⃻࿷)㧙㧙10㧚ႎ๔ᦠ
1㧕 ᫪↰໪ਯ㧦ᐔᚑ 15 ᐕᐲ㧙17 ᐕᐲ⑼ቇ⎇ⓥ⾌⵬ഥ㊄ၮ⋚⎇ⓥ(B)(2)⎇ⓥᚑᨐႎ๔ᦠ㧦㐳ᦼ㑆㊀ജᄌൻߦኻߔࠆᓴⅣ㧘⥄ᓞ␹⚻㧘ਛᨔᔕ╵ߩࡕ࠺࡞૞ᚑ(2006 ᐕ 3 ᦬)
2㧕 ᫪↰໪ਯ㧦╙ 8 ࿁㧔ᐔᚑ 17 ᐕᐲ㧙19 ᐕᐲ㧕ㆬቯቝቮⅣႺ೑↪ߦ㑐ߔࠆ౏൐࿾਄⎇ⓥᚑᨐႎ๔ᦠ㧦೨ᐸ㧙േ⣂ⴊ࿶⺞▵♽ߩน႟ᕈߦ㑐ߔࠆၮ␆⊛߅ࠃ߮⥃ᐥ⊛⎇ⓥ(2008 ᐕ 7 ᦬)
3㧕 ↰ਛ㇌ᒾ㧘᫪↰໪ਯ㧦ᐔᚑ 19 ᐕᐲᰴ਎ઍవ┵ቝቮ᦯ⷐ⚛ᛛⴚ㧔ࠣࡠ࡯ࡉ㧕ߩ⎇ⓥ11㧚ႎ㆏
1㧕 ᫪↰໪ਯ㧦‫ⴊޟ‬ᩖ∝㕦ਅߢ੍㒐㧦㔚ᵹߢ╭⡺ೝỗ‫ޠ‬㧦ᦺᣣᣂ⡞(2006 ᐕ 1 ᦬ 10 ᣣ)
2㧕 ↰ਛ㇌ᒾ㧦㐿ዪ 7 ๟ᐕ⸥ᔨ⇟⚵‫ޟ‬The Moon‫ޠ‬㧦ᰴ਎ઍ࿖↥ቝቮ᦯㐿⊒㧦BS ࠫࡖࡄࡦ(2008 ᐕ 3 ᦬ 8ᣣ)12㧚⥄Ꮖ⹏ଔ
⹏ଔ
ᐔᚑ 17~19 ᐕᐲߦᄢቇ㒮↢ߣߒߡ࿷ቇߒߚቇ↢ߪ㧘ᄢቇ㒮තᬺᓟ㧘ᣣᧄቇⴚᝄ⥝ળ․೎⎇ⓥຬߣߒߡ
↢ℂቇಽ㊁ߢ⎇ⓥࠍ⛮⛯ߒߡ޿ࠆ‫ߚ߹ޕ‬㧘ઁᄢቇߩකቇㇱቇ↢ߩၮ␆㈩ዻࠍᒁ߈ฃߌߚ‫ߩߘޕ‬ቇ↢ߪ㧘තᓟ⎇ୃవߣߒߡጘ㒂ᄢቇࠍㆬᛯߒ㧘⎇ୃ⚳ੌᓟጘ㒂ᄢቇᄢቇ㒮කቇ♽⎇ⓥ⑼ߦ౉ቇ੍ቯߢ޽ࠆ‫ޕ‬ၮ␆කቇ♽ߩᷓೞߥ⧯ᚻ⎇ⓥ⠪ਇ⿷߆ࠄ㐓ߺߡ㧘ዊߐߥ⧘ߢ޽ࠆ߇⧯ᚻ⎇ⓥ⠪ࠍฃߌ౉ࠇࠄࠇࠆ⎇ⓥⅣႺࠍᢛ߃ߟߟ޽ࠆߎߣߪ⹏ଔߦ୯ߔࠆ‫ߚ߹ޕ‬㧘ጘ㒂ᄢቇઁቇㇱߩቇㇱቇ↢߿ᄢቇ㒮↢߳ߩ⎇ⓥᜰዉ߽Ⓧᭂ⊛ߦⴕ޿㧘ቇㇱߩᨒࠍ⿥߃ߚ⎇ⓥᵴേࠍᐢߍߟߟ޽ࠆ‫ޕ‬⃻⁁ߩ໧㗴ὐ෸߮ߘߩኻᔕ╷ᚒ‫߇ޘ‬ቇ↢ߩ㗃㧘ᄢቇߢ௛ߊᢎቭ㧘⎇ⓥ⠪ࠍ⷗ߡ㧘‫ޟ‬ᭉߒߘ߁ߛߥ࡯㧘௢ߚߜ߽ᄢቇߢ௛߈ߚ޿ߥ࡯‫ޠ‬ߣᙏࠇߚ߽ߩߢ޽ࠆ‫ߡߒߚߪޕ‬㧘⃻࿷ߩቇ↢߇ᚒ‫ߩޘ‬ᆫࠍ⷗ߡ㧘‫ޟ‬ᭉߒߘ߁ߛߥ࡯㧘௢ߚߜ߽ᄢቇߦᱷࠅ
ߚ޿㧘⎇ⓥߒߡߺߚ޿‫ߣޠ‬ᕁߞߡߊࠇࠆ߆㧫ᄙಽ㧘no ߢ޽ࠈ߁‫߽ᦨ߇ߣߎߩߎޕ‬ᷓೞߥ໧㗴ߢ޽ࠆ‫ޕ‬ኻᔕ╷㧦ࡑ࡯ࡏ࠴ࡏ࠴ᭉߒߊ߿ࠅ߹ߔ‫ޕ‬੹ᓟߩዷᦸ੹ᓟ߽ߎࠇ߹ߢห᭽㧘⛔ว⊛ⷞὐߦ┙ߜ㧘⥄ᓞ␹⚻♽㧘ᔃ࡮ᓴⅣ♽㧘ਛᨔ␹⚻♽ߩࠪࠬ࠹ࡓ⸃ᨆࠍⴕ
޿㧘ᦨ⚳⊛ߦߪ㧘⸃ᨆ࠺࡯࠲ࠍၮߦߎࠇࠄߩᯏ⢻ࠍᢙቇ⊛ߦ⸥ㅀߒ㧘↢૕ࠍ೙ᓮߔࠆߎߣࠍ⋡ᮡߣߔࠆ‫ޕ‬ක↪Ꮏቇ޽ࠆ޿ߪౣ↢කቇߩᛛⴚࠍ↪޿㧘ᄬࠊࠇߚ⤳ེᯏ⢻ࠍ࿁ᓳߐߖࠆߎߣ߇⃻ታ๧ࠍ߅߮ߡ߈ߚ‫ޕ‬ߒ߆ߒ㧘ߎࠇࠄߩᛛⴚࠍ↪޿ߡ૞ᚑߐࠇߚੱᎿ⤳ེߪ㧘↢૕ᧄ᧪ߩ೙ᓮ♽߆ࠄਵ㔌ߔࠆน⢻ᕈ߇޽ࠆ‫ޕ‬ᓥߞߡ㧘ੱᎿ⤳ེ߇ቢᚑߒߚᰴߩᲑ㓏ߣߒߡ㧘ߎࠇࠄߩ⤳ེࠍߤߩࠃ߁ߦ೙ᓮߔࠆ߆߇㎛ࠍីࠆᛛⴚߣ
ߥࠆ‫ޕ‬ᚒ‫⸃ࡓ࠹ࠬࠪࠆ޿ߡߞⴕߩޘ‬ᨆᚻᴺࠍ↪޿ߚ↢૕⎇ⓥߪ㧘ߎࠇࠄߩ⤳ེࠍ೙ᓮߔࠆࡁ࠙ࡂ࠙ࠍឭ
ଏߔࠆ߽ߩߣ⏕ାߔࠆ‫ޕ‬㧙㧙㧔3㧕ࠬࡐ࡯࠷ක⑼ቇಽ㊁1㧚⎇ⓥߩ᭎ⷐ
⇣ߥࠆⅣႺਅߦ߅޿ߡㆇേࠍⴕ߁ߎߣߦࠃࠆߐ߹ߑ߹ߥ↢ℂ⊛ᄌൻߦߟ޿ߡߩ⎇ⓥࠍⴕߞߡ޿ࠆ‫ޕ‬߅߽ߥ⎇ⓥ࠹࡯ࡑߪ
1㧕ㄭ⿒ᄖ✢ಽశᴺࠍ↪޿ߡ㧘㜞࿾߹ߚߪૐ㉄⚛ⅣႺߦ߅ߌࠆㆇേ߇╭ౝ㉄⚛േᘒߦ෸߷ߔᓇ㗀
2㧕ㆇേ߇⥄ᓞ␹⚻♽ߦ෸߷ߔᓇ㗀
3㧕㜞㦂⠪ߩᐔⴧᯏ⢻ߦ㑐ߔࠆ⎇ⓥ
4㧕⊓ጊߦ߅ߌࠆකቇ⊛ࠟࠗ࠼࡜ࠗࡦ૞ᚑߦะߌߚၮ␆⊛⎇ⓥߘߩઁߦߪ㜞㦂⠪ߩ⠌ᘠ⊛ߥㆇേ߇ᱠⴕ⢻ജ㧘ోりߩ╭⡺㊂㧘ᐔⴧᯏ⢻ߦ෸߷ߔᓇ㗀ߩ⎇ⓥࠍⴕ޿㧘ㆇേᒝᐲ࡮㗫ᐲߩ㆑޿߇り૕ߦਈ߃ࠆᓇ㗀ߦߟ޿ߡ⎇ⓥࠍⴕߞߡ޿ࠆ‫ޕ‬
2㧚ฬ★
ᢎ᝼㧦
⻠Ꮷ㧦
ഥᢎ㧦

᧻ጟᢅ↵
㐳ፒᐘ㓶
ട⮮⟵ᒄ

Toshio Matsuoka
Sachio Nagasaki
Yoshihiro Kato

3㧚⎇ⓥᚑᨐߩ⊒⴫⪺ᦠ㧔๺ᢥ㧕
ߥߒ⪺ᦠ㧔᰷ᢥ㧕
ߥߒ✚⺑㧔๺ᢥ㧕
ߥߒ✚⺑㧔᰷ᢥ㧕
ߥߒේ⪺㧔๺ᢥ㧕
1㧕 ዊᩙ๺㓶㧘ട⮮⟵ᒄ㧘㤥Ꮉᷕ৻㧘੗਄ᐢ࿖㧘ᷰㄝ㇚㓶㧘᧻ጟᢅ↵㧚㜞ᩞ 1 ᐕ↢↵ᅚߦ߅ߌࠆ㓝ࠇ⢈ḩ⠪ߩⴊᷡ⢽⾰ᕈ⁁㧘૕ജ⑼ቇ 2006 ᐕ㧧55 Ꮞ㧦155㧙164㧚
2㧕 ᣁℙ㧘㐳ፒᐘ㓶㧘ᳯଐᴺ㧘ട⮮⟵ᒄ㧘ฎ↰ༀષ㧘᧻ጟᢅ↵㧚┙૏ᆫ൓ᤨߩり૕േំ೙ᓮ߅ࠃ߮ⷞⷡߩᓇ㗀ߦߟ޿ߡ㧘૕ജ⑼ቇ 2006 ᐕ㧧55㧦469㧙476㧚
3㧕 㐳ፒᐘ㓶㧘ᳯଐᴺ㧘ᣁℙ㧘ᧁ᧛⧷♿㧘ࡒ࡞ࡏ࠼࡮࠮ࠗ࠼࡮ࡕࡂࡑ࠼㧘ട⮮⟵ᒄ㧘᧻ጟᢅ↵㧘ฎ↰ༀષ㧚㛽⋚ߩേജቇࡕ࠺࡞ߦၮߠߊࡅ࠻⥄ὼ┙૏ᤨり૕േំߩ⸃ᨆ㧘ᢎ⢒කቇ 2006 ᐕ㧧51 Ꮞ㧦242㧙252㧚
4㧕 ട⮮⟵ᒄ㧘᧻ጟᢅ↵㧘ၔᒉ⍮ᳯ㧘㜞⷗೰㧚࿖ౝ⊓ጊߢߩ㜞ጊ∛㧙ᅏⓄ㜞⸻≮ᚲߢߩ⚻㛎ࠃࠅ㧙㧘ᣣᧄක੐ᣂႎ 2006 ᐕ㧧4286 ภ㧦66㧙70㧚
5㧕 ᳯଐᴺ㧘㐳ፒᐘ㓶㧘ኹፉᱜᏆ㧘ᧁ᧛⧷♿㧚ࡅ࠻ᐔⴧ⢻ജߦ㑐ߔࠆ⎇ⓥ㧦ォୟ੍㒐ߦะߌߡ㧘ੱ㑆⑔␩ቇળ⹹ 2006 ᐕ㧧6 Ꮞ㧦58㧙62㧚
6㧕 Ꮉἑ᥍⟤㧘ᣧᎹᕶᳯ㧘ട⮮⟵ᒄ㧘᧻ጟᢅ↵㧘ᷡፉḩ㧚╭ࠫࠬ࠻ࡠࡈࠖ࡯ᖚ⠪ߦ߅ߌࠆᔃቶᕈᦼᄖ෼❗ߩ㊀∝ᐲಽ㘃ߣฦ⒳ࡄ࡜ࡔ࡯࠲࡯ᬌᩏ⚿ᨐߩ㑐ଥᬌ⸛㧘කቇᬌᩏ 2006 ᐕ㧧55 Ꮞ㧦639㧙643㧚
7㧕 㤥Ꮉᷕ৻㧘ዊᩙ๺㓶㧘ട⮮⟵ᒄ㧘੗਄⌀ੱ㧘’㊁๺ᒾ㧘ᷰㄝ㇚㓶㧘᧻ጟᢅ↵㧚㘧㛗ᓮᎪ㜞ේ㜞ᚲ࠻࡟࡯࠾
ࡦࠣวኋߦ߅ߌࠆ 3 ᐕ㑆ߩ POMS ૶↪⚻㛎㧘⥃ᐥࠬࡐ࡯࠷කቇ 2007 ᐕ㧧15 Ꮞ㧦291㧙296㧚
8㧕 ട⮮⟵ᒄ㧘ᄢᐔᐘሶ㧘᧻ጟᢅ↵㧘ᷰㆻ㇚㓶㧚࠻࡟࠶ࠠࡦࠣߩഞ⟋̆ૐ࿶ૐ㉄⚛ⅣႺߣ㜞ጊ∛̆㧘଻ஜߩ⑼ቇ 2007 ᐕ㧧49 Ꮞ㧦541㧙544㧚
9㧕 ᄢᐔᐘሶ㧘ട⮮⟵ᒄ㧘᧻ጟᢅ↵㧘㜞⷗೰㧚ਛ㜞ᐕ⊓ጊ⠪ߩታᘒ⺞ᩏ̆ᅏⓄ㜞ጪ⊓ጊ⠪ࠍኻ⽎ߣߒߡ࡯㧘⊓ጊකቇ 2007 ᐕ㧧27 Ꮞ㧦39㧙42㧚
10㧕 ᳯଐᴺ, 㐳ፒᐘ㓶, ኹፉᱜᏆ, ᧁ᧛⧷♿. ᜛ᢔࡕ࠺࡞ߦࠃࠆାภߩᚑಽಽᨆߣ⥄ᓞ␹⚻♽ᯏ⢻⹏ଔ߳ߩᔕ↪,ੱ㑆⑔␩ቇળ⹹ 2008 ᐕ㧧7 Ꮞ㧦107㧙112㧚
11㧕 ട⮮⟵ᒄ㧘ᄢᐔᐘሶ㧘᧻ጟᢅ↵㧚ᶏᄖᷰ⥶⠪㑐ㅪ∔ᖚߩኻ╷㧙㜞ጊ∛㧙㧘⥃ᐥߣ⎇ⓥ 2008 ᐕ㧧85 Ꮞ 9ภ㧦19㧙22㧚
12㧕 ᷰㆺᕡᄦ, ᫪↰✍ሶ, ቝ㊁↱㉿ሶ, ᨋᕶሶ, Ꮉἑ᥍⟤, ട⮮⟵ᒄ, ᧻ጟᢅ↵, દ⮮ᒄᐽ, ᷡፉḩ㧚ዊఽߦ߅ߌ
ࠆ⢽⢌⢄ߣࡊ࡟ࡔ࠲ࡏ࡝࠶ࠢࠪࡦ࠼ࡠ࡯ࡓߩ㑐ㅪᕈߦߟ޿ߡ㧘⿥㖸ᵄᬌᩏᛛⴚ 2008 ᐕ㧧33 Ꮞ㧦18㧙25㧚
13㧕 ട⮮⟵ᒄ, ᄢᐔᐘሶ, ၔᒉ⍮ᳯ, ᧻ጟᢅ↵㧚ᓮᎪ⚃⪲⊓ጊෳട⠪ߩࡔ࠺ࠖࠞ࡞࠴ࠚ࠶ࠢ㧘⊓ጊකቇ 2008ᐕ㧧28 Ꮞ㧦135㧙140㧚
14㧕 ጯ㗅ᴦ, ㋈ᧁჽ, 㤥Ꮉᷕ৻, 㜞ᯅᱜ♿, ᧻ጟᢅ↵㧚General Health Questionnaire(GHQ)߆ࠄߺߚࠕࠬ࡝࡯
࠻ߩ♖␹ஜᐽᐲߩ․ᓽ㧘ጘ㒂⚻ᷣᄢቇ⺰㓸 2008 ᐕ㧧41 Ꮞ㧦25㧙36㧚㧙㧙

15㧕 ⮳ᧄ଻, ⑔ንᖈ, ⷏᧛ᱜ᣿, ጤ⿧ᐽ⌀, ᩊ↰␭ᨐ, ᷰㆻ㓶੺, ฎ↰ༀષ, ੹੗৻, ᧻ጟᢅ↵㧚᛫㊀ജᆫ൓ᵴേ
ࠍਛᔃߣߒߚ࡝ࡂࡆ࡝࠹࡯࡚ࠪࡦ೨ᓟߦ߅ߌࠆ⣖ᕈ߹߭ఽߩ⥄ᓞ␹⚻♽ߩᄌൻߣஜᐽఽߣߩᲧセ, ℂቇ≮ᴺ⑼ቇ 2008 ᐕ㧧23 Ꮞ㧦647㧙651㧚
ේ⪺㧔᰷ᢥ㧕
1㧕 Jiang Y, Nagasaki S, Kimura H. A dynamic model of body sway control during upright stance inhuman. Jpn J Phys Fitness Sports Med. 2006;55:231-236.
2㧕 Jiang Y, Nagasaki S, Matsuura Y, Zhou J. Dynamic studies on human body sway by using a simple
model with special concerns on the pelvic and muscle roles. Asian J Control. 2006;8:297-306.
3㧕 Kazuo Oguri, Hajime Fujimoto, Hiroyuki Sugimori, Kei Miyamoto, Toshiki Tachi, Sachio
Nagasaki,Yoshihiro Kato, Toshio Matsuoka, Pronouced muscle deoxygenation during supramaximal
exercise under simulated hypoxia in sprint athletes. J Sports Sci Med. 2008;3:182-189.

4㧚⎇ⓥ⾌₪ᓧ⁁ᴫ
1㧕┹੎⊛⾗㊄1㧕 ⎇ⓥઍ⴫⠪㧦᧻ጟᢅ↵㧧⁛┙ⴕ᡽ᴺੱᣣᧄቇⴚᝄ⥝ળ⑼ቇ⎇ⓥ⾌⵬ഥ㊄ၮ⋚⎇ⓥ(C)㧦㜞࿾ⅣႺਅߩή㉄⚛ᕈㆇേ߇╭ౝ㉄⚛േᘒߦ෸߷ߔᓇ㗀㧧ᐔᚑ 17㧙18 ᐕᐲ㧧3,700 ජ౞(3,100㧦600 ජ౞)
2㧕 ⎇ⓥઍ⴫⠪㧦ട⮮⟵ᒄ㧧⁛┙ⴕ᡽ᴺੱᣣᧄቇⴚᝄ⥝ળ⑼ቇ⎇ⓥ⾌⵬ഥ㊄ၮ⋚⎇ⓥ(C)㧦ਛ㜞ᐕ⊓ጊ⠪ߩߚ߼ߩකቇ⊛ࠟࠗ࠼࡜ࠗࡦ૞ᚑߦะߌߚၮ␆⊛⎇ⓥ㧧ᐔᚑ 18㧙19 ᐕᐲ㧧2,200 ජ౞(1,000㧦1,200ජ౞)
3㧕 ⎇ⓥઍ⴫⠪㧦᧻ጟᢅ↵㧧⁛┙ⴕ᡽ᴺੱᣣᧄቇⴚᝄ⥝ળ⑼ቇ⎇ⓥ⾌⵬ഥ㊄ၮ⋚⎇ⓥ(C)㧦ਛ࡮㜞㦂⠪ߩૐ㉄⚛ⅣႺਅ㧔ૐ㉄⚛ቶ㧕ߩㆇേ߇ࠛࡀ࡞ࠡ࡯ᶖ⾌㊂෸߮╭ߦ෸߷ߔᓇ㗀㧧ᐔᚑ 19㧙20 ᐕᐲ㧧2,860
ජ౞(1,560㧦1,300 ජ౞)
2㧕ฃ⸤⎇ⓥߥߒ
3㧕౒ห⎇ⓥߥߒ
5㧚⊒᣿࡮․⸵಴㗿⁁ᴫߥߒ
6㧚ቇળᵴേ
1㧕ቇળᓎຬ᧻ጟᢅ↵㧦
1㧕 ᣣᧄᢎ⢒කቇળ⹏⼏ຬ(㨪⃻࿷)㐳ፒᐘ㓶㧦1㧕 ᣣᧄ↢ℂቇળ⹏⼏ຬ(㨪⃻࿷)2㧕 ᣣᧄㆇേ↢ℂቇળ⹏⼏ຬ(㨪⃻࿷)3㧕 ᣣᧄᢎ⢒කቇળ⹏⼏ຬ(㨪⃻࿷)ട⮮⟵ᒄ㧦1㧕 ᣣᧄ⥃ᐥࠬࡐ࡯࠷කቇળ⹏⼏ຬ(㨪⃻࿷)2㧕 ⧯ᐕ⠪ᔃ∔ᖚኻ╷ද⼏ળ⹏⼏ຬ(㨪⃻࿷)2㧕ቇળ㐿௅
1㧕 ╙ 4 ࿁ 2006 ᐕጘ㒂ࠕࠬ࡟࠹ࠖ࠶ࠢ࡝ࡂࡆ࡝࠹࡯࡚ࠪࡦ⎇ⓥળ(ᐔᚑ 18 ᐕ 2 ᦬㧘ጘ㒂)2㧕 ╙ 5 ࿁ 2007 ᐕጘ㒂ࠕࠬ࡟࠹ࠖ࠶ࠢ࡝ࡂࡆ࡝࠹࡯࡚ࠪࡦ⎇ⓥળ(ᐔᚑ 19 ᐕ 2 ᦬㧘ጘ㒂)
3㧕 ╙ 6 ࿁ 2008 ᐕጘ㒂ࠕࠬ࡟࠹ࠖ࠶ࠢ࡝ࡂࡆ࡝࠹࡯࡚ࠪࡦ⎇ⓥળ(ᐔᚑ 20 ᐕ 2 ᦬㧘ጘ㒂)
3㧕ቇⴚ㔀⹹ߥߒ㧙㧙

7㧚ቇળ᜗ᓙ⻠Ṷ㧘᜗ᓙࠪࡦࡐࠫࠬ࠻㧘ᐳ㐳᧻ጟᢅ↵㧦
1㧕 ᐔᚑ 17 ᐕᐲࡆࠢ࠻࡝࡯ࠨࡒ࠶࠻(ᐔᚑ 18 ᐕ 2 ᦬㧘ጘ㒂㐳⦟Ꮉࠬࡐ࡯࠷ࡊ࡜ࠩ㧘㆏਄㕒㚅․೎⻠Ṷ‫ޟ‬ᣣᧄ࠹࠾ࠬㆬᚻߩ⢒ᚑ࡮ᒝൻ‫ޠ‬ᐳ㐳)2㧕 ╙ 10 ࿁ᣣᧄ૕ജකቇળ᧲ᶏ࿾ᣇળ(ᐔᚑ 18 ᐕ 3 ᦬㧘ᦺᣣᄢቇ㧘․೎⻠Ṷ‫ޟ‬り૕ߦ⴫⃻ߐࠇߚߎߎࠈ‫ޠ‬ᐳ㐳)3㧕 ጘ㒂⋵␠ળ଻㒾ㇱ(ᐔᚑ 18 ᐕ 8 ᦬㧘ጘ㒂㧘⻠Ṷ‫ޟ‬㜞㦂⠪ߩ૕ജߣߪ㧫ߤߩࠃ߁ߦ⹏ଔߔߴ߈߆㧫‫ޠ‬Ṷ⠪)
4㧕 นఽᏒஜᐽߠߊࠅㆇേ᥉෸ផㅴද⼏ળ(ᐔᚑ 18 ᐕ 10 ᦬㧘นఽ㧘⻠Ṷ‫ޟ‬ਛ㜞ᐕߩ↢ᵴ⠌ᘠ∛ߣㆇേ‫ޠ‬Ṷ⠪)5㧕 ጘ㒂⋵ஜᐽ⑔␩ㇱ(ᐔᚑ 18 ᐕ 8 ᦬㧘ጘ㒂㧘⻠Ṷ‫⥄ޟ‬ቛߢ◲න㧍ࠄߊࠄߊ╭ജ૕ᠲ‫ޠ‬Ṷ⠪)6㧕 ⪇᧲Ꮷ▸ᄢቇ૕⢒ஜᐽቇ㒮(ᐔᚑ 18 ᐕ 10 ᦬㧘ਛ࿖਄ᶏ㧘․೎⻠Ṷ‫ޟ‬ᣣᧄߦ߅ߌࠆ㜞ᚲ࠻࡟࡯࠾ࡦࠣ‫ޠ‬Ṷ⠪)7㧕 ฦോේᏒᢎ⢒ᆔຬળቇᩞᢎ⢒଻ஜળ(ᐔᚑ 18 ᐕ 11 ᦬㧘ጘ㒂㧘⻠Ṷ‫ޟ‬ஜᐽߣㆇേ‫ޠ‬Ṷ⠪)8㧕 ╙ 12 ࿁ᣣ࡮㖧ஜᐽᢎ⢒ࠪࡦࡐࠫ࠙ࡓ౗╙ 55 ࿁ᣣᧄᢎ⢒කቇળ(ᐔᚑ 19 ᐕ 8 ᦬㧘ฬฎደᏒ┙ᄢቇ㧘ࠪࡦࡐࠫ࠙ࡓᐳ㐳)9㧕 ฦോේᏒᢎ⢒ᆔຬળ(ᐔᚑ 19 ᐕ 9 ᦬㧘ጘ㒂㧘ࡄࡀ࡞࠺ࠖࠬࠞ࠶࡚ࠪࡦ‫੹ޟ‬ᣣ߆ࠄᆎ߼ࠃ߁ᣧኢᣧ⿠
߈ᦺߏߪࠎ‫ޠ‬Ṷ⠪)10㧕 ጘ㒂⋵ℂቇ≮ᴺቇળ(ᐔᚑ 20 ᐕ 3 ᦬㧘ጘ㒂㧘․೎⻠Ṷ‫ޟ‬㜞㦂⠪ߩㆇേߣ․ᕈ‫ޠ‬Ṷ⠪)11㧕 ጘ㒂ᄢቇࠪ࠾ࠕࠞ࡟࠶ࠫ(ᐔᚑ 20 ᐕ 10 ᦬㧘ጘ㒂㧘⻠Ṷ‫ޟ‬㜞㦂⠪ߩஜᐽߣ૕ജ‫ޠ‬Ṷ⠪)ട⮮⟵ᒄ㧦
1㧕 ╙ 10 ࿁ᣣᧄ૕ജකቇળ᧲ᶏ࿾ᣇળ(ᐔᚑ 18 ᐕ 3 ᦬㧘ᦺᣣᄢቇ㧘․೎⻠Ṷ‫ޟ‬ጘ㒂⋵ߦ߅ߌࠆࠬࡐ࡯࠷
⃻႐ߣࠬࡐ࡯࠷ක⑼ቇߩㅪ៤‫ޠ‬ᐳ㐳)8㧚ቇⴚ⾨╬ߩฃ⾨⁁ᴫߥߒ9㧚␠ળᵴേ᧻ጟᢅ↵㧦
1㧕 ᣣᧄቇⴚᝄ⥝⑼ቇ⎇ⓥ⾌ᆔຬળኾ㐷ᆔຬ(ᐔᚑ 19 ᐕᐲ㨪20 ᐕᐲ)
2㧕 ጘ㒂⋵૕⢒දળࠬࡐ࡯࠷ක⑼ቇකຬળᆔຬ(㨪⃻࿷)3㧕 ጘ㒂ࠕࠬ࡟࠹ࠖ࠶ࠢ࡝ࡂࡆ࡝࠹࡯࡚ࠪࡦ⎇ⓥળળ㐳(㨪⃻࿷)4㧕 ጘ㒂⋵࠻࡟࡯࠾ࡦࠣ⑼ቇ࠮ࡦ࠲࡯㜞࿾࠻࡟࡯࠾ࡦࠣࠬ࡯ࡄ࡯ࡃࠗࠩ࡯(㨪⃻࿷)5㧕 ጘ㒂⋵ஜᐽ㐳ኼ⽷࿅੍㒐੐ᬺࡕ࠺࡞ታᣉᡰេ੐ᬺࠕ࠼ࡃࠗࠩ࡯(ᐔᚑ 18 ᐕᐲ)
6㧕 ጘ㒂⋵㊁⃿ද⼏ળ⋧⺣ᓎ(ᐔᚑ 19 ᐕᐲ㨪⃻࿷)7㧕 ጘ㒂⋵කᏧળቇᩞᔃ⤳ᬌ⸻ᆔຬળᆔຬ(㨪⃻࿷)8㧕 ጘ㒂⋵ᔃ⣢∔ᖚኻ╷ᆔຬળᆔຬ(㨪⃻࿷)9㧕 ጘ㒂⋵࡜ࠣࡆ࡯ࡈ࠶࠻ࡏ࡯࡞දળℂ੐㐳(ᐔᚑ 19 ᐕᐲ㨪⃻࿷)10㧕 㑐⷏࡜ࠣࡆ࡯ࡈ࠶࠻ࡏ࡯࡞දળℂ੐(ᐔᚑ 19 ᐕᐲ)
11㧕 ጘ㒂᧲ᵗකቇ⎇ⓥળ਎⹤ੱ(ᐔᚑ 20 ᐕᐲ㨪⃻࿷)㐳ፒᐘ㓶㧦1㧕 ጘ㒂⋵ᨵ㆏දળක⑼ቇᆔຬ(㨪⃻࿷)2㧕 ጘ㒂⋵ቇ↢ᨵ㆏ㅪ⋖ℂ੐(㨪⃻࿷)ട⮮⟵ᒄ㧦1㧕 ጘ㒂⋵ࠬࡐ࡯࠷࠼ࠢ࠲࡯ද⼏ળℂ੐(㨪⃻࿷)2㧕 ጘ㒂⋵ቇ↢ᨵ㆏ㅪ⋖ℂ੐(㨪⃻࿷)3㧕 ጘ㒂⋵කᏧળᔃ⤳ᬌ⸻ᆔຬળᆔຬ(㨪⃻࿷)4㧕 ጘ㒂⋵කᏧળᔃ㔚࿑್ቯᆔຬળᆔຬ(㨪⃻࿷)5㧕 ጘ㒂⋵ᔃ⣢∔ᖚኻ╷ᆔຬળᆔຬ(㨪⃻࿷)6㧕 ጘ㒂⋵ᨵ㆏දળක⑼ቇᆔຬ(㨪⃻࿷)㧙㧙7㧕 ጘ㒂⋵૕⢒දળක⑼ቇකຬળᆔຬ(㨪⃻࿷)8㧕 ࠬ࠹ࠖ࠶ࠢ࡞ࡃ࠶ࠢࠬࡐ࡯࠷ࠢ࡜ࡉℂ੐(㨪⃻࿷)9㧕 ጘ㒂⋵࡜ࠣࡆ࡯දળකോᆔຬ(㨪⃻࿷)10㧚ႎ๔ᦠ
1㧕 㐳ፒᐘ㓶㧦㜞㦂⠪ߩᐔⴧ⢻ജߣォୟߩ㑐ଥ߅ࠃ߮ォୟ੍㒐ᴺߦ㑐ߔࠆ⎇ⓥ㧦ᐔᚑ 15 ᐕᐲ㧙17 ᐕᐲ⑼ቇ⎇ⓥ⾌⵬ഥ㊄ ၮ⋚⎇ⓥ(C)✚᜝ႎ๔ᦠ㧦1㧙58(2006 ᐕ 3 ᦬)
2㧕 ᧻ጟᢅ↵㧦㜞࿾ⅣႺਅߩή㉄⚛ᕈㆇേ߇╭ౝ㉄⚛േᘒߦ෸߷ߔᓇ㗀㧦⁛┙ⴕ᡽ᴺੱᣣᧄቇⴚᝄ⥝ળ⑼ቇ⎇ⓥ⾌⵬ഥ㊄ၮ⋚⎇ⓥ(C)✚᜝ႎ๔ᦠ㧦1㧙58(2008 ᐕ 3 ᦬)
11㧚ႎ㆏
1㧕 ᧻ጟᢅ↵㧦᳓ಽ៨ข㧦ጘ㒂⋵૕⢒දળࠬࡐ࡯࠷ක⑼ቇᆔຬળ࡟ࡐ࡯࠻(2007 ᐕ 3 ᦬)
12㧚⥄Ꮖ⹏ଔ
⹏ଔᢎ⢒ߦ㑐ߒߡߪ౒ㅢᢎ⢒㧘කቇㇱᢎ⢒ߦᄙᄢߥ⽸₂ࠍߒߡ޿ࠆ‫ࠍࠬ࡯ࠦ࡞ࠕ࡝࠻࡯ࡘ࠹ߚ߹ޕ‬ᜂᒰߒߡ߅ࠅ㧘໧㗴ߪߥ޿ߣᕁࠊࠇࠆ‫ޕ‬ᄖㇱ⾗㊄ߦ㑐ߒߡߪ⑼ቇ⎇ⓥ⾌ߪᲤᐕ₪ᓧߒߡ߅ࠅ㧘⋡ᮡߪ㆐ᚑߢ߈ߡ޿ࠆߣᕁࠊࠇࠆ‫ޕ‬ᄢቇߩᵴᕈൻ⚻⾌╬ߦ߽Ⓧᭂ⊛ߦᔕ൐ߒߡ޿ࠆ߇₪ᓧߢ߈ߡ޿ߥ޿‫ޕ‬ᅑቇነ㒝㊄ߦ㑐ߒߡߪᲤᐕหߓ
ߣߎࠈ߆ࠄ㗂޿ߡ޿ࠆ߇㧘ദജߒߡ޿ࠆ߇Ⴧടߔࠆ߹ߢߦߪ⥋ߞߡ޿ߥ޿‫ޕ‬໧㗴ὐߪ⺰ᢥᢙ߇․ߦ⧷ᢥߩ⺰ᢥᢙ߇ዋߥ޿ࠃ߁ߦᕁࠊࠇ㧘ദജࠍⷐߔࠆ‫ޕ‬ᄢቇ㒮↢ߪߎߎᢙᐕ౉ቇߒߡ޿ࠆ߇␠ળੱ౉ቇ↢߇ᄙߊ㧘૛ࠅᜰዉߢ߈ߡ߅ࠄߕ㧘⺰ᢥ߽ᦠߌߡ޿ߥ
޿‫੹ޕ‬ᓟߪߒߞ߆ࠅߒߚᜰዉ૕೙ߩਅߢᜰዉߔࠆߎߣ߇ᔅⷐߣᕁࠊࠇࠆ‫ޕ‬⃻⁁ߩ໧㗴ὐ෸߮ߘߩኻᔕ╷ࠬ࠲࠶ࡈ߇ዋߥ޿ߎߣߢ޽ࠆ‫ޕ‬ነઃ㊄߇ᄙߌࠇ߫㧘㓹↪ߔࠆߎߣ߽น⢻ߢ޽ࠆ߇㧘ߘߩ⾗㊄ߪਇน⢻ߦㄭ޿‫ޕ‬ቇᝄߩᄖ࿖ੱ․೎⎇ⓥ⠪ߥߤߩ൐㓸ߦኻߒߡ߽ᔕ൐ࠍߒߡ޿ࠆ߇㧘ੱ᧚⏕଻ߪ㔍ߒ޿‫ޕ‬ᄢቇ㒮↢߽ᤤ㑆ࠦ࡯ࠬߩੱ᧚⏕଻߇㊀ⷐߢ޽ࠆߣᕁࠊࠇࠆ‫ޕ‬੹ᓟߩዷᦸߎߎᢙᐕߪࠬࡐ࡯࠷ㆬᚻߩ┹ᛛജะ਄ࠍ⋡ᜰߔ⎇ⓥࠃࠅ㧘⊓ጊߦ㑐ߔࠆ⎇ⓥ߿㜞㦂⠪ߩᣣᏱ↢ᵴߢߩஜᐽჇㅴ㧘∔∛੍㒐ߦ㑐ߔࠆ㜞㦂⠪ࠍኻ⽎ߣߒߡ⎇ⓥࠍㅴ߼ߡ߅ࠅ㧘੍㒐කቇߦ߅ߌࠆࠬࡐ࡯࠷කቇߩ
㊀ⷐᕈࠍᮨ⚝ߒߡ޿ࠆ‫␠ߦࠄߐޕ‬ળ⊛ߦ⽸₂ߔߴ߈ߎߣߩ⎇ⓥࠍㅴ߼ߥߌࠇ߫ߣ⠨߃ߡ޿ࠆ‫ޕ‬㧙㧙㧔4㧕␹⚻ౝ⑼࡮⠧ᐕቇಽ㊁1㧚⎇ⓥߩ᭎ⷐ
ੱ㑆ߩዅ෩ࠍ౨ߔ⹺⍮ᯏ⢻߿ㆇേᯏ⢻ߩ㓚ኂࠍᒁ߈⿠ߎߔ⣖␹⚻♽ߩ∔ᖚߩᴦ≮ߪὶ⋲ߩ⊛ߢ޽ࠆ‫␹ޕ‬⚻♽ߩ㓚ኂ࿃ሶ㧘ୃᓳଦㅴ࿃ሶࠍ᣿ࠄ߆ߦߒߡᴦ≮߳ߩᔕ↪ࠍ߼ߑߒߡขࠅ⚵ࠎߢ߈ߚ‫৻ޕ‬ᣇ㧘␹⚻㔍∛߿㜞㦂␠ળࠍᡰ߃ࠆߚ߼ߦ㧘ක≮࡮⑔␩࡮଻ஜߩㅪ៤ࠍ⢒ߡࠆขࠅ⚵ߺ߽ߔߔ߼ߡ߈ߚ‫ޕ‬ᓥ᧪߆ࠄߩ‫❱⚵⚻␹ޟ‬㓚ኂᯏᐨߩ⸃᣿ߣୃᓳ࡮ౣ↢‫ߦޠ‬ᴪߞߡ㧘ࡔ࠲ࡠ࠴ࠝࡀࠗࡦ㑐ㅪ⎇ⓥ߇ᢥ⑼⋭ߩ⑼⎇(B)㧘ቇౝ⎇ⓥᵴᕈൻ⚻⾌㧘↥ቭቇ౒หផㅴ⚻⾌ࠍขᓧߒ㧘ᄢቇ㒮↢ߩ੤ᵹࠍㅢߓᄢቇ㑆ߩ౒ห⎇ⓥࠍᷓ߼ߡ߈ߚ‫∉఺ߩ♽⚻␹ޕ‬ቇ⊛㓚ኂᯏᐨߩ⸃᣿ࠍ⋡ᜰߒߚ᛫␹⚻᛫૕ߩ⹺⼂᛫ේߩᬌ⚝߇㧘ᢥ⑼⋭ߣෘഭ⋭ߩ⑼⎇㧘㜞ᯏ⢻ߩ LC-MS/MS ᯏེߩ౒ห೑↪ߦࠃߞߡㅴ᝞ߒ㧘৻ㇱߩ᛫ේ߇᣿ࠄ߆ߦߐࠇߚ‫⚻␹ޕ‬ᄌᕈ∔ᖚߩ⥄ᓞ␹⚻♽ᯏ⢻㓚ኂߦ㑐ߔࠆ࡙࠾࡯ࠢߥ⎇ⓥ߽ቇౝ⎇ⓥᵴᕈൻ⚻⾌ߣቇౝߩදജࠍᓧߡⴕࠊ
ࠇߡ߈ߚ‫ޕ‬ᢥ⑼⋭⑼⎇(⪚⧘)ߦࠃࠆ‫⚻␹ޟ‬㔍∛ᖚ⠪ߩ࠾࡯࠭ߦㆡวߒߚ IT ᯏེᵴ↪ߣᔃߩࡅࡘ࡯ࡑࡦࡀ
࠶࠻ࡢ࡯ࠢ‫ߪޠ‬㧘ቇౝ࡮࿾ၞߩ㑐ଥ⠪ࠍᏎ߈ㄟߺ⎇ⓥࠍㅢߓߡᄢ߈ߥੱߩベࠍ૞ࠆߦ⥋ߞߚ‫ޕ‬
2005 ᐕᐲ߆ࠄෘ↢ഭ௛⑼ቇ⎇ⓥ⾌⵬ഥ㊄㧘㔍ᴦᕈ∔ᖚస᦯⎇ⓥ੐ᬺ‫ޟ‬㊀∝㔍∛ᖚ⠪ߩ࿾ၞක≮૕೙ߩ᭴▽ߦ㑐ߔࠆ⎇ⓥ⃰‫ޠ‬㧘߅ࠃ߮ห⵬ഥ㊄㧘ߎߎࠈߩஜᐽ⑼ቇ⎇ⓥ੐ᬺ ‫ޟ‬ᕆᕈ⣖Ἳߩࠣ࡞࠲ࡒࡦ㉄ฃኈ૕⥄Ꮖ఺∉∛ᘒߩ⸃᣿߆ࠄᣂߚߥᴦ≮ᴺ⏕┙ߦะߌߚ⎇ⓥ⃰(ᕆᕈ⣖Ἳߩ⥄Ꮖ఺∉࡮ᴦ≮⎇ⓥ⃰)‫ߦޠ‬ෳടߔࠆߎߣߦߥߞߚ‫ߦࡦࡕࠬߦࠄߐޕ‬㑐ߔࠆ⺞ᩏ⎇ⓥ㧘ࡊ࡝ࠝࡦ∛ߦ㑐ߔࠆ⺞ᩏ⎇ⓥ߇ടࠊࠅ㧘ᒰ㒮ߩ㔍∛᜚ὐ∛㒮ᜰฬߣ⋧߹ߞߡⴕ᡽ࠍᏎ߈ㄟࠎߛ⋵ౝ␹⚻ౝ⑼ක≮ߩᢛ஻లታߦߟߥ߇ࠆ⎇ⓥ߇⛮⛯ਛߢ޽ࠆ‫ޕ‬
2㧚ฬ★
ᢎ᝼㧦
ಎᢎ᝼㧦
⥃ᐥ⻠Ꮷ㧦
⥃ᐥ⻠Ꮷ㧦
⥃ᐥ⻠Ꮷ㧦
කຬ㧦
කຬ㧦

›Ⴆ ⾆
଻૑ ഞ
↰ਛఝม
ᧁ᧛ᥙᄦ
ᨋ ␭৻
ᰞ੗ጪ㇢
ጊ↰ ᕺ

Takashi Inuzuka
Isao Hozumi
Yuji Tanaka
Akio Kimura
Yuichi Hayashi
Takeo Sakurai
Megumi Yamada

3㧚⎇ⓥᚑᨐߩ⊒⴫⪺ᦠ㧔๺ᢥ㧕
1㧕 ›Ⴆ ⾆㧚ற⣲≌ᕈ␹⚻∝୥⟲㧦ዊᨋ␽ᵏ࡮᳓Ỉ⧷ᵗ ✬㧚␹⚻∔ᖚ ᦨᣂߩᴦ≮ 2006-2008, ᧲੩㧦ධᳯၴ㧧
2006 ᐕ㧦292㧙294㧚
2㧕 ›Ⴆ ⾆㧚ౝ⑼∔ᖚߦ઻߁␹⚻㓚ኂ㧦ᬮ ㅴ ✬㧚⥃ᐥ∛ᘒቇ㧘᧲੩㧦NOUVELLE HIROKAWA㧧2006 ᐕ㧦
221㧙227㧚3㧕 ›Ⴆ ⾆㧚ࡄ࡯ࠠࡦ࠰ࡦ∛ߣࡄ࡯ࠠࡦ࠰ࡦ∝୥⟲㧦ᄢౝዄ⟵ ⋙ୃ㧚ᣣᏱ⸻≮ߦᵴ߆ߔ⠧ᐕ∛ࠟࠗ࠼ࡉ࠶ࠢ
╙ 6 Ꮞ 㜞㦂⠪ߦᄙ޿∔ᖚߩ⸻≮ߩታ㓙㧘᧲੩㧦ࡔࠫࠞ࡞ࡆࡘ࡯㧧2006 ᐕ㧦2㧙5㧚
4㧕 ↰ਛఝม㧘›Ⴆ ⾆㧚⢽ṁᕈࡆ࠲ࡒࡦᰳਲ∝ߩᴦ≮ߪ㧦ጟᧄᐘᏒ࡮᫜ᯅ♿ᄦ࡮᳓Ỉ⧷ᵗ ✬㧚 EBM ␹⚻∔ᖚߩᴦ≮ 2007-2008㧘᧲੩㧦ਛᄖකቇ␠㧧2007 ᐕ㧦293㧙301㧚
5㧕 ↰ਛఝม㧘›Ⴆ ⾆㧚࿷ቛ⚻▤ᩕ㙃೷ߩ⒳㘃ߣ․ᓽ㧦㒙ㇱᐽੑ ✬㧚␹⚻㔍∛ߩߔߴߡ㨪∝⁁࡮⸻ᢿ߆ࠄᦨ
వ┵ᴦ≮㧘⑔␩ߩታ㓙߹ߢ㧘᧲੩㧦ᣂ⥝කቇ಴ 㧧2007 ᐕ㧦331㧙341㧚
6㧕 ›Ⴆ ⾆㧚㗡∩㧦ᣣᧄ⠧ᐕකቇળ ✬㧚⠧ᐕකቇ࠹ࠠࠬ࠻ᡷ⸓╙ 3 㧘᧲੩㧦ࡔ࠵ࠞ࡞ࡆࡘ࡯␠㧧2008 ᐕ㧦
83㧙85㧚
7㧕 ›Ⴆ ⾆㧚⸒⺆㓚ኂ㧦ᣣᧄ⠧ᐕකቇળ ✬㧚⠧ᐕකቇ࠹ࠠࠬ࠻ᡷ⸓╙ 3 㧘᧲੩㧦ࡔ࠵ࠞ࡞ࡆࡘ࡯␠㧧2008ᐕ㧦95㧙96㧚8㧕 ›Ⴆ ⾆㧚ᱠⴕ㓚ኂ㧦ᣣᧄ⠧ᐕකቇળ ✬㧚⠧ᐕකቇ࠹ࠠࠬ࠻ᡷ⸓╙ 3 㧘᧲੩㧦ࡔ࠵ࠞ࡞ࡆࡘ࡯␠㧧2008ᐕ㧦101㧙103㧚
9㧕 ଻૑ ഞ㧚ᚻ⿷ߩߒ߮ࠇ㧦ᣣᧄ⠧ᐕකቇળ ✬㧚⠧ᐕකቇ࠹ࠠࠬ࠻ᡷ⸓╙ 3 㧘᧲੩㧦ࡔ࠵ࠞ࡞ࡆࡘ࡯␠㧧
2008 ᐕ㧦90㧙94㧚
10㧕 ↰ਛఝม㧘›Ⴆ ⾆㧚ᄙ⊒ᕈ⎬ൻ∝ߩ㐓೎⸻ᢿ㧦ศ⦟Ả৻ ✬㧚ᄙ⊒ᕈ⎬ൻ∝ߩ⸻ᢿߣᴦ≮㧘᧲੩㧦ᣂ⥝කቇ಴ 㧧2008 ᐕ㧦93㧙99㧚⪺ᦠ㧔᰷ᢥ㧕
ߥߒ✚⺑㧔๺ᢥ㧕
1㧕 ›Ⴆ ⾆㧚਄⌒┃ⵚ∝୥⟲㧦⌒┃వ┵∝୥⟲㧘Clinical Neuroscience 2007 ᐕ㧧25 Ꮞ㧦1030㧙1031㧚
2㧕 ᧁ᧛ᥙᄦ㧘଻૑ ഞ㧘㜞ᯅᐘ೑㧘›Ⴆ ⾆㧚᛫ GluR2 ᛫૕㓁ᕈᚑੱᕆᕈ⣖Ἳᖚ⠪ߩ⥃ᐥ⊛․ᓽߥࠄ߮ߦ఺

㧙㧙∉⚵❱ቇ⊛⸃ᨆ㧘කቇߩ޽ࠁߺ 2007 ᐕ㧧223 Ꮞ㧦300㧙301㧚
3㧕 ›Ⴆ ⾆㧚᛫␹⚻᛫૕㓁ᕈㄝ✼♽⣖Ἳߩ∛ᘒ㧘Clinical Neuroscience 2008 ᐕ㧧26 Ꮞ㧦506㧙507㧚
4㧕 ›Ⴆ ⾆㧘᪊↰㆏ੱ㧘ᰞ੗ጪ㇢㧘ศ㊁ ⧷㧘᦯ㇱ⋥᮸㧚ற⣲≌ᕈ␹⚻∝୥⟲ߩ⸻ᢿ࡮∛ℂ∛ᘒ࡮ᴦ≮㧘ᣣౝ
ળ⹹ 2008 ᐕ㧧97 Ꮞ㧦1855㧙1866㧚
5㧕 ଻૑ ഞ㧚ࡔ࠲ࡠ࠴ࠝࡀࠗࡦߣ␹⚻∔ᖚ-ᣂዷ㐿ߔࠆࡔ࠲ࡠ࠴ࠝࡀࠗࡦ⎇ⓥ-㧘කቇߩ޽ࠁߺ 2008 ᐕ㧧224
Ꮞ㧦482㧙483㧚
6㧕 ↰ਛఝม㧘›Ⴆ ⾆㧚ᧃ᪳␹⚻㓚ኂ(CIDP ࠍ฽߻)㧘Modern Physician 2008 ᐕ㧧28 Ꮞ㧦664㧙673㧚✚⺑㧔᰷ᢥ㧕
ߥߒේ⪺㧔๺ᢥ㧕
1㧕 ↰ਛఝม㧘⷏↰ ᶈ㧘ᨋ⇐⟤ሶ㧘›Ⴆ ⾆㧘ᄢᮎ⟤૫㧚ᕆᕈᢔ࿷ᕈ⣖⣄㜑Ἳߦࠃࠆ⣖᪞㔌ᢿ∝୥⟲㧘⥃ᐥ␹⚻ቇ 2006 ᐕ㧧46 Ꮞ㧦50㧙54㧚
2㧕 ↰ਛఝม㧘଻૑ ഞ㧘›Ⴆ ⾆㧚ᖡᕈ࡝ࡦࡄ⣲ߩ⚻ㆊਛߦᕆᕈゲ⚝㓚ኂဳᄙ⊒␹⚻Ἳࠍ߈ߚߒߚ 1 ଀㧘ᧃ᪳␹⚻ 2006 ᐕ㧧17 Ꮞ㧦225㧙227㧚
3㧕 ᧁ᧛ᥙᄦ㧘ᰞ੗ጪ㇢㧘㚅᧛ᓆብ㧘㋈ᧁᰵብ㧘↰ਛఝม㧘଻૑ ഞ㧘›Ⴆ ⾆㧚ᄙ⊒࠾ࡘ࡯ࡠࡄ࠴࡯ߦߡ⊒∝ߒ㧘㗡ㇱ MRI ਄ኻ⒓ᕈ߮߹ࠎᕈ∛Ꮍࠍ๒ߒߚ CNS ࡞࡯ࡊࠬߩ 1 ଀㧘Neuroimmunology 2006 ᐕ㧧14
Ꮞ㧦169㧙174㧚
4㧕 ᰞ੗ጪ㇢㧘ᧁ᧛ᥙᄦ㧘↰ਛఝม㧘଻૑ ഞ㧘›Ⴆ ⾆㧚ᕆᕈዊ⣖ᄬ⺞ߢ HIV ᗵᨴࠍ઻߁␹⚻᪢Ქߩ 1 ଀㧘␹⚻ౝ⑼ 2006 ᐕ㧧64 Ꮞ㧦609㧙613㧚
5㧕 ᫪↰ᶈਯ㧘ቝ㊁ཅᒄ㧘⍹Ⴆ㆐ᄦ㧘଻૑ ഞ㧘›Ⴆ ⾆㧚කቇ↢ߩ⸰໧⋴⼔૕㛎ታ⠌ߩ⹏ଔ㧘කቇᢎ⢒ 2006ᐕ㧧37 Ꮞ㧦311㧙315㧚
6㧕 ↰ਛఝม㧘⷏↰ ᶈ㧘›Ⴆ ⾆㧚㗖㜑⎬⤑ᄖ⤥≌ᓟߦ⣄㜑ⓨᵢᒻᚑࠍ߈ߚߒߚ 1 ଀㧘⥃ᐥ␹⚻ 2007 ᐕ㧧47
Ꮞ㧦90㧙95㧚
7㧕 ↰ਛఝม㧘⷏↰ ᶈ㧘›Ⴆ ⾆㧚⚻ᤨ⊛ MRA ߢਥᐙേ⣂ߩ㐽Ⴇࠍ⹺߼ߚ⚿ᩭᕈ㜑⤑Ἳߦࠃࠆ⣖᪪Ⴇ㧘⣖ත
ਛ 2007 ᐕ㧧29 Ꮞ㧦635㧙641㧚
8㧕 ᰞ੗ጪ㇢㧘ᧁ᧛ᥙᄦ㧘↰ਛఝม㧘଻૑ ഞ㧘ዊୖ⌀ᴦ㧘›Ⴆ ⾆㧚㓸ቇ⊛ೋᦼᴦ≮ߦࠃࠅᴦ≹ߒߚᚑੱࠗࡦ
ࡈ࡞ࠛࡦࠩ⣖∝ߩ 1 ଀㧘⥃ᐥ␹⚻ 2007 ᐕ㧧47 Ꮞ㧦639㧙643㧚
9㧕 ㋈ᧁ(ᱞ੗)⌀ℂሶ㧘ᨋ ␭৻㧘ᧁ᧛ᥙᄦ㧘᳗ᴛ ቞㧘㚅᧛ᓆብ㧘ᰞ੗ጪ㇢㧘↰ਛఝม㧘଻૑ ഞ㧘›Ⴆ ⾆㧚੺⼔ᓥ੐⠪ߦߺࠄࠇߚ᳓∧⣄㜑Ἳ㧘⣖ߣ␹⚻ 2008 ᐕ㧧60 Ꮞ㧦79㧙83㧚
10㧕 ᰞ੗ጪ㇢㧘↰ਛఝม㧘㚅᧛ᓆብ㧘ᨋ ␭৻㧘ᧁ᧛ᥙᄦ㧘଻૑ ഞ㧘☨↰ ⺈㧘›Ⴆ ⾆㧚Creutzfeldt-Jakob∛ߣ㘃ૃߩ⥃ᐥ⚻ㆊࠍ␜ߒߚ㧘Basedow ∛ࠍ઻ߞߚᯅᧄ⣖∝ߩ 1 ଀㧘⣖ߣ␹⚻ 2008 ᐕ㧧60 Ꮞ㧦559㧙
565㧚
11㧕 ⍫㊁ᄢੳ㧘᪢᧛ ᷕ㧘ਛጊೣਯ㧘ᄢᳯ⋥ⴕ㧘౎චᎹ㓶࿑㧘ᨋ ␭৻㧘଻૑ ഞ㧘›Ⴆ ⾆㧘ጤ㑆 ੧㧚᷆⫷⃿ౝ▵ೝỗⴚ߇ᄼഞߒߚ᦭᫚⿒ⴊ⃿⥰〯∛ߩ 1 ଀㧘ᯏ⢻⣖␹⚻ᄖ⑼ 2008 ᐕ㧧47 Ꮞ㧦114㧙118㧚ේ⪺㧔᰷ᢥ㧕
1㧕 Hozumi I, Uchida Y, Watabe K, Sakamoto T, Inuzuka T. Growth inhibitory factor (GIF㧕can protectfrom brain damage due to stab wounds in rat brain. Neurosci Lett. 2006;395:220-223.
2㧕 Hayashi Y, Hashizume T, Wakida K, Satoh M, Uchida Y, Watabe K, Matsuyama Z, Kimura A, Inuzuka
T, Hozumi I. Association between metallothionein genes polymorphisms and sporadic amyotrophic
lateral sclerosis. Amyotroph Lateral Sc. 2006;7:22-26.
3㧕 Hayashi Y, Kawazoe Y, Sakamoto T, Ojima M, Wang W, Takazawa T, Miyazawa D, Ohya W, Funakoshi
H, Nakamura T, Watabe K. Adenoviral gene transfer of hepatocyte growth factor prevents death of
injured adult motoneurons after peripheral nerve avulsion. Brain Res. 2006;1111:187-195.
4㧕 Wakida K, Morimoto N, Shimazawa M, Hozumi I, Nagase H, Inuzuka T, Hara H. Cilostazol reducesischemic brain damage partly by inducing metallothionein-1 and -2. Brain Res. 2006;1116:187-193.
5㧕 Hozumi I. Care and care-education system foe elderly people with dementia in Japan and Sweden.
Geriatr Gerontrol Int. 2007;7:89-90.
6㧕 Kimura A, Sakurai T, Suzuki Y, Hayashi Y, Hozumi I, Watanabe O, Arimura K, Takahashi Y, Inuzuka
T. Autoantibodies against glutamate receptor 2 subunit detected in a subgroup of patients withreversible autoimmune limbic encephalitis. Eur J Neurol. 2007;58:152-158.
7㧕 Wakida K, Shimazawa M, Hozumi I, Satoh M, Nagase H, Inuzuka T, Hara H. Neuroprotective effect oferythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia. Neurol Sci.
2007;148:105-114.
8㧕 Ichiyama T, Shoji H, Takahashi Y, Matsushige T, Kajimoto M, Inuzuka T, Furukawa S. Cerebrospinal
fluid levels of cytokines in non-herpetic limbic encephalitis: Comparison with herpes simplex
encephalitis. Cytokine. 2008;44:149-153.
9㧕 Hozumi I, Yamada M, Uchida Y, Ozawa K, Takahashi H, Inuzuka T. The expression of
metallothioneins is diminished in the spinal cords of patients with sporadic ALS. Amyotroph LateralSc. 2008;9:294-298.
10㧕 Hozumi I, Suzuki JS, Kanazawa H, Hara A, Saio M, Inuzuka T, Miyairi S, Naganuma A, Tohyama C.

㧙㧙

IF 2.085

IF 2.754

IF 2.218
IF 2.218

IF 2.580

IF 1.006

IF 1.986

IF 2.754

Metallothionein-3 is expressed in the brain and various peripheral organs of the rat. Neurosci Lett.
2008;438:54-58.
11㧕 Kimura A, Sakurai T, Tanaka Y, Hozumi I, Takahashi K, Takemura M, Saito K, Seishima M, Inuzuka
T. Proteomic analysis of autoantibodies in neuropsychiatric systemic lupus erythematosus patientwith white matter hyperintensities on brain MRI. Lupus. 2008;17:16-20.
12㧕 Kimura A, Sakurai T, Koumura A, Suzuki Y, Tanaka Y, Hozumi I, Nakajima H, Ichiyama T, Inuzuka T.
Longitudinal analysis of cytokines and chemokines in cerebrospinal fluid of patient with neuro-Sweet
disease presenting with recurrent encephalomeningitis. Intern Med. 2008;47:135-141.
13㧕 Hayashi Y, Kimura A, Kato S, Koumura A, Sakurai T, Tanaka Y, Hozumi I, Sunden Y, Orba Y, Sawa H,
Takahasi H, Inuzuka T. Progressive multifocal leukoencephalopathy and CD4+ T- lymphocytopenia ina patient with Sjoogren syndrome. J Neurol Sci. 2008;268:195-198.
14㧕 Hayashi Y, Sakurai T, Kimura A, Ikeda T, Matsuyama Z, Suzuki Y, Tanaka Y, Hozumi I, Takahasi H,
Inuzuka T. Selective cauda equine hypertrophy with idiopathic inflammation. Muscle Nerve.
2008;38:1065-1069.
15㧕 Nagasao J, Hayashi Y, Kawazoe Y, Kawakami E, Watabe K, Oyanagi K. Relationship between
ribosomal RNA gene transcription activity and motoneuron death: Observations of avulsion andaxotomy of the facial nerve in rats. J Neurosci Res. 2008;86:435-442.
16㧕 Koumura A, Nonaka Y, Hyakkoku K, Oka T, Shimazawa M, Hozumi I, Inuzuka T, Hara H. A novel
calpain inhibitor, ((1S)- 1((((1S)- 1- benzyl- 3- cyclopropylamino- 2,3- di- oxopropyl) amino) carbonyl)- 3methylbutyl) carbamic acid 5-methoxy-3-oxapentyl ester, protects neuronal cells from cerebral
ischemia-induced damage in mice. Neuroscience. 2008;157:309-318.

IF 2.085

IF 2.248

IF 2.315

IF 2.424

IF 3.268

IF 3.352

4㧚⎇ⓥ⾌₪ᓧ⁁ᴫ
1㧕┹੎⊛⾗㊄1㧕 ⎇ⓥઍ⴫⠪㧦଻૑ ഞ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ ⪚⧘⎇ⓥ㧦␹⚻㔍∛㧔ALS㧕ᖚ⠪ߩ࠾࡯࠭ߦㆡ
วߒߚ IT ᯏེᵴ↪ߣᔃߩࡅࡘ࡯ࡑࡦࠤࠕ࡮ࡀ࠶࠻ࡢ࡯ࠢ᭴▽ߩ⎇ⓥ㧧ᐔᚑ 17㧙18 ᐕᐲ㧧3,598 ජ౞(1,968㧦1,630 ජ౞)
2㧕 ⎇ⓥઍ⴫⠪㧦ᧁ᧛ᥙᄦ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ ⧯ᚻ⎇ⓥ B㧦᛫ GluR2 ᛫૕㓁ᕈᚑੱ⣖Ἳߩ⥃
ᐥߣ᛫ GluR2 ᛫૕ߩ․⇣ᕈߦ㑐ߔࠆ⎇ⓥ㧧ᐔᚑ 16㧙18 ᐕᐲ㧧2,800 ජ౞(1,200㧦1,000㧦600 ජ౞)
3㧕 ⎇ⓥઍ⴫⠪㧦㜞ᯅᐘ೑㧘⎇ⓥಽᜂ⠪㧦›Ⴆ ⾆㧧ෘ↢ഭ௛⋭⑼ቇ⎇ⓥ⾌⵬ഥ㊄ ߎߎࠈߩஜᐽ⑼ቇ⎇ⓥ੐ᬺ㧦ᕆᕈ⣖Ἳߩࠣ࡞࠲ࡒࡦ㉄ฃኈ૕⥄Ꮖ఺∉∛ᘒߩ⸃᣿߆ࠄᣂߚߥᴦ≮ᴺ⏕┙ߦะߌߚ⎇ⓥ⃰(ᕆᕈ⣖Ἳߩ⥄Ꮖ఺∉࡮ᴦ≮⎇ⓥ⃰) [㜞ᯅ⃰]㧦ᐔᚑ 18㧙20 ᐕᐲ㧧2,400 ජ౞(800㧦600㧦1,000 ජ౞)
4㧕 ⎇ⓥઍ⴫⠪㧦♻ጊᵏੱ㧘⎇ⓥಽᜂ⠪㧦›Ⴆ ⾆㧧ෘ↢ഭ௛⋭⑼ቇ⎇ⓥ⾌⵬ഥ㊄ 㔍ᴦᕈ∔ᖚస᦯⎇ⓥ
੐ᬺ㧦㊀∝㔍∛ᖚ⠪ߩ࿾ၞක≮૕೙ߩ᭴▽ߦ㑐ߔࠆ⎇ⓥ⃰ [♻ጊ⃰]㧦ᐔᚑ 18㧙20 ᐕᐲ㧧2,200 ජ౞(700㧦700㧦800 ජ౞)
5㧕 ⎇ⓥઍ⴫⠪㧦᧻ጟᐘᒾ㧘⎇ⓥಽᜂ⠪㧦›Ⴆ ⾆㧧ෘ↢ഭ௛⋭⑼ቇ⎇ⓥ⾌⵬ഥ㊄ 㔍ᴦᕈ∔ᖚస᦯⎇ⓥ
੐ᬺ㧦ࠬࡕࡦߦ㑐ߔࠆ⎇ⓥ⃰ [᧻ጟ⃰]㧦ᐔᚑ 18㧙20 ᐕᐲ㧧2,100 ජ౞(700㧦700㧦700 ජ౞)
6㧕 ⎇ⓥઍ⴫⠪㧦ᧁ᧛ᥙᄦ㧧ෘ↢ഭ௛⋭⑼ቇ⎇ⓥ⾌⵬ഥ㊄ ߎߎࠈߩஜᐽ⑼ቇ⎇ⓥ੐ᬺ㧦⥄Ꮖ఺∉∔ᖚߦ઻߁ਛᨔ␹⚻㓚ኂߦ㑐ㅪߔࠆ᛫␹⚻᛫૕ߩᬌ⚝ߣ᛫ේᯏ⢻ߩ⸃ᨆ㧦∛ᘒߩ⸃᣿߆ࠄᴦ≮ᴺ⏕┙ߦะߌߡ㧧ᐔᚑ 18㧙20 ᐕᐲ㧧18,000 ජ౞(600㧦600㧦600 ජ౞)
7㧕 ⎇ⓥઍ⴫⠪㧦଻૑ ഞ㧧ጘ㒂ᄢቇᄢቇ㒮කቇ♽⎇ⓥ⑼⎇ⓥᵴᕈൻᡰេ੐ᬺ㧦⣖⯯ⴊ㧘␹⚻ᄌᕈ∔ᖚࡕ࠺࡞േ‛ߦ߅ߌࠆᣂߚߥⷞὐߢߩ␹⚻ౣ↢ᴦ≮ߩ⹜ߺ㧧ᐔᚑ 18 ᐕᐲ㧧1,000 ජ౞8㧕 ⎇ⓥઍ⴫⠪㧦↰ਛఝม㧧ጘ㒂ᄢቇᄢቇ㒮කቇ♽⎇ⓥ⑼⎇ⓥᵴᕈൻᡰេ੐ᬺ㧦ࡄ࡯ࠠࡦ࠰ࡦ∛(PD)ߩ
⿥ᣧᦼ⸻ᢿߦ㑐ߔࠆ⎇ⓥ -ᧂᴦ≮ߩᣧᦼࡄ࡯ࠠࡦ࠰ࡦ∛ߦ߅ߌࠆᶖൻ▤ᯏ⢻ߦ㑐ߔࠆᬌ⸛-㧧ᐔᚑ 18
ᐕᐲ㧧200 ජ౞
9㧕 ⎇ⓥઍ⴫⠪㧦ᨋ ␭৻㧧ᬞ␹⚻∔ᖚ⎇ⓥၮ㊄⎇ⓥ⾌⵬ഥ㊄㧦╭⪜❗ᕈ஥⚝⎬ൻ∝ߦኻߔࠆ᛫㉄ൻ‛⾰ߣㆇേ≮ᴺߩലᨐ㧦ᐔᚑ 18 ᐕᐲ㧧300 ජ౞
10㧕 ⎇ⓥઍ⴫⠪㧦଻૑ ഞ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ ၮ⋚⎇ⓥ(B)㧦⠧ൻ㧘⣖⯯ⴊ߅ࠃ߮ࡔ࠲ࡏ࡝࠶ࠢ
∝୥⟲ߦ߅ߌࠆࡔ࠲ࡠ࠴ࠝࡀࠗࡦߩᓎഀߣഃ⮎ߩ⎇ⓥ㧧ᐔᚑ 19㧙21 ᐕᐲ㧧17,540 ජ౞(12,740㧦
2,700㧦2,100 ජ౞)
11㧕 ⎇ⓥઍ⴫⠪㧦ᨋ ␭৻㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ ⧯ᚻ⎇ⓥ(B)㧦╭⪜❗ᕈ஥⚝⎬ൻ∝ࡕ࠺࡞ࡑ࠙ࠬ
ߦኻߔࠆㆇേ≮ᴺߣ᛫㉄ൻ‛⾰ߩ૬↪ᴦ≮ലᨐߦߟ޿ߡ㧧ᐔᚑ 19㧙21 ᐕᐲ㧧3,200 ජ౞(1,600㧦800㧦
800 ජ౞)12㧕 ⎇ⓥઍ⴫⠪㧦ᧁ᧛ᥙᄦ㧧ጘ㒂ᄢቇᵴᕈൻ⚻⾌㧦ᄙ⊒ᕈ⎬ൻ∝ᖚ⠪ߦ߅ߌࠆᣂⷙ᛫␹⚻᛫૕ߩᬌ⚝߅ࠃ߮⹺⼂᛫ේߩหቯ-⸻ᢿ߅ࠃ߮ᴦ≮ᴺߩ㐿⊒ߦะߌߡ-㧧ᐔᚑ 19 ᐕᐲ㧧1,130 ජ౞
13㧕 ⎇ⓥઍ⴫⠪㧦᳓Ỉ⧷ᵗ㧘⎇ⓥಽᜂ⠪㧦›Ⴆ ⾆㧧ෘ↢ഭ௛⋭⑼ቇ⎇ⓥ⾌⵬ഥ㊄ 㔍ᴦᕈ∔ᖚస᦯⎇ⓥ㧙㧙੐ᬺ㧦ࡊ࡝ࠝࡦ∛෸߮ㆃ⊒ᕈ࠙ࠗ࡞ࠬᗵᨴ∝ߦ㑐ߔࠆ⺞ᩏ⎇ⓥ⃰ [᳓Ỉ⃰]㧧ᐔᚑ 20㧙22 ᐕᐲ㧧3,000ජ౞(1,000㧦1,000㧦1,000 ජ౞)
14㧕 ⎇ⓥઍ⴫⠪㧦›Ⴆ ⾆㧦ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(C)㧦ࡊࡠ࠹ࠝࡒࠢࠬߦࠃࠆ╭ήജ∝࡮╭Ἳ․⇣⊛⥄Ꮖ᛫૕ߩᬌ⚝ߣࡃࠗࠝࡑ࡯ࠞ࡯ߩ⏕┙㧧ᐔᚑ 20 ᐕᐲ㧧1,600 ජ౞
15㧕 ⎇ⓥઍ⴫⠪㧦଻૑ ഞ㧧ਃ੗૑෹ᶏ਄⑔␩⽷࿅⎇ⓥഥᚑ ࠕ࡞࠷ࡂࠗࡑ࡯∛╬㜞㦂⠪␹⚻ᄌᕈ∔ᖚᖚ⠪ߦ߅ߌࠆ㜑ᶧ㊀㊄ዻߣ᛫㉄ൻ‛⾰ߩ᷹ቯߣഃ⮎߳ߩᔕ↪㧦ᐔᚑ 20 ᐕᐲ㧧1,550 ජ౞
16㧕 ⎇ⓥઍ⴫⠪㧦଻૑ ഞ㧧ᐔᚑ 20 ᐕᐲጘ㒂ᄢቇᛛⴚ੤ᵹ⎇ⓥળડ↹൐㓸 ᧲ᶏࡔ࠲ࡠ࠴ࠝࡀࠗࡦ⎇ⓥ
ળ㧦ᐔᚑ 20 ᐕᐲ㧧150 ජ౞
17㧕 ⎇ⓥઍ⴫⠪㧦଻૑ ഞ㧧ᐔᚑ 20 ᐕᐲጘ㒂ᄢቇᄢቇ㒮කቇ♽⎇ⓥ⑼ၮ␆කቇ⎇ⓥᵴᕈൻ࡮⧯ᚻ⢒ᚑ࡙࠾࠶࠻ ࡔ࠲ࡠ࠴ࠝࡀࠗࡦ߅ࠃ߮ࡔ࠲࡞ࡃࠗࠝࠨࠗࠛࡦࠬ㧦ᐔᚑ 20 ᐕᐲ㧧1,000 ජ౞
18㧕 ⎇ⓥઍ⴫⠪㧦ᧁ᧛ᥙᄦ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(C)㧧ᄙ⊒ᕈ⎬ൻ∝ߦ߅ߌࠆᄢ⣖⤑Ⱞ⊕ߦኻߔࠆᣂⷙ⥄Ꮖ᛫૕ߩᬌ⚝ߣࡃࠗࠝࡑ࡯ࠞ࡯ߩ⏕┙㧦ᐔᚑ 20 ᐕᐲ㧧2,600 ජ౞)
2㧕ฃ⸤⎇ⓥߥߒ

3㧕౒ห⎇ⓥߥߒ

5㧚⊒᣿࡮․⸵಴㗿⁁ᴫߥߒ

6㧚ቇળᵴേ
1㧕ቇળᓎຬ›Ⴆ ⾆㧦
1㧕 ᣣᧄ␹⚻ቇળ⹏⼏ຬ(㨪⃻࿷)2㧕 ᣣᧄ␹⚻ቇળ↢ᶦᢎ⢒ᆔຬ(㨪⃻࿷)3㧕 ᣣᧄౝ⑼ቇળ⹏⼏ຬ(㨪⃻࿷)4㧕 ᣣᧄ⠧ᐕකቇળ⹏⼏ຬ(㨪⃻࿷)5㧕 ᣣᧄ⠧ᐕකቇળᢎ⢒ᆔຬ(㨪⃻࿷)6㧕 ᣣᧄ⠧ᐕකቇળ✬㓸ᆔຬ(㨪ᐔᚑ 19 ᐕ 3 ᦬)
7㧕 ᣣᧄ⠧ᐕකቇળࡁࡃ࡞࠹ࠖࠬ⎇ⓥၮ㊄ㆬ⠨ᆔຬ(㨪⃻࿷)8㧕 ᣣᧄ␹⚻ᴦ≮ቇળ⹏⼏ຬ(㨪⃻࿷)9㧕 ᣣᧄ␹⚻఺∉ቇળℂ੐(ᐔᚑ 20 ᐕ 4 ᦬㨪⃻࿷)10㧕 ᣣᧄ␹⚻఺∉ቇળ⹏⼏ຬ(㨪⃻࿷)11㧕 ᣣᧄ␹⚻఺∉ቇળ✬㓸ᆔຬ(㨪⃻࿷)12㧕 ᣣᧄ␹⚻ᗵᨴ∝ቇળ⹏⼏ຬ(㨪⃻࿷)଻૑ ഞ㧦1㧕 ᣣᧄ␹⚻ቇળ⹏⼏ຬ(㨪⃻࿷)2㧕 ᣣᧄౝ⑼ቇળౝ⑼ኾ㐷කળ⹏⼏ຬ(㨪⃻࿷)3㧕 ᣣᧄౝ⑼ቇળ∛ᱧⷐ⚂⹏ଔᆔຬ(㨪⃻࿷)4㧕 ᣣᧄ⠧ᐕකቇળ⹏⼏ຬ(㨪⃻࿷)5㧕 ᣣᧄ⠧ᐕකቇળ੐଀ᬌ⸛ᆔຬ(ᐔᚑ 20 ᐕᐲ㨪⃻࿷)
6㧕 ࡔ࠲ࡠ࠴ࠝࡀࠗࡦ⎇ⓥળᐙ੐(㨪⃻࿷)2㧕ቇળ㐿௅›Ⴆ ⾆㧦
1㧕 ᐔᚑ 17 ᐕᐲᣣᧄ␹⚻ቇળ᧲ᶏർ㒽࿾඙↢ᶦᢎ⢒⻠Ṷળ(ᐔᚑ 18 ᐕ 1 ᦬㧘ฬฎደ)2㧕 ᐔᚑ 18 ᐕᐲᣣᧄ␹⚻ቇળ᧲ᶏർ㒽࿾඙↢ᶦᢎ⢒⻠Ṷળ(ᐔᚑ 19 ᐕ 3 ᦬㧘ฬฎደ)3㧕 ╙ 203 ࿁ᣣᧄౝ⑼ቇળ᧲ᶏ࿾ᣇળ(ᐔᚑ 19 ᐕ 10 ᦬㧘ฬฎደ)
4㧕 ᐔᚑ 19 ᐕᐲᣣᧄౝ⑼ቇળ᧲ᶏᡰㇱᏒ᳃౏㐿⻠ᐳ(ᐔᚑ 19 ᐕ 10 ᦬㧘ጘ㒂)
5㧕 ᐔᚑ 19 ᐕᐲᣣᧄ␹⚻ቇળ᧲ᶏർ㒽࿾඙↢ᶦᢎ⢒⻠Ṷળ(ᐔᚑ 20 ᐕ 3 ᦬㧘ฬฎደ)㧙㧙6㧕 ╙ 9 ࿁⠧ᐕ∔ᖚ⎇ⓥળ(ᐔᚑ 20 ᐕ 7 ᦬㧘ጘ㒂)7㧕 ╙ 19 ࿁ᣣᧄ⠧ᐕකቇળ᧲ᶏ࿾ᣇળ(ᐔᚑ 20 ᐕ 10 ᦬㧘ฬฎደ)଻૑ ഞ㧦
1㧕 ╙ 120 ࿁ᣣᧄ␹⚻ቇળ᧲ᶏർ㒽࿾ᣇળ(ᐔᚑ 20 ᐕ 3 ᦬㧘ฬฎደ)
3㧕ቇⴚ㔀⹹›Ⴆ ⾆㧦
1㧕 ᣣᧄౝ⑼ቇળ㔀⹹㧧✬㓸ᆔຬ(ᐔᚑ 19 ᐕ 4 ᦬㨪⃻࿷)2㧕 ᣣᧄ⠧ᐕකቇળ⹹㧧✬㓸ᆔຬ(㨪ᐔᚑ 19 ᐕ 3 ᦬)
3㧕 Geriatrics Gerontology International, Associate Editor(ᐔᚑ 18 ᐕ 4 ᦬㨪⃻࿷)
4㧕 ᣣᧄ␹⚻఺∉ቇળ⹹㧧✬㓸ᆔຬ(㨪⃻࿷)5㧕 කቇߩ޽ࠁߺ㧧✬㓸දജ⠪(ᐔᚑ 19 ᐕ 4 ᦬㨪⃻࿷)7㧚ቇળ᜗ᓙ⻠Ṷ㧘᜗ᓙࠪࡦࡐࠫࠬ࠻㧘ᐳ㐳›Ⴆ ⾆㧦
1㧕 ╙ 47 ࿁ᣣᧄ␹⚻ቇળ✚ળ(ᐔᚑ 18 ᐕ 5 ᦬㧘᧲੩㧘⻠Ṷળ‫ޟ‬AD એᄖߩ Dementia࡮⥃ᐥᓽ୥࡮⣖ᵄ࡮⺃⊒㔚૏‫ޠ‬ᐳ㐳)2㧕 ╙ 43 ࿁ᣣᧄ⠧ᐕකቇળ✚ળ(ᐔᚑ 18 ᐕ 6 ᦬㧘㊄ᴛ㧘⻠Ṷળ‫⹺ဳ࡯ࡑࠗࡂ࠷࡞ࠕޟ‬⍮∝⎇ⓥߩᦨㄭߩㅴᱠ-ࠕࡐ࡝ࡐⰮ⊕ E ࡈࠚࡁ࠲ࠗࡊߣߩ㑐ଥ-‫ޠ‬ᐳ㐳)
3㧕 ╙ 11 ࿁ᣣᧄ␹⚻ᗵᨴ∝ቇળ(ᐔᚑ 18 ᐕ 10 ᦬㧘દ൓㧘⻠Ṷળ‫ޠࠕ࡝࠹ࠬ࡝ޟ‬ᐳ㐳)
4㧕 ╙ 104 ࿁ᣣᧄౝ⑼ቇળ✚ળ(ᐔᚑ 19 ᐕ 4 ᦬㧘᧲੩㧘⻠Ṷળ‫⚻␹ޟ‬ԛ‫ޠ‬ᐳ㐳)
5㧕 ╙ 48 ࿁ᣣᧄ␹⚻ቇળ✚ળ(ᐔᚑ 19 ᐕ 5 ᦬㧘ฬฎደ㧘ࠪࡦࡐࠫ࠙ࡓ‫∔⚻␹ޟ‬ᖚߣ⥄Ꮖ᛫૕‫ޠ‬ᐳ㐳)
6㧕 ╙ 44 ࿁ᣣᧄ⠧ᐕකቇળ✚ળ(ᐔᚑ 19 ᐕ 6 ᦬㧘ᧅᏻ㧘⻠Ṷળ‫⹺ޟ‬⍮∝ԙ‫ޠ‬ᐳ㐳)7㧕 ╙ 8 ࿁⠧ᐕ∔ᖚ⎇ⓥળ(ᐔᚑ 19 ᐕ 7 ᦬㧘シ੗ᴛ㧘⻠Ṷળᐳ㐳)8㧕 ╙ 12 ࿁ᣣᧄ␹⚻ᗵᨴ∝ቇળ✚ળ(ᐔᚑ 19 ᐕ 10 ᦬㧘⑔ጟ㧘ࡢ࡯࡚ࠢࠪ࠶ࡊ‫ޟ‬ㅴⴕᕈᄙᎽᕈ⊕⾰⣖∝(PML)‫ޠ‬ᐳ㐳)9㧕 ╙ 19 ࿁ᣣᧄ⠧ᐕකቇળ᧲ᶏ࿾ᣇળ(ᐔᚑ 19 ᐕ 10 ᦬㧘ฬฎደ㧘․೎⻠Ṷ‫੍⼔੺ޟ‬㒐ߩࠛࡆ࠺ࡦࠬ‫ޠ‬ᐳ㐳)
10㧕 ╙ 19 ࿁ᣣᧄ⠧ᐕකቇળ᧲ᶏ࿾ᣇળ(ᐔᚑ 19 ᐕ 10 ᦬㧘ฬฎደ㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬ᓟᦼ㜞㦂⠪ක≮೙ᐲ߇ዉ౉ߐࠇߡ‫ޠ‬ᐳ㐳)଻૑ ഞ㧦
1㧕 ╙ 2 ࿁᧲ᶏࡔ࠲ࡠ࠴ࠝࡀࠗࡦ⎇ⓥળ(ᐔᚑ 18 ᐕ 9 ᦬㧘ฬฎደ㧘․೎⻠Ṷ‫❗⪜╭ޟ‬ᕈ஥⚝⎬ൻ∝ߣࡔ࠲ࡠ࠴ࠝࡀࠗࡦ‫ޠ‬Ṷ⠪)
2㧕 ╙ 4 ࿁᧲ᶏࡔ࠲ࡠ࠴ࠝࡀࠗࡦ⎇ⓥળ(ᐔᚑ 19 ᐕ 3 ᦬㧘ጘ㒂㧘․೎⻠Ṷ‫ޟ‬⢈ḩ࡮ࠬ࠻࡟ࠬ߆ࠄࡔ࠲ࡠ
࠴ࠝࡀࠗࡦߩ↢ℂ⊛ᓎഀࠍ⠨߃ࠆ‫ޠ‬ᐳ㐳)
3㧕 ࡔ࠲ࡠ࠴ࠝࡀࠗࡦ߅ࠃ߮ࡔ࠲࡞ࡃࠗࠝࠨࠗࠛࡦࠬ⎇ⓥળ(ᐔᚑ 19 ᐕ 9 ᦬㧘ᓼፉ㧘ࠪࡦࡐࠫ࠙ࡓ․೎
⻠Ṷ‫⚻␹ޟ‬ᄌᕈ∔ᖚߦ߅ߌࠆࡔ࠲ࡠ࠴ࠝࡀࠗࡦߣࡔ࠲࡞ߩᓎഀ‫ޠ‬Ṷ⠪)
4㧕 ╙ 41 ࿁ᣣᧄౝ⑼ቇળ᧲ᶏᡰㇱ↢ᶦᢎ⢒⻠Ṷળ(ᐔᚑ 19 ᐕ 10 ᦬㧘ฬฎደ㧘․೎⻠Ṷ‫∔⚻␹ޟ‬ᖚߣࡔ࠲ࡠ࠴ࠝࡀࠗࡦ‫ޠ‬Ṷ⠪)
5㧕 ᣣᧄ⮎ቇળ᧲ᶏᡰㇱ⻠Ṷળ(╙ 12 ࿁⮎ቇ࠮ࡒ࠽࡯)(ᐔᚑ 19 ᐕ 12 ᦬㧘ฬฎደ㧘․೎⻠Ṷ‫∔⚻␹ޟ‬ᖚߣࡔ࠲ࡠ࠴ࠝࡀࠗࡦ-ᣂዷ㐿ߔࠆࡔ࠲ࡠ࠴ࠝࡀࠗࡦ⎇ⓥ-‫ޠ‬Ṷ⠪)
6㧕 ╙ 120 ࿁ᣣᧄ␹⚻ቇળ᧲ᶏർ㒽࿾ᣇળ(ᐔᚑ 20 ᐕ 3 ᦬㧘ฬฎደ㧘࡜ࡦ࠴࡚ࡦ࠮ࡒ࠽࡯‫⚻␹ޟ‬ᄌᕈ∔ᖚߩࠨࠗࠛࡦࠬ-⃻⁁ߣ੹ᓟߩዷᦸ-‫ޠ‬ᐳ㐳)ᨋ ␭৻㧦
1㧕 ╙ 12 ࿁ᣣᧄ␹⚻ᗵᨴ∝ቇળ✚ળ(ᐔᚑ 19 ᐕ 10 ᦬㧘⑔ጟ㧘ࡢ࡯࡚ࠢࠪ࠶ࡊ‫ޟ‬Sjogren ∝୥⟲ߦࠃࠆ
ੑᰴᕈ CD4 㓁ᕈ T ⚦⢩ᷫዋ∝ߣㅴⴕᕈᄙᎽᕈ⊕⾰⣖∝‫ޠ‬Ṷ⠪)8㧚ቇⴚ⾨╬ߩฃ⾨⁁ᴫ
ߥߒ

㧙㧙

9㧚␠ળᵴേ›Ⴆ ⾆㧦
1㧕 ጘ㒂⋵࿖᳃ஜᐽ଻㒾࿅૕ㅪวળ੺⼔⛎ઃ⾌ክᩏᆔຬ(㨪ᐔᚑ 20 ᐕ 3 ᦬)
2㧕 ਛㇱ≮⼔࠮ࡦ࠲࡯౉㒮ክᩏᆔຬ(㨪⃻࿷)3㧕 ጘ㒂⋵㔍∛ක≮ㅪ⛊ද⼏ળ೽ળ㐳(㨪⃻࿷)4㧕 ጘ㒂⋵කᏧળ੺⼔⑔␩ᆔຬ(㨪⃻࿷)5㧕 ጘ㒂⋵කᏧળઍ⼏ຬ(㨪⃻࿷)6㧕 ጘ㒂⋵⹺⍮∝࿾ၞᡰេ૕೙᭴▽╬ផㅴᆔຬળᆔຬ(ᐔᚑ 19 ᐕ㨪⃻࿷)7㧕 ᣣᧄ ALS දળጘ㒂⋵ᡰㇱ․೎㘈໧(ᐔᚑ 20 ᐕ 4 ᦬㨪⃻࿷)8㧕 ࠢࡠࠗ࠷ࡈࠚ࡞࠼ࡗࠦࡉ∛ࠨ࡯ࡌࠗ࡜ࡦࠬᆔຬ(ో࿖)(ᐔᚑ 20 ᐕ 4 ᦬㨪⃻࿷)9㧕 ࠢࡠࠗ࠷ࡈࠚ࡞࠼ࡗࠦࡉ∛ࠨ࡯ࡌࠗ࡜ࡦࠬᆔຬ(ጘ㒂⋵ᜂᒰ)(㨪⃻࿷)଻૑ ഞ㧦1㧕 ᣣᧄ ALS දળጘ㒂⋵ᡰㇱ․೎㘈໧(㨪⃻࿷)↰ਛఝม㧦1㧕 ጘ㒂⋵࿖᳃ஜᐽ଻㒾࿅૕ㅪวળ੺⼔⛎ઃ⾌ክᩏᆔຬ(ᐔᚑ 20 ᐕ 4 ᦬㨪⃻࿷)10㧚ႎ๔ᦠ
1㧕 ›Ⴆ ⾆㧘↰ਛఝม㧘ᧁ᧛ᥙᄦ㧘଻૑ ഞ㧘቟⮮᥍⟤㧘᧻↰ਯ೑㧦ጘ㒂⋵ߦ߅ߌࠆ␹⚻㔍∛ߣߘߩ≮㙃ᡰេߩ⃻⁁㧚ᐔᚑ 17 ᐕᐲෘ↢ഭ௛⑼ቇ⎇ⓥ⾌⵬ഥ㊄ 㔍ᴦᕈ∔ᖚస᦯੐ᬺ ㊀∝㔍∛ᖚ⠪ߩ࿾ၞක≮૕೙ߩ᭴▽ߦ㑐ߔࠆ⎇ⓥ⃰ ✚᜝࡮ಽᜂ⎇ⓥႎ๔ᦠ㧦42㧙43(2006 ᐕ 3 ᦬)
2㧕 ›Ⴆ ⾆㧘↰ਛఝม㧘ᧁ᧛ᥙᄦ㧘଻૑ ഞ㧘ၳ↰޽ߌߺ㧦ጘ㒂⋵ߦ߅ߌࠆ࡟ࠬࡄࠗ࠻౉㒮ߩฃߌ౉ࠇ
⁁ᴫߦ㑐ߔࠆ⃻⁁ߣ⺖㗴㧦ෘ↢ഭ௛⑼ቇ⎇ⓥ⾌⵬ഥ㊄ 㔍ᴦᕈ∔ᖚస᦯⎇ⓥ੐ᬺ ㊀∝㔍∛ᖚ⠪ߩ࿾ၞක≮૕೙ߩ᭴▽ߦ㑐ߔࠆ⎇ⓥ⃰ ᐔᚑ 18 ᐕᐲ✚᜝࡮ಽᜂ⎇ⓥႎ๔ᦠ㧦51㧙52 (2007 ᐕ 3 ᦬)
3㧕 ›Ⴆ ⾆㧘ᧁ᧛ᥙᄦ㧘↰ਛఝม㧘଻૑ ഞ㧦㕖ற⣲≌ᕈ㕖ࡋ࡞ࡍࠬᕈㄝ✼♽⣖Ἳᖚ⠪ߦ߅ߌࠆੑᰴర
఺∉ࡉࡠ࠶࠹ࠖࡦࠣ߅ࠃ߮㜞ᗵᐲ࠽ࡁ LC-MS/MS ࠪࠬ࠹ࡓࠍ↪޿ߚⴊᷡਛ᛫␹⚻⚵❱᛫૕ߩ✂⟜⊛⸃ᨆ㧦ෘ↢ഭ௛⑼ቇ⎇ⓥ⾌⵬ഥ㊄ ߎߎࠈߩஜᐽ⑼ቇ⎇ⓥ੐ᬺ ᕆᕈ⣖Ἳߩࠣ࡞࠲ࡒࡦ㉄ฃኈ૕⥄Ꮖ఺∉∛ᘒߩ⸃᣿߆ࠄᣂߚߥᴦ≮ᴺ⏕┙ߦะߌߚ⎇ⓥ⃰ ᐔᚑ 18 ᐕᐲ✚᜝࡮ಽᜂႎ๔ᦠ㧦45㧙
46(2007 ᐕ 3 ᦬)
4㧕 ␲ῳᳯర㧘᦯ㇱ⋥᮸㧘ዊᳰᤐ᮸㧘ᳰ↰ୃ৻㧘᎑↰ ⼾㧘ᨋ ᱜ↵㧘ᩙጊ ൎ㧘›Ⴆ ⾆㧘ᯅᧄୃੑ㧘Ḵญഞ৻㧘㣐⷗ᐘᒾ㧘኷⃨ጊ⒤㧘Ⴧ੗ᕡᄦ㧘᳁ᐔ㜞ᢅ㧘ች↰๺᣿㧘ዊ㐳⼱ᱜ᣿㧘᧻ጟᐘᒾ㧦ᐔᚑ 18 ᐕᐲਛㇱ࿾඙ࠬࡕࡦᖚ⠪ߩታᘒ㧦ෘ↢ഭ௛⑼ቇ⎇ⓥ⾌⵬ഥ㊄ 㔍ᴦᕈ∔ᖚస᦯⎇ⓥ੐ᬺ ࠬࡕࡦߦ㑐ߔࠆ⎇ⓥ⃰ ᐔᚑ 18 ᐕᐲ✚᜝࡮ಽᜂ⎇ⓥႎ๔ᦠ㧦29㧙31 (2007 ᐕ 3 ᦬)
5㧕 ଻૑ ഞ㧦㔍∛ᖚ⠪ߩ࠾࡯࠭ߦㆡวߒߚ IT ᯏེᵴ↪ߣᔃߩࠤࠕߦ㑐ߔࠆࡀ࠶࠻ࡢ࡯ࠢ᭴▽㧦ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⾌⵬ഥ㊄(⪚⧘⎇ⓥ) ᐔᚑ 18 ᐕᐲ㧙19 ᐕᐲ✚᜝⎇ⓥႎ๔ᦠ(2007 ᐕ 3 ᦬)
6㧕 ᧁ᧛ᥙᄦ㧦⥄Ꮖ఺∉∔ᖚߦ઻߁ਛᨔ␹⚻㓚ኂߦ㑐ㅪߔࠆ᛫␹⚻᛫૕ߩᬌ⚝ߣ᛫ේᯏ⢻ߩ⸃ᨆ-∛ᘒߩ⸃᣿߆ࠄᴦ≮ᴺ⏕┙ߦะߌߡ- ෘ↢ഭ௛⋭⑼ቇ⎇ⓥ⾌⵬ഥ㊄ ߎߎࠈߩஜᐽ⑼ቇ⎇ⓥ੐ᬺ ᐔᚑ 18 ᐕᐲ✚᜝⎇ⓥႎ๔ᦠ(2007 ᐕ 3 ᦬)
7㧕 ›Ⴆ ⾆㧘ᧁ᧛ᥙᄦ㧘↰ਛఝม㧘଻૑ ഞ㧦CNS ࡞࡯ࡊࠬᖚ⠪ߦ߅ߌࠆᣂⷙ᛫␹⚻᛫૕ߩᬌ಴ߣ⹺⼂᛫ේߩหቯ. ෘ↢ഭ௛⑼ቇ⎇ⓥ⾌⵬ഥ㊄ ߎߎࠈߩஜᐽ⑼ቇ⎇ⓥ੐ᬺ ᕆᕈ⣖Ἳߩࠣ࡞࠲ࡒࡦ㉄ฃኈ૕⥄Ꮖ఺∉∛ᘒߩ⸃᣿߆ࠄᣂߚߥᴦ≮ᴺ⏕┙ߦะߌߚ⎇ⓥ⃰ ᐔᚑ 19 ᐕᐲ✚᜝࡮ಽᜂႎ๔ᦠ㧦68㧙
69(2008 ᐕ 3 ᦬)
8㧕 ␲ῳᳯర㧘᦯ㇱ⋥᮸㧘ዊᳰᤐ᮸㧘ᳰ↰ୃ৻㧘᎑↰ ⼾㧘ᨋ ᱜ↵㧘ᩙጊ ൎ㧘›Ⴆ ⾆㧘ᯅᧄୃੑ㧘Ḵญഞ৻㧘㣐⷗ᐘᒾ㧘኷⃨ጊ⒤㧘ਣጊ᤯ੑ㧘Ⓑ⪲㕒ઍ㧘ች↰๺᣿㧘ዊ㐳⼱ᱜ᣿㧘᧻ጟᐘᒾ㧦ᐔᚑ 19 ᐕᐲਛㇱ࿾඙ࠬࡕࡦᖚ⠪ߩታᘒ㧚ෘ↢ഭ௛⑼ቇ⎇ⓥ⾌⵬ഥ㊄ 㔍ᴦᕈ∔ᖚస᦯⎇ⓥ੐ᬺ ࠬࡕࡦߦ㑐ߔࠆ⎇ⓥ⃰ ᐔᚑ 19 ᐕᐲ✚᜝࡮ಽᜂ⎇ⓥႎ๔ᦠ㧦27㧙29(2008 ᐕ 3 ᦬)
11㧚ႎ㆏
1㧕 ଻૑ ഞ㧦৻⥸ౝ⑼ක߇⍮ߞߡ߅߈ߚ޿⹺⍮∝ߩ㐓೎ߣ๟ㄝ∝⁁㧦ጘ㒂කᏧળߛࠃࠅ(ᐔᚑ 19 ᐕ 1 ᦬)
2㧕 ଻૑ ഞ㧦ࡄ࡯ࠠࡦ࠰ࡦ∛ߣ㘃✼∔ᖚ㧙㐓೎ߣᦨᣂߩᴦ≮㧙㧦KNG(ᐔᚑ 19 ᐕ 1 ᦬)
3㧕 ›Ⴆ ⾆㧦╙ 18 ࿁ NPO ᴺੱጘ㒂⋵㔍∛࿅૕ㅪ⛊ද⼏ળ⸳┙⸥ᔨᄢળߦ޽ߚߞߡ㧦KNG(ᐔᚑ 19 ᐕ
5 ᦬)

㧙㧙

4㧕 ›Ⴆ ⾆㧦ࡄ࡯ࠠࡦ࠰ࡦ∛ߩೋᦼ⸻ᢿߣᴦ≮㧦ጘ㒂⋵଻㒾කᣂ⡞(ᐔᚑ 19 ᐕ 10 ᦬ 10 ᣣ)
5㧕 ଻૑ ഞ㧦∛᳇ㅴⴕࠍㆃࠄߖࠆ⮎೷㐿⊒㧦ጘ㒂ᣂ⡞(ᐔᚑ 19 ᐕ 12 ᦬ 4 ᣣ)
12㧚⥄Ꮖ⹏ଔ
⹏ଔ‫⎇ޣ‬ⓥ‫ޤ‬ᩉᚭࠠࡖࡦࡄࠬ߳ߩᣂ▽⒖ォ㧔2004㧕ߦࠃߞߡ㧘ೋ߼ߡ⥄೨ߩታ㛎ቶ߇ߢ߈㧘⠉ᐕߦߪേ‛㘺⢒߇น⢻ߦߥߞߚ߇㧘ߎߩ 3 ᐕ㑆㧘ߘߩᚑᨐ߇⺰ᢥߣߒߡ಴ߡߊࠆࠃ߁ߦߥߞߡ߈ߚ‫ޕ‬ታ㛎࡮⚿ᨐߩᬌ⸛࡮ቇળ⊒⴫࡮⎇ⓥ⾌↳⺧ߣ޿ߞߚᣣᏱ⊛⎇ⓥᵴേ߇ᰴ╙ߦቯ⌕ߒ㧘వⴕߒߡ޿ߚ⸻≮㧘ᢎ⢒㧘␠ળᵴേߣ૬ߖ㧘ࠃ߁߿ߊࡃ࡜ࡦࠬߩߣࠇߚᢎቶߦߥߞߡ߈ߚ‫߽ࠇߕ޿ޕ‬ℂᗐߦߪ߹ߛ㆙޿߇㧘ߎߎ 2 ᐕ㑆㧘ᣂ౉ዪකᏧ߇ߥߊᢎቶຬฦ⥄ߩᚑ㐳ߣ♖৻᧰ߩദജߦࠃࠆ⾦‛ߢ޽ࠆ‫⮎ߚ߹ޕ‬ቇ߆ࠄߩ㒮↢౉ቇ߽ᄢ߈
ߥജߢ޽ߞߚ‫ޕ‬ᢥㇱ⑼ቇ⋭߅ࠃ߮ෘ↢ഭ௛⋭ߩ⑼ቇ⎇ⓥ⾌㧘ෘഭ⋭⃰ળ⼏ࠍߪߓ߼┹੎⊛⎇ⓥ⾌ߩ₪ᓧߪ⋡ᮡ࡟ࡌ࡞⋧ᒰߢ޽ߞߚ‫ޕ‬‫ޤ≮⸻ޣ‬㒢ࠄࠇߚᢎຬ/කຬᢙߣ∛ᐥᢙߢⷙᮨ⊛ߦߪ㒢⇇߇޽ࠆ߇㧘ᄢቇ∛㒮ߦ߅ߌࠆ⸻≮ౝኈߪ⼾ንߢ㧘␹⚻ᢇᕆ߆ࠄ㔍∛ߩ⏕ቯ⸻ᢿ࡮␠ળ⾗Ḯߩ⺞ᢛ߹ߢ᏷ᐢߊኻᔕߒߡ߈ߚ‫ ߩߎޕ‬3 ᐕ㑆㧘ᒰಽ㊁↢߃ᛮ߈ߩ␹⚻ౝ⑼ኾ㐷ක߇ 4 ฬ㧘⠧ᐕ∛ኾ㐷ක 2 ฬ߇޿ߕࠇ߽⹜㛎ࠍ 1 ࿁ߢวᩰߒߡ⺀↢ߒߚ‫ޕ‬කᏧ㧘⋴⼔Ꮷ㧘ㅪ៤࠮ࡦ࠲࡯㧘⮎೷Ꮷ㧘ℂቇ/૞ᬺ≮ᴺ჻ࠍ੤߃ߚቯᦼ⊛∛᫟ળ⼏㧘࿾ၞߩක≮/⑔␩ࠬ࠲࠶ࡈࠍ੤߃ߚ᜛
ᄢࠞࡦࡈࠔ࡟ࡦࠬ࡜ࡦࠬߩ㓐ᤨ㐿௅㧘߆߆ࠅߟߌකߣߩ⸻≮ㅪ៤߇ㅴߺ㧘ቇౝᄖߩ␹⚻ౝ⑼⸻≮ߪ᣿ࠄ߆ߦෘߺࠍჇߒߚ‫ޕ‬‫ޣ‬ᢎ⢒‫⥃ޤ‬ᐥታ⠌߽㒢ࠄࠇߚᢎຬ/කຬߣዋߥ޿∛ᐥߢᎿᄦࠍಝࠄߒߡขࠅ⚵ߺ㧘6 ᐕ↢ߩࠢ࡝࠾ࠞ࡞ࠢ࡜
࡯ࠢࠪ࠶ࡊߪ߶߷ታ⃻ߒߡ޿ࠆ‫࡞ࠕ࡝࠻ࡘ࠴ޕ‬㑐ㅪ⻠⟵㧘⥃ᐥ౉㐷ታ⠌ߥߤߪ㧘ዋߥ޿ᢎቶຬ✚಴ߢኻᔕߒߡ߈ߚ‫⸰ߚ߹ޕ‬໧⋴⼔૕㛎ታ⠌ߪጘ㒂Ꮢ෸߮ᧄᎽකᏧળߩߏදജࠍᓧߡ㧘2000 ᐕ߆ࠄ⛮⛯⊛ߦⴕࠊࠇߡ޿ࠆ߇ቇ↢ߩ⹏ଔ߽㜞޿‫ޕ‬‫␠ޣ‬ળᵴേ‫ޤ‬ᄢቇ∛㒮߇㔍∛᜚ὐ∛㒮ߦᜰቯߐࠇ㧘㔍∛ኾ㐷ຬ߇⸳⟎ߐࠇߚߎߣ߆ࠄ␹⚻㔍∛ߩኻᔕߪᩰ
Ბߦᡷༀߐࠇߚ‫ޕ‬㔍∛ኾ㐷ຬߣ౒หߒߡ⑔␩ⴕ᡽ࠬ࠲࠶ࡈ㧘⸰໧⋴⼔Ꮷ࡮ࡋ࡞ࡄ࡯ߩᢎ⢒߇ߔߔࠎߢ޿
ࠆ‫ߦࠄߐޕ‬ጘ㒂⋵㔍∛ㅪߩขࠅ⚵ߺߦ߽Ⓧᭂ⊛ߦෳടߒ㧘࿾ၞߩ␹⚻㔍∛ኻᔕߩᐩ਄ߍߦ⽸₂ߒߡ߈ߚ‫ޕ‬␹⚻㔍∛╬ߦ߅޿ߡ㧘߆߆ࠅߟߌකߣߩㅪ៤ࠍᷓ߼ 2 ੱਥᴦක೙ࠍផㅴߒߡ␹⚻ౝ⑼ක≮ࠍᐢ߼ࠆߣߣ
߽ߦ㧘ᄢቇ∛㒮ߩᣂᖚ࡮㊀∝⠪ኻᔕജࠍ⏕଻ߒߡ߈ߚ‫ߌߟࠅ߆߆ޕ‬කߩ⹺⍮∝ኻᔕജะ਄⎇ୃ㧘࿾ၞߩ⹺⍮∝ࡀ࠶࠻ࡢ࡯ࠢߟߊࠅߩᵴേߦ㧘⻠Ꮷ߿ડ↹ߩ৻ㇱࠍᜂᒰߔࠆߥߤⓍᭂ⊛ߦෳടߒ㧘ጘ㒂⋵ߩ⹺⍮∝ኻᔕߩၮ⋚૞ࠅߦ⽸₂ߒߡ߈ߚ‫ޕ‬ቇౝᄖߩ⋴⼔Ꮷ㧘≮ᴺ჻ߩ㙃ᚑߦ߽⻠⟵╬ߦࠃࠅⓍᭂ⊛ߦ⽸₂ߒߚ‫ޕ‬⃻⁁ߩ໧㗴ὐ෸߮ߘߩኻᔕ╷૗ࠃࠅ߽ੱ᧚ߩ⏕଻߇໧㗴ߢ޽ࠆ‫⎇ޕ‬ⓥ࡮⸻≮࡮ᢎ⢒╬㧘૗ࠍ߿ࠆߦߒߡ߽߹ߕੱ᧚ߢ޽ࠆ‫⚻␹ޕ‬ౝ⑼ක≮߇࿾ၞߦᢛ஻ߐࠇߡ޿ߥ޿ᚲ߶ߤ㧘࿾ၞߩ∛㒮⎇ୃකߦ౉ዪߩ௛߈߆ߌ߇ߢ߈ߕ㧘ߐࠄߦᢛ஻߇
ㆃࠇࠆ᭴࿑ߪ㧘ᣂකᏧ⥃ᐥ⎇ୃ೙ᐲ߇ᚒ‫ߚߒࠄߚ߽ߦޘ‬෩ߒߔ߉ࠆ⹜✵ߢ޽ࠆߣᗵߓߡ޿ࠆ‫ޕ‬ኻ╷ߣߒߡߪ㧘ᣢߦขࠅ⚵ࠎߢ߈ߚߎߣߢߪ޽ࠆ߇㧘ታ⠌╬ߢߩቇ↢ߣߩ✕ኒߥធ⸅ߣߘߩ⛮⛯ࠍ࿑ࠆߎߣߢ޽
ࠆ‫ߛߚޕ‬තᓟ⎇ୃߩ 2 ᐕ㑆㧘లಽߥࠕࡊࡠ࡯࠴߇ߢ߈ߥ޿ߎߣߪଐὼ໧㗴ߢ޽ࠆ‫ޕ‬એਅߩ໧㗴ὐߦ౒ㅢߔࠆߩߪੱ᧚ਇ⿷ߢ޽ࠆ‫ޕ‬1㧕ᄖ᧪ኻᔕജ߇ਇචಽߢ޽ࠅᣂᖚ੍⚂ᦼ㑆㧘⸻ኤᓙߜᤨ㑆߇㐳ߊᡷༀ߇᳞߼ࠄࠇߡ޿ࠆߎߣ‫ߩߎޕ‬ὐߪ㧘 ߆߆ࠅߟߌකߣߩㅪ៤ࠍߐࠄߦᷓ߼ࠆᔅⷐ߽޽ࠆ‫ޕ‬
2㧕౉㒮࿷㒮ᣣᢙ߇㐳ߊ㧘౉㒮ᓙᯏ⠪߇Ᏹᤨᄙ޿ߎߣ‫ߩߎޕ‬ὐߪㅪ៤࠮ࡦ࠲࡯ߣㅌ㒮⺞ᢛࠍߐࠄߦㅴ߼ࠆ‫ޕ‬
3㧕࿾ၞߩ␹⚻ౝ⑼ኾ㐷ක߇߹ߞߚߊਇ⿷ߒߡ߅ࠅ㧘࿾ၞක≮ᯏ㑐߳ߩࡄ࡯࠻಴ᒛࠨࡐ࡯࠻߽࠾࡯࠭ߦㅊ
޿ߟ߆ߕ㧘ᄢᄌㆮᙝߦᗵߓߡ޿ࠆ‫ޕ‬4㧕ቇ↢ᢎ⢒ߦ߅޿ߡ 5 ᐕ↢ߩࠢ࡝࠾ࠞ࡞ࠢ࡜࡯ࠢࠪ࠶ࡊߩቢోታᣉ
ߦߪ߹ߛ㆙޿ߎߣ‫ޕ‬5㧕⸻≮࡮ᢎ⢒ߩᄙᔔൻ߽޽ࠅ⎇ⓥߦኾᔨߢ߈ࠆᤨ㑆߇ዋߥ޿ߎߣ‫ޕ‬એ਄㧘ੱ᧚ߩ⏕଻ߣ૬ߖߡ∛㒮ߩᢎຬࡐࠬ࠻㧔⃻࿷⥃ᐥ⻠Ꮷ 1㧕ߩჇ⸳߇㊀ⷐߢ޽ࠆ‫ޕ‬੹ᓟߩዷᦸోജࠍ޽ߍߡ૗ߣߒߡ߽ㄭ޿዁᧪㧘ᣂߚߥ౉ዪ⠪ࠍ᱑ㄫߒߚ޿‫ޕ‬㓞ធ⒖ォߒߡߊࠆ⮎⑼ᄢቇ߅ࠃ߮ቇ
ㇱౝಽ㊁ߣߩㅪ៤ࠍߐࠄߦᷓ߼㧘㔍ᴦᕈ␹⚻∔ᖚߩ⸃᳿ߦะߌߚ⎇ⓥߩિዷࠍ࿑ࠅߚ޿‫ߡ޿ߟߦ≮⸻ޕ‬ߪᄙ⡯⒳ߦࠃࠆቯᦼ⊛∛᫟ળ⼏㧘߆߆ࠅߟߌකߣߩㅪ៤ࠍᦝߦㅴ߼㧘ᣣᏱ߅ࠃ߮ᢇᕆ⸻≮ኻᔕജࠍ⏕଻ߒߡ޿ߊ‫∛ߦࠄߐޕ‬㒮ߩᢎຬࡐࠬ࠻ߩჇ⸳ࠍ᳞߼ߡ޿ߊ‫ޕ‬ቇ↢ᢎ⢒ߢߪᢎ᧚ߩᢛ஻㐿⊒ࠍㅴ߼ࠆߣ౒ߦ㧘㔍∛ߦኻߔࠆ⎇ⓥߩ㝯ജߣᔅⷐᕈ㧘␹⚻ౝ⑼߇✚ว⊛ක≮޽ࠅ㧘࿾ၞㅪ៤߇㊀ⷐߢ޽ࠆߎߣࠍᒝ⺞ߒߡ޿߈ߚ޿‫ޕ‬㔍∛ኾ㐷ຬߣදജߒߡ࿾ၞ␠ળߩ㔍∛ኻᔕജࠍ㜞߼ࠆദജࠍ⛯ߌߚ޿‫ߚ߹ޕ‬࿾ၞߩ⹺⍮∝ኻᔕജߩะ਄㧘ࠦࡔ࠺㨲ࠞ࡞ࠬ࠲࠶ࡈߩ␹⚻ౝ⑼࡮⠧ᐕ⑼ᢎ⢒ߦᒁ߈⛯߈⽸₂ߒߡ޿ߊ‫ޕ‬㧙㧙㧔5㧕♖␹∛ℂቇಽ㊁
1㧚⎇ⓥߩ᭎ⷐ
♖␹∛ℂቇಽ㊁ߦ߅ߌࠆ⎇ⓥߪ㧘2008 ᐕ 6 ᦬ߦ╙ 5 ઍႮ౉ବ᮸ᢎ᝼߇ዞછߒ㧘ᣂߚߥࠬ࠲࡯࠻ࠍㄫ߃
ߚ‫ߢ߹ࠇߎޕ‬ੑචᢙᐕ㑆ߦࠊߚࠅ㧘৻⽾ߒߡ⥃ᐥࠍ㊀ⷞߒ㧘ߘߎߦၮ⋚ࠍ⟎޿ߚ⎇ⓥࠍ⋡ᜰߒߡ߈ߚ‫੹ޕ‬
ᓟ߽ᒰಽ㊁ߩવ⛔ࠍ↢߆ߒߟߟ㧘ᦨᣂߩ࠾ࡘ࡯ࡠࠨࠗࠛࡦࠬߩ᭽‫ߥޘ‬ᚻᴺࠍขࠅ౉ࠇߡ㧘ᣂߚߥ⎇ⓥࠍⴕ
ߞߡࠁߊ੍ቯߢ޽ࠆ‫ޕ‬⤳ེ⒖ᬀ╬ߦઍ⴫ߐࠇࠆ㜞ᐲవㅴක≮߇น⢻ߣߥߞߚ৻ᣇ㧘ଔ୯ⷰ߿↢๮୶ℂߩᄙ᭽ൻࠍ⢛᥊ߣߒߡࠃ
ࠅ㐿߆ࠇߚක≮߇᳞߼ࠄࠇߡ޿ࠆ‫ߚ߹ޕ‬㧘㜞ᐲᖱႎൻߦࠃࠆㆊࠬ࠻࡟ࠬ␠ળߩ಴⃻㧘ዋሶ㜞㦂ൻ߿ㆊ⇹ൻ㧘
ⅣႺ໧㗴╬ߣ޿ߞߚ⻉໧㗴ߦኻߒ㧘ක≮ߪ੹߹ߢએ਄ߦㆡಾ߆ߟචಽߥኻᔕࠍߔߴ߈ߢ޽ࠆ‫ޕ‬ᄢቇߦ☋ࠍ⟎ߊක≮ੱߩ⡯ോߪ㧘వ┵⊛↢๮⑼ቇߦ㑐ߔࠆᢎ⢒࡮⎇ⓥߦ㊀߈ࠍ⟎߈ߟߟ߽㧘⥃ᐥߦ⋥⚿ߒߚ∔∛ߩ⸻ᢿ࡮ᴦ≮ߦᓎ┙ߟត⚝ဳ⎇ⓥࠍផㅴߒ㧘࿾ၞ␠ળߣ਎⇇ߩක≮ߦ⽸₂ߔࠆߎߣߢ޽ࠆ‫৻ޕ‬ᣇ㧘⥃ᐥ⻠ᐳߢߩ⎇ⓥߪ㧘਎⇇ߦㅢ↪ߔࠆ⎇ⓥ⠪ࠍ૞ࠆߎߣߛߌ߇⋡⊛ߢߪߥߊ㧘ߘ߁ߒߚ⎇ⓥࠍㅢߒߡ⥃ᐥ⢻ജࠍ⎇߈㧘⚿ᨐ⊛ߦᖚ⠪᭽ߩߚ߼ߦߥࠆ߽ߩߢߥߌࠇ߫ߥࠄߥ޿‫ޕ‬ᓥߞߡ㧘‫ߕ߹ޟ‬ೋ߼ߦ㧘⥃ᐥ޽ࠅ߈‫߁޿ߣޠ‬㧘⥃
ᐥ㊀ⷞߩᆫ൓ߪᦨ߽㊀ⷐߢ޽ࠆ‫ޕ‬ᒰಽ㊁ߢߪ㧘ᣣᏱ⥃ᐥߩਛߦ⎇ⓥߩ㐹߈ࠍᗵߓขࠇࠆක≮ੱࠍヘ಴ߔࠆߎߣࠍ⋡ᮡߣߒߡ㧘એਅߩ⎇ⓥࠍⴕߞߡ޿ߊ‫ޕ‬1㧕♖␹∔ᖚߩ Neuroimaging ⎇ⓥ㧔PET㧘f-MRI㧘MRS㧘NIRS ╬㧕
2㧕♖␹∔ᖚߩ⥄ᓞ␹⚻⎇ⓥ㧔Baroreflex㧘Papillary light reflex ╬㧕3㧕♖␹⑼⸻ᢿቇߦ㑐ߔࠆ⎇ⓥ㧔DSM-Φ㧘ICD-10 ╬㧕4㧕♖␹∔ᖚߣ↢ᵴ⠌ᘠ∛ߦ㑐ߔࠆ⎇ⓥ㧔DM ߿⯯ⴊᕈᔃ∔ᖚ ╬㧕5㧕⊒㆐㓚ኂߩ∉ቇ෸߮ Neuroimaging ⎇ⓥ㧔⥄㐽ᕈ㓚ኂ㧘Asperger 㓚ኂ㧘ADHD ╬㧕
6㧕ἴኂ♖␹කቇߦ㑐ߔࠆ⎇ⓥ
7㧕♖␹∔ᖚߩㆮવሶ⎇ⓥ
2㧚ฬ★
Ⴎ౉ବ᮸
ᢎ᝼㧦
㜞ጟ ஜ
ಎᢎ᝼㧦
⻠Ꮷ㧦
ᬀᧁ໪ᢥ
⻠Ꮷ㧦
㜞↰⍮ੑ
⥃ᐥ⻠Ꮷ㧦 ᷓየ ℉⥃ᐥ⻠Ꮷ㧦 ᚭፒᘕᄥ㇢
⥃ᐥ⻠Ꮷ㧦 ᄤ㊁㓶ᐔ⥃ᐥ⻠Ꮷ㧦 ᓟ⮮߹ߤ߆
කຬ㧦
➚➓ᘕ਽
කຬ㧦
ᰞᐸ ᵏ

Toshiki Shioiri
Ken Takaoka
Hirofumi Ueki
Tomoji Takata
Taku Fukao
Shintaro Tosaki
Yuhei Amano
Madoka Goto
Shinya Kouketsu
Akira Sakuraba

3㧚⎇ⓥᚑᨐߩ⊒⴫⪺ᦠ㧔๺ᢥ㧕
1㧕 ࠫࡖ࠶ࠢ㧩ࠕ࡜ࡦ࡮ࡒ࡟࡯࡞✬㧚ዊ಴ᶈਯ㧘㋈ᧁ࿡ᢥ㧘⩲ේ⺈৻⸶㧘ࠫࡖ࠶ࠢ࡮࡜ࠞࡦኻ⽎㑐ଥ(਄/ਅ)㧘
᧲੩㧦ጤᵄᦠᐫ㧧2006 ᐕ㧚
2㧕 㜞ጟ ஜ✬⪺㧚<ᣂⵝჇ⵬ᡷ⸓ >ቅ┙ࠍᕟࠇࠆߥ㧍㧘᧲੩㧦ᛕ⹏␠㧧2006 ᐕ㧚
3㧕 㜞ጟ ஜ㧘౎ᨰ㦖♿⪺㧚ᚢᓟ⁁ᴫ⺰㧘᧲੩㧦㔕Უᦠᚱ㧧2006 ᐕ㧚
4㧕 ⍹Ꮉᙗᒾ㧘㜞ጟ ஜ⪺㧚ߎߎࠈߩ∛ߪߎ߁ߒߡߟߊࠄࠇࠆ㧘᧲੩㧦ᛕ⹏␠㧧2006 ᐕ㧚
5㧕 㜞ጟ ஜ㧘ችบ⌀ม✬⪺㧚ߎߎࠈߩ⌀⺰㧘᧲੩㧦࠙ࠚࠗ࠷㧧2006 ᐕ㧚
6㧕 ᬀᧁ໪ᢥ㧚ᛥ߁ߟߩ⇣⒳ᕈ㧦ർ᧛ବ஥✬㧚ᛥ߁ߟߩ⃻ઍ⊛⻉⋧㧙ᔃℂ⊛࡮␠ળ⊛஥㕙߆ࠄ⑼ቇߔࠆ㧙㧘᧲੩㧦ࠁ߹ߦᦠᚱ㧧2006 ᐕ㧚
7㧕 㜞ጟ ஜ㧚ᒁ߈ߎ߽ࠅ⁚ࠅ㧦㜞ጟ ஜ㧘⧔ᴛବ੺✬㧘ᒁ߈ߎ߽ࠅ⁚ࠅ㧘᧲੩㧦㔕Უᦠᚱ㧧2007 ᐕ㧦113㧙
148㧚
8㧕 㜞ጟ ஜ㧚り૕ߪߥߗ᛫߁ߟ⮎ࠍ㘩ߴ⛯ߌࠆߩ߆㧦㜞ጟ ஜ㧘⍹Ꮉ ಎ✬㧚り૕ࠍ߼ߋࠆ࡟࠶ࠬࡦ 3 ⣂ᛂߟり૕㧘᧲੩㧦ጤᵄᦠᐫ㧧2007 ᐕ㧦49㧙73㧚
9㧕 㜞ጟ ஜ㧚⥄㐽∝⺰ߩේὐ㧘᧲੩㧦㔕Უᦠᚱ㧧2007 ᐕ㧚
10㧕 㜞ጟ ஜ㧚ㄭઍߩ⚳ࠊࠅ㧙ዋᐕᴺ߳ߩㆮ೙ߩᷙᶳߣᣂ⥄↱ਥ⟵㧙㧦૒⮮ᐙᄦ㧘ጊᧄ⼑ม✬㧚ዋᐕ‽⟋෩⟏
ൻ⑳ߪߎ߁⠨߃ࠆ㧘᧲੩㧦ᵗᴰ␠㧧2007 ᐕ㧦222㧙239㧚
11㧕 㜞ጟ ஜ㧚ࡔࡦ࠲࡞ࡋ࡞ࠬߞߡ㨯㨯㨯㧫㧦⮮ᧄ ⼾㧘㜞ᯅ ৻㧘ᨋ ৻ᅢ✬㧚ࠦࡔ࠺ࠖࠞ࡞ࠬ࠲࠶ࡈߩߚ߼ߩ
♖␹㓚ኂ Q㧒A㧘᧲੩㧦ਛᄩᴺⷙ㧧2007 ᐕ㧦26㧙27㧚
12㧕 㜞ጟ ஜ㧚ᢎ⢒⃻႐ߢߩ㓚ኂ㧦⮮ᧄ ⼾㧘㜞ᯅ ৻㧘ᨋ ৻ᅢ✬㧚ࠦࡔ࠺ࠖࠞ࡞ࠬ࠲࠶ࡈߩߚ߼ߩ♖␹㓚㧙㧙ኂ Q㧒A㧘᧲੩㧦ਛᄩᴺⷙ㧧2007 ᐕ㧦76㧙77㧚
13㧕 㜞ጟ ஜ㧚ᕁᤐᦼߩ♖␹㓚ኂ㧦♖␹଻ஜ⑔␩⊕ᦠ✬㓸ᆔຬળ✬㧚♖␹଻ஜ⑔␩⊕ᦠ 2008 ᐕ 㧘᧲੩㧦ਛ
ᄩᴺⷙ㧧2007 ᐕ㧦168㧚
14㧕 ᬀᧁ໪ᢥ㧚ౝ࿃ᕈ♖␹∛ߩ੍ᓟቇ㧘ᴦ≮ߣ∝⁁ᡷༀߦኻߔࠆ߁ߟ∛⠪ߩ૕㛎ߦߟ޿ߡ㧦 Max-PaulEngelmeier㧘Horst Mester㧘㘵↰ ⋿㧘࡜ࠗ࠽࡯࡮࠹࡟✬㧚ᄙᰴర♖␹කቇ㧙࠴ࡘ࡯ࡆࡦࠥࡦቇᵷߣߘߩ
⃻ઍ⊛ᗧ⟵㧙㧘᧲੩㧦ጤፒቇⴚ಴ ␠㧧2007 ᐕ㧦125㧙175㧘247㧙263㧘345㧙347㧘349㧙350㧚
15㧕 ዊ಴ᶈਯ㧘⷏የᓆᵏ㧚ᅦᗐߪߥߗᔅⷐ߆㧙࡜ࠞࡦᵷߩ♖␹∛⥃ᐥ㧙㧘᧲੩㧦ጤᵄᦠᐫ㧧2008 ᐕ㧚
16㧕 ዊ಴ᶈਯ㧚♖␹∛ℂቇ౉㐷㧦ዊ಴ᶈਯᢎ᝼ㅌቭ⸥ᔨ⺰ᢥ㓸✬㓸ᆔຬળ(ઍ⴫ 㜞ጟ ஜ)✬㧚♖␹∛ℂቇߩ
⫷ⓧ㧘᧲੩㧦㊄೰಴ 㧧2008 ᐕ㧦11㧙38㧚
17㧕 ዊ಴ᶈਯ㧚⛯㨯♖␹∛ℂቇ౉㐷㧦ᴦ≮✬㧦ዊ಴ᶈਯᢎ᝼ㅌቭ⸥ᔨ⺰ᢥ㓸✬㓸ᆔຬળ(ઍ⴫ 㜞ጟ ஜ)✬㧚♖
␹∛ℂቇߩ⫷ⓧ㧘᧲੩㧦㊄೰಴ 㧧2008 ᐕ㧦39㧙84㧚
18㧕 㜞ጟ ஜ㧚߿ߐߒ޿⊒㆐㓚ኂ⺰㧘᧲੩㧦ᛕ⹏␠㧧2008 ᐕ㧚
19㧕 㜞ጟ ஜ㧚⸻ᢿ⺰ࡁ࡯࠻㧦ዊ಴ᶈਯᢎ᝼ㅌቭ⸥ᔨ⺰ᢥ㓸✬㓸ᆔຬળ(ઍ⴫ 㜞ጟ ஜ)✬㧚♖␹∛ℂቇߩ⫷ⓧ㧘᧲੩㧦㊄೰಴ 㧧2008 ᐕ㧦87㧙96㧚
20㧕 ᧻ᧄ㓷ᒾ㧘㜞ጟ ஜ✬㧚⊒㆐㓚ኂߣ޿߁⸥ภ㧘᧲੩㧦ᛕ⹏␠㧧2008 ᐕ㧚
21㧕 㜞ጟ ஜ㧚∛ℂ㧦ጘ㒂ᄢቇᢎ⢒ቇㇱ․೎ᡰេᢎ⢒⎇ⓥળ(ઍ⴫ ဈᧄ ⵨)✬㧚․೎ᡰេᢎ⢒ࠍቇ߱[╙ 2 ]㧘੩ㇺ㧦࠽ࠞ࠾ࠪࡗ಴ 㧧2008 ᐕ㧚
22㧕 ᬀᧁ໪ᢥ㧚␠ળ㨯ᢥൻ⊛໧㗴㧦਄ፉ࿖೑㧘ᮘญノᒾ㧘㊁᧛✚৻㇢㧘ᄢ㊁ ⵨㧘␹ᐸ㊀ା㧘የፒ♿ᄦ✬㧚᳇ಽ㓚ኂ㧘᧲੩㧦කቇᦠ㒮㧧2008 ᐕ㧦328㧙332㧚
23㧕 ᬀᧁ໪ᢥ㧚⡯ၞߩ໧㗴ߦ߅޿ߡ⥃ᐥ♖␹කቇ߇ᨐߚߔᓎഀ㧙‫ࠬ࡟࠻ࠬޟ‬㧙⣀ᒙᕈ‫ⷰߩ࡞࠺ࡕޠ‬ὐ߆ࠄ㧙㧦ዊ಴ᶈਯᢎ᝼ㅌቭ⸥ᔨ⺰ᢥ㓸✬㓸ᆔຬળ(ઍ⴫ 㜞ጟ ஜ)✬㧚♖␹∛ℂቇߩ⫷ⓧ㧘᧲੩㧦㊄೰಴ 㧧2008ᐕ㧦126㧙134㧚
24㧕 ㊁፸ ℂ㧘ᬀᧁ໪ᢥ㧚᳇ಽ㓚ኂߣ⸥ᙘ㧘᰼േ㧦ዊ಴ᶈਯᢎ᝼ㅌቭ⸥ᔨ⺰ᢥ㓸✬㓸ᆔຬળ(ઍ⴫ 㜞ጟ ஜ)✬㧚♖␹∛ℂቇߩ⫷ⓧ㧘᧲੩㧦㊄೰಴ 㧧2008 ᐕ㧦117㧙125㧚
25㧕 㜞↰⍮ੑ㧚⹺⍮∝ᖚ⠪ߩᤨ㑆ߣ਎⇇㧦ዊ಴ᶈਯᢎ᝼ㅌቭ⸥ᔨ⺰ᢥ㓸✬㓸ᆔຬળ(ઍ⴫ 㜞ጟ ஜ)✬㧚♖␹
∛ℂቇߩ⫷ⓧ㧘᧲੩㧦㊄೰಴ 㧧2008 ᐕ㧦173㧙182㧚
26㧕 ᷓየ ℉㧚ੱᩰ㓚ኂߩ෻ᓳ⥄்ߣකᏧߩᔕถ⟵ോ㧦ዊ಴ᶈਯᢎ᝼ㅌቭ⸥ᔨ⺰ᢥ㓸✬㓸ᆔຬળ(ઍ⴫ 㜞ጟஜ)✬㧚♖␹∛ℂቇߩ⫷ⓧ㧘᧲੩㧦㊄೰಴ 㧧2008 ᐕ㧦147㧙152㧚⪺ᦠ㧔᰷ᢥ㧕
ߥߒ✚⺑㧔๺ᢥ㧕
1㧕 㜞ጟ ஜ㧚✚⺰㧦ࡔ࡜ࡦࠦ࡝࡯ߩᓐጯ߳㧙シ∝ൻ࡮ᷙว⁁ᘒ࡮㕖ቯဳൻ㧙㧘♖␹ක≮ 2008 ᐕ㧧52 Ꮞ㧦
25㧙32㧚
✚⺑㧔᰷ᢥ㧕
ߥߒේ⪺㧔๺ᢥ㧕
1㧕 㜞ጟ ஜ㧚⊒㆐㓚ኂߪ‽⟋ࠍᗖ⿠ߔࠆ߆㧘ᢎ⢒ߣᢥൻ 2006 ᐕ㧧42 Ꮞ㧦6㧙14㧚
2㧕 ᬀᧁ໪ᢥ㧘ዊᎹ⋥ᔒ㧘㘵↰ብ᮸㧚߁ߟ∛ߩᱷㆮ∝⁁ߦኻߒߡ ECT ߇⪺ߒߚ 1 ଀㧘⥃ᐥ♖␹කቇ 2006 ᐕ㧧
35 Ꮞ㧦1195㧙1200㧚
3㧕 ᬀᧁ໪ᢥ㧚ᣣᧄੱߩ߁ߟ∛ߣᄖ࿖ੱߩ߁ߟ∛㧙ᣣᧄੱߩ߁ߟ∛ᖚ⠪ߣ⻉ᄖ࿖ߩ߁ߟ∛ᖚ⠪㑆ߦߪᕈᩰ㕙ߣ∝⁁㕙ߦ߅߅ߌࠆ㆑޿ߪ޽ࠆߩ߆㧙㧘කቇߩ޽ࠁߺ 2006 ᐕ㧧219 Ꮞ㧦930㧙934㧚
4㧕 ᷓየ ℉㧚࿎㔍ߥ∝଀߆ࠄቇ߱㧙ᴦ≮࠴࡯ࡓ߇ᅦᗐߦขࠅㄟ߹ࠇߡߒ߹ߞߚࠤ࡯ࠬ㧙㧘Schizophrenia
Frontier 2006 ᐕ㧧7 Ꮞ㧦50㧙53㧚
5㧕 ⷏የᓆᵏ㧚‫౉⸃⺒ࡦࠞ࡜ޟ‬㐷‫ޠ‬I.R.S.㧙ࠫࡖ࠶ࠢ࡮࡜ࠞࡦ⎇ⓥ㧙No.5㧘ᣣᧄ࡜ࠞࡦදળ 2006 ᐕ㧧250㧙265㧚
6㧕 ⮮၂㤗⴩ሶ㧘㜞↰⍮ੑ㧘ዊ಴ᶈਯ㧚ᣧᦼߦ↢ᵴ⁁ᴫߦᡷༀࠍ⹺߼ߚᕁᤐᦼᅦᗐ∝ߩ 1 ଀㧘♖␹⑼ 2006 ᐕ㧧
8 Ꮞ㧦408㧙412㧚
7㧕 㜞ጟ ஜ㧚♖␹කቇℂ⺰ߩෂᯏࠍ߼ߋࠆᢿ┨㧘♖␹ක≮ 2007 ᐕ㧧45 Ꮞ㧦92㧙99㧚
8㧕 㜞ጟ ஜ㧚ࠕࠬࡍ࡞ࠟ࡯∝୥⟲ߣ෻␠ળ⊛ⴕേ㧙มᴺ੐଀߆ࠄ㧙㧘♖␹≮ᴺ 2007 ᐕ㧧33 Ꮞ㧦462㧙467㧚
9㧕 㑐 ᱜ᮸㧘㜞ጟ ஜ㧚ቯဳ⊒㆐ఽߩਇ⊓ᩞߣᐢ᳢ᕈ⊒㆐㓚ኂఽߩਇ⊓ᩞߩᲧセ㧘ᦨᣂ♖␹කቇ 2007 ᐕ㧧
12 Ꮞ㧦461㧙465㧚
10㧕 ᬀᧁ໪ᢥ㧘⷏የᓆᵏ㧘ዊᎹ⋥ᔒ㧚⡯႐ߩࡔࡦ࠲࡞ࡋ࡞ࠬߦ߅ߌࠆ⥄Ვߩࡐࠬ࠻ࡌࡦ࡚ࠪࡦᵴേߦ㑐ߔࠆ৻⠨ኤ㧘ᦨᣂ♖␹කቇ 2007 ᐕ㧧13 Ꮞ㧦103㧙110㧚
11㧕 㒸 ፋᢥ㧘ᬀᧁ໪ᢥ㧘㜞੗ᤘ⵨㧘ฎᎹᄈ੫㧚㜞㦂⠪߁ߟ∛ߩ⹺⍮㨯ⴕേ⊛․ᓽߩᬌ⸛㧙⹺⍮ⴕേ≮ᴺࡊࡠࠣ࡜ࡓߩ㐿⊒ߦะߌߡ㧙㧘ฎᎹ⽷࿅ᴺੱ᣿ᴦ቟↰ߎߎࠈߩஜᐽ⽷࿅ 2006 ᐕᐲ⎇ⓥഥᚑ⺰ᢥ㓸 2007 ᐕ㧧171
㧙180㧚
12㧕 㜞↰⍮ੑ㧘㜞ጟ ஜ㧘㊄ጟ❥⵨㧚⑳⊛♖␹㐓ቯߩᗧ⟵㧘⥃ᐥ♖␹කቇ 2007 ᐕ㧧36 Ꮞ㧦1075㧙1081㧚
13㧕 㜞↰⍮ੑ㧘㜞ጟ ஜ㧘㊄ጟ❥⵨㧚ⶄ㔀㈻㈦ߣ⽿છ⢻ജ㧘♖␹කቇ 2007 ᐕ㧧49 Ꮞ㧦1263㧙1273㧚
14㧕 ⷏የᓆᵏ㧘ᓟ⮮ᄥ㇢㧘ᬀᧁ໪ᢥ㧚♖␹⑼ߢߩり૕᜔᧤ᖚ⠪ߦ߅ߌࠆᷓㇱ㕒⣂ⴊᩖ∝㧘♖␹␹⚻ቇ㔀⹹ 2007
ᐕ㧧109 Ꮞ㧦998㧙1007㧚㧙㧙15㧕 ⷏የᓆᵏ㧘ᬀᧁ໪ᢥ㧚ᘟᕈ߁ߟ∛ߦኻߔࠆ⡊੺≮ᴺ㧘ᦨᣂ♖␹කቇ 2007 ᐕ㧧12 Ꮞ㧦55㧙56㧚
16㧕 Ⴎ౉ବ᮸㧘ICD-10 ߩ໧㗴ὐߣ ICD-11 ߦะߌߡߩ⺖㗴:F4 ␹⚻∝ᕈ㓚ኂ㧘ࠬ࠻࡟ࠬ㑐ㅪ㓚ኂ߅ࠃ߮り૕⴫⃻ᕈ㓚ኂ㧘♖␹␹⚻ቇ㔀⹹ 2008 ᐕ㧧110 Ꮞ㧦887㧙979㧚
17㧕 ㆙⮮ᄥ㇢㧘Ⴎ౉ବ᮸㧘ᨴ⍫ବᐘ㧘ᐢ᳢ᕈ⊒㆐㓚ኂߩ⣖ౝ↢ൻቇઍ⻢⇣Ᏹ㧘♖␹␹⚻ቇ㔀⹹ 2008 ᐕ㧧110
Ꮞ㧦797㧙804㧚
18㧕 㜞ጟ ஜ㧘㜞↰⍮ੑ㧘ⵙ್ຬ೙ᐲߣ♖␹㐓ቯ㨯㐓ቯੱ዆໧(Letter)㧘♖␹කቇ 2008 ᐕ㧧50 Ꮞ㧦826㧚
19㧕 㜞ጟ ஜ㧘␠ળᕟᔺ(␠ળਇ቟㓚ኂ)㧘♖␹⑼ᴦ≮ቇ 2008 ᐕ㧧23 Ꮞ㧦341㧙344㧚
20㧕 㜞ጟ ஜ㧚ᐢ᳢ᕈ⊒㆐㓚ኂߣ♖␹㐓ቯ㧘ᔃߣ␠ળ 2008 ᐕ㧧39 Ꮞ㧦22㧙26㧚
21㧕 ᬀᧁ໪ᢥ㧘⷏የᓆᵏ㧘ዊᎹ⋥ᔒ㧚⡯႐ߩࡔࡦ࠲࡞ࡋ࡞ࠬߦ߅ߌࠆ⥄Ვߩࡐࠬ࠻ࡌࡦ࡚ࠪࡦᵴേߦ㑐ߔࠆ৻⠨ኤ㧘ᦨᣂ♖␹කቇ 2008 ᐕ㧧13 Ꮞ㧦83㧙90㧚
22㧕 ⷏የᓆᵏ㧘ᬀᧁ໪ᢥ㧘♖␹⑼ᖚ⠪ߦ߅ߌࠆᘟᕈଢ⒁ߩᴦ≮㧘♖␹⑼ᴦ≮ቇ 2008 ᐕ㧧23 Ꮞ㧦1271㧙1278㧚
23㧕 㜞↰⍮ੑ㧘㜞ጟ ஜ㧘ౝ↰޽߅޿㧘ዊፉਭౖ㧘Paroxetine ߩㅌ⮎ߢੑ㊀り߇಴⃻ߒߚ 1 ଀㧘⥃ᐥ♖␹⮎ℂ
2008 ᐕ㧧11 Ꮞ㧦155㧙158㧚
24㧕 㜞↰⍮ੑ㧘㜞ጟ ஜ㧘㊄ጟ❥⵨㧚⑳⊛♖␹㐓ቯߩᗧ⟵㧘ቄೀೃ੐ᑯ⼔ 2008 ᐕ㧧53 Ꮞ㧦134㧙140㧚
25㧕 㜞↰⍮ੑ㧘㜞ጟ ஜ㧚㜞㦂⠪ߩࡄ࡜ࡁࠗࠕ⁁ᘒ㧙♖␹㐓ቯ଀߆ࠄߩᬌ⸛㧙㧘⥃ᐥ♖␹∛ℂ 2008 ᐕ㧧28
Ꮞ㧦257㧙264㧚
26㧕 㜞↰⍮ੑ㧘㜞ጟ ஜ㧚Aripiprazole ߇ᄼലߒߚญ⣧ౝ࠮ࡀࠬ࠻ࡄ࠴࡯ߩ 1 ∝଀㧘⥃ᐥ♖␹කቇ 2008 ᐕ㧧
37 Ꮞ㧦825㧙829㧚ේ⪺㧔᰷ᢥ㧕
1㧕 Ueki H, C Holzapfel, Sakado K, Washino K, Inoue M, Ogawa N, Ietsugu T, Takai A. Prevalance ofTypus Melancholicus in Healthy Germans. Psychopathology. 2006;39:113-119.
IF 0.750
2㧕 Takaoka K, Takata T. Catatonia in high-functioning autism spectrum disorders:case report and review
of literature. Psychological Rep. 2007;101:961-969.
IF 0.364
3㧕 Ogawa N, Ueki H. Clinical importance of caffeine dependence and abuse. Psychia Clin Neurosci.
2007;61:263-268.
IF 1.1324㧚⎇ⓥ⾌₪ᓧ⁁ᴫ
1㧕┹੎⊛⾗㊄1㧕 ⎇ⓥઍ⴫⠪㧦Ⴎ౉ବ᮸㧧⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(C)(2)㧦ࡄ࠾࠶ࠢ㓚ኂᖚ⠪ᚳ᩶૕ߦ߅ߌࠆࠣ࡞࠲ࡒ
ࡦ㉄෸߮ǫ㧙ࠕࡒࡁ㈼㉄ઍ⻢⇣Ᏹߦ㑐ߔࠆ⎇ⓥ㧧ᐔᚑ 19㧙20 ᐕᐲ㧧3,500 ජ౞(2,100㧦1,400 ජ౞)
2㧕 ⎇ⓥಽᜂ⠪㧦Ⴎ౉ବ᮸㧧⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(A)㧦ἴኂᤨߦ߅ߌࠆലᨐ⊛ᔃℂ⊛ᡰេߚ߼ߩㅪ៤
දജߦ㑐ߔࠆ⎇ⓥ㧧ᐔᚑ 19㧙21 ᐕᐲ㧧1,960 ජ౞(1,160㧦800 ජ౞)
2㧕ฃ⸤⎇ⓥߥߒ
3㧕౒ห⎇ⓥߥߒ
5㧚⊒᣿࡮․⸵಴㗿⁁ᴫߥߒ
6㧚ቇળᵴേ
1㧕ቇળᓎຬႮ౉ବ᮸㧦
1㧕 ᣣᧄ↢‛ቇ⊛♖␹කቇળ⹏⼏ຬ(㨪⃻࿷)2㧕 ᣣᧄ♖␹⑼⸻ᢿቇળ⹏⼏ຬ(㨪⃻࿷)3㧕 ᣣᧄ✚ว∛㒮♖␹කቇળ⹏⼏ຬ(㨪⃻࿷)4㧕 ᣣᧄ⛔วᄬ⺞∝ቇળ⹏⼏ຬ(㨪⃻࿷)5㧕 ᣣᧄਇ቟㓚ኂቇળ⹏⼏ຬ(㨪⃻࿷)㜞ጟ ஜ㧦
1㧕 ᣣᧄ♖␹␹⚻ቇળ⹏⼏ຬ(㨪⃻࿷)2㧕 ᣣᧄఽ┬㕍ᐕ♖␹කቇળ⹏⼏ຬ(~⃻࿷)
3㧕 ᣣᧄ✚ว∛㒮♖␹කቇળ⹏⼏ຬ(㨪⃻࿷)4㧕 ᣣᧄ♖␹∛ℂቇળ⹏⼏ຬ(㨪⃻࿷)㧙㧙ᬀᧁ໪ᢥ㧦
1㧕 ᣣᧄ♖␹␹⚻ቇળ⹏⼏ຬ(㨪⃻࿷)2㧕 ᣣᧄࡊ࡜ࠗࡑ࡝㨯ࠤࠕቇળ⹏⼏ຬ(㨪⃻࿷)3㧕 ᣣᧄ✚ว∛㒮♖␹කቇળ⹏⼏ຬ(㨪⃻࿷)4㧕 ᣣᧄ♖␹⑼⸻ᢿቇળ⹏⼏ຬ(㨪⃻࿷)5㧕 ᣣᧄᔃりකቇળઍ⼏ຬ(㨪⃻࿷)㜞↰⍮ੑ㧦1㧕 ᣣᧄ✚ว∛㒮♖␹කቇળ⹏⼏ຬ(㨪⃻࿷)2㧕 ᣣᧄ⠧ᐕ♖␹කቇળ⹏⼏ຬ(㨪⃻࿷)3㧕 ᣣᧄ✚ว∛㒮♖␹කቇળ᦭ᐥ✚ว∛㒮♖␹ක≮໧㗴ᆔຬળᆔຬ(㨪⃻࿷)4㧕 ᣣᧄ✚ว∛㒮♖␹කቇળ⸻≮ႎ㈽ᆔຬળᆔຬ(㨪⃻࿷)5㧕 ᧲ᶏ♖␹␹⚻ቇળㆇ༡ᆔຬ(㨪⃻࿷)ᷓየ ℉㧦
1㧕 ᣣᧄఽ┬㕍ᐕ♖␹කቇળ⹏⼏ຬ(~⃻࿷)
2㧕ቇળ㐿௅
ߥߒ
3㧕ቇⴚ㔀⹹
ߥߒ
7㧚ቇળ᜗ᓙ⻠Ṷ㧘᜗ᓙࠪࡦࡐࠫࠬ࠻㧘ᐳ㐳Ⴎ౉ବ᮸㧦
1㧕 ╙ 28 ࿁ᣣᧄ♖␹⑼⸻ᢿቇળ(2008 ᐕ 10 ᦬㧘ᧅᏻ㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬ICD-11 ߳ะߌߡࠕࠫࠕ࡮ᣣᧄ߆
ࠄߩឭ⸒㧦␹⚻∝ᕈ㓚ኂ㑐ㅪ∔ᖚ‫ޠ‬Ṷ⠪)㜞ጟ ஜ㧦
1㧕 ᣣᧄሶߤ߽࠰࡯ࠪࡖ࡞ࡢ࡯ࠢදળ(2006 ᐕ 2 ᦬㧘᧲੩㧘ࠪࡦࡐࠫ࠙ࡓ‫⯦ޟ‬ᓙߣࠕ࠳࡞࠻࠴࡞࠼࡟ࡦ
ࠍ⠨߃ࠆ‫ޠ‬Ṷ⠪)
2㧕 ᣣᧄሶߤ߽࠰࡯ࠪࡖ࡞ࡢ࡯ࠢදળ(2006 ᐕ 6 ᦬㧘᧲੩㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬ሶߤ߽ߦߣߞߡߩᄢੱ໧㗴‫ޠ‬Ṷ⠪)3㧕 ‫࡞࡯ࠢࠬ࡞࠲ࡦࡔ࡮ࠗࠕޟ‬੐ઙ‫ࠍޠ‬⠨߃ࠆᗲ⍮ߩળ(2006 ᐕ 7 ᦬㧘ฬฎደ㧘ࠪࡦࡐࠫ࠙ࡓ‫࡮ࠗࠕޟ‬ࡔࡦ࠲࡞ࠬࠢ࡯࡞ኰ↢ᱫ੢੐ઙࠍ⠨߃ࠆ㓸޿‫ޠ‬Ṷ⠪)
4㧕 ╙ 47 ࿁ᣣᧄఽ┬㕍ᐕ♖␹කቇળ(2006 ᐕ 10 ᦬㧘ජ⪲㧘ࡄࡀ࡞࠺ࠖࠬࠞ࠶࡚ࠪࡦมળ)5㧕 ᣣᧄሶߤ߽࠰࡯ࠪࡖ࡞ࡢ࡯ࠢදળ(2006 ᐕ 12 ᦬㧘᧲੩㧘ࠪࡦࡐࠫ࠙ࡓ‫ⷫޟ‬Ვߒࠍߖߑࠆࠍ߃ߥ޿ዋ
ᐕ‫ޠ‬Ṷ⠪)
6㧕 18th World Congress of IACAPAP (2007.04㧙05㧘Istanbul㧘Competency to stand trial in autism.)7㧕 ╙ 35 ࿁ᣣᧄ‽⟋␠ળቇળ(2008 ᐕ 10 ᦬㧘᧲੩㧘ዋᐕ㕖ⴕߣ‫ޟ‬ᐢ᳢ᕈ⊒㆐㓚ኂ‫࡞ࡉ࡯࠹࠼ࡦ࠙࡜ޠ‬࠺ࠖࠬࠞ࠶࡚ࠪࡦ⹤㗴ឭଏ⠪)8㧚ቇⴚ⾨╬ߩฃ⾨⁁ᴫߥߒ9㧚␠ળᵴേႮ౉ବ᮸㧦
1㧕 ጘ㒂⋵♖␹଻ஜ⑔␩දળ೽ળ㐳(㨪⃻࿷)2㧕 ጘ㒂⋵♖␹ක≮ክᩏળᆔຬ(㨪⃻࿷)㜞ጟ ஜ㧦
1㧕 ጘ㒂⋵♖␹ක≮ክᩏળᆔຬ(㨪⃻࿷)㧙㧙ᬀᧁ໪ᢥ㧦
1㧕 ጘ㒂ഭ௛ዪ࿾ᣇഭἴᆔຬ(㨪⃻࿷)2㧕 ጘ㒂Ꮢ↢ᵴ଻⼔ᴺක≮ᛔഥክᩏળᆔຬ(㨪⃻࿷)3㧕 ጘ㒂⋵♖␹଻ஜ⑔␩දળක≮ኾ㐷ᆔຬળᆔຬ(㨪⃻࿷)ᷓየ ℉㧦
1㧕 ጘ㒂ഭ௛ዪ࿾ᣇഭἴᆔຬ(㨪⃻࿷)10㧚ႎ๔ᦠ
1㧕 㜞ጟ ஜ㧚มᴺ㧦৻⥸♖␹⑼කߩߚ߼ߩሶߤ߽ߩᔃߩၮ␆⍮⼂㧦ᐔᚑ 18 ᐕᐲෘ↢ഭ௛⑼ቇ⎇ⓥ⾌⵬ഥ㊄(ሶߤ߽ኅᐸ✚ว⎇ⓥ੐ᬺ)‫ޟ‬ሶߤ߽ߩᔃߩ⸻≮ߦ៤ࠊࠆኾ㐷⊛ੱ᧚ߩ⢒ᚑߦ㑐ߔࠆ⎇ⓥ‫ޠ‬㧘2007ᐕ㧧44㧙45㧚2㧕 㤥Ꮉᷕ৻㧘ጤ↰ᒄᢅ㧘ᬀᧁ໪ᢥ㧘੗ᄹᵄ⦟৻㧘੗਄⋿ੱ㧘✎⽾࡞ࡒሶ㧘᦯ㇱ౏ᒾ㧘ᳰ↰ਭၮ㧘૒⮮Ẵሶ㧚♖␹∔ᖚߢભ⡯ߒߚഭ௛⠪ߦኻߔࠆ⡯႐ᓳᏫᡰេߦ㑐ߔࠆ⎇ⓥ㧦ᐔᚑ 19 ᐕᐲ↥ᬺ଻ஜ⺞ᩏ⎇ⓥႎ๔ᦠ㧘2008 ᐕ㧚
11㧚ႎ㆏
1㧕 㜞ጟ ஜ㧦‫ᤨޟ‬ઍ∛‫⑼␹♖┬ఽޠ‬ක߇⺆ࠆ੹ߩሶߤ߽㧦ᢎ⢒ක੐ᣂ⡞(2006 ᐕ㧘256(ઃ㍳)3)
2㧕 㜞ጟ ஜ㧦ᤨઍᤋߔ♖␹㐓ቯ ⵙ್ࠍᄌ߃ࠆ㧫㧦↥⚻ᣂ⡞(2006 ᐕ 1 ᦬ 16 ᣣ)
3㧕 㜞ጟ ஜ㧦૒਎଻੐ઙ࡮ടኂዋᅚ㧦⷏ᣣᧄᣂ⡞(2006 ᐕ 1 ᦬ 16 ᣣ)
4㧕 㜞ጟ ஜ㧦ዋᅚߩᦝᱜ㗅⺞ߣ⹏ଔ㧦⷏ᣣᧄᣂ⡞(2006 ᐕ 5 ᦬ 27 ᣣ)
5㧕 㜞ጟ ஜ㧦ήℂ߿ࠅߢߪ⁁ᴫᖡൻ㧦ਛᣣᣂ⡞(2006 ᐕ 5 ᦬ 30 ᣣ)
6㧕 ᬀᧁ໪ᢥ㧦㜞㦂⠪ߩ߁ߟ∛ߣߪ㧦ጘ㒂᡼ㅍ‫᦬ޟ‬㊄࡜ࠫࠝ 2 ᤨ 6 ᤨ‫(ޠ‬2007 ᐕ 4 ᦬ 5 ᣣ)
7㧕 ᬀᧁ໪ᢥ㧦㜞㦂⠪ߩ߁ߟ∛ߩ੍㒐㧦ጘ㒂᡼ㅍ‫᦬ޟ‬㊄࡜ࠫࠝ 2 ᤨ 6 ᤨ‫(ޠ‬2007 ᐕ 4 ᦬ 12 ᣣ)
8㧕 㜞ጟ ஜ㧦‫ ߨ߻߅߅ޟ‬12 ᱦ‫ޠ‬ᡷᱜዋᐕᴺࠍ⠨߃ࠆ(਄)㧦㐳ፒᣂ⡞(౒หㅢା㈩ା)(2007 ᐕ 5 ᦬ 29 ᣣ)
9㧕 㜞ጟ ஜ㧦Უߣߩ㑐ଥ⸅ࠇߕਇචಽ㧦⑔ፉ᳃෹(౒หㅢା㈩ା)(2008 ᐕ 2 ᦬ 27 ᣣ)
10㧕 㜞ጟ ஜ㧦ᒁ߈ߎ߽ࠅߣ⧯⠪ߩੱᮭ㧦ᄢੱදㅢା No.8(2008 ᐕ)
11㧕 㜞ጟ ஜ㧦⡯႐ߩℂ⸃ᄢಾ㧦ᦺᣣᣂ⡞(2008 ᐕ 7 ᦬ 25 ᣣ)
12㧚⥄Ꮖ⹏ଔ
⹏ଔ਄⸥ߩࠃ߁ߦ㧘♖␹∛ℂቇ⊛⎇ⓥߩਅ㧘᭽‫⎇ߥޘ‬ⓥᚑᨐ߇਄߇ߞߡ߈ߡ޿ࠆ‫ߪࠄࠇߘޕ‬㧘ᣣᏱ⥃ᐥߦ⋥⚿ߔࠆ߽ߩߢ޽ࠅ㧘࿾ၞߢߩ♖␹ක≮ߩዷ㐿ߦ߅޿ߡ߽ᄢ߈ߥೝỗߣߥߞߡ޿ࠆ‫ߚ߹ޕ‬㧘਄⸥ߩႎ๔
ߩઁߦ㧘♖␹∛ℂቇಽ㊁ࠍ᜼ߍߡⓍᭂ⊛ߦมᴺ♖␹㐓ቯࠍⴕߞߡ߅ࠅ㧘ߘ߁޿ߞߚὐߢ߽␠ળ⊛⽸₂ࠍ
ᨐߚߒߡ޿ࠆ‫ޕ‬⃻⁁ߩ໧㗴ὐ෸߮ߘߩኻᔕ╷ᄢቇ߽ੱຬਇ⿷ߩߚ߼㧘ฦࠬ࠲࠶ࡈ߇⥃ᐥ㧘ᢎ⢒㧘⎇ⓥߣ⿛ࠅ࿁ߞߡ޿ࠆ‫ߦࠄࠇߎޕ‬㑐ߒߡߪ㧘ᛮᧄ
⊛ߥ⸃᳿ᴺࠍᬌ⸛ߒߡ޿ߊߎߣ߇⺖㗴ߢ޽ࠆ‫ޕ‬੹ᓟߩዷᦸ⃻࿷ߩකᏧ⥃ᐥ⎇ୃ೙ᐲߢߪ㧘♖␹⑼⎇ୃߪᔅୃߣߥߞߡ޿ࠆ‫ߪߩࠆ޿ߡࠇ߹ᦸߢߎߘޕ‬㧘ࡊ࡜ࠗࡑ
࡝ࠤࠕࠍ㊀ⷞߒߚㅢᏱߩ♖␹ක≮ߢ޽ࠅ㧘ߘࠇߪ♖␹∛ℂቇߦ┙⣉ߒߡߎߘน⢻ߣߥࠆ߽ߩߢ޽ࠆ‫ߎޕ‬ߩ㗔ၞߦὶὐࠍᝪ߃⎇ⓥࠍㅴ߼ߡ޿ࠆᄢቇߪᱷᔨߥ߇ࠄዋߥ޿‫߃ࠁࠇߘޕ‬㧘ᒰ♖␹∛ℂቇಽ㊁ߩሽ࿷ᗧ⟵ߪ㧘࿖᳃ߩ࠾࡯࠭ߣ޿ߞߚὐ߆ࠄ߽㧘੹ᓟ߹ߔ߹ߔ㜞߹ߞߡ޿ߊ߽ߩߣᦼᓙߢ߈ࠆ‫ޕ‬㧙㧙㧔6㧕⣖␹⚻ᄖ⑼ቇಽ㊁1㧚⎇ⓥߩ᭎ⷐ
⣖⯯ⴊߦ㑐ߔࠆ⎇ⓥߣߒߡ㧘ࡑ࠙ࠬ⣖⯯ⴊࡕ࠺࡞ࠍ↪޿ߡࡈ࡝࡯࡜ࠫࠞ࡞ࠬࠞࡌࡦࠫࡖ࡯ߢ޽ࠆࠛ࠳࡜
ࡏࡦ߅ࠃ߮᛫ⴊዊ᧼⮎ߢ޽ࠆࠪࡠࠬ࠲࠱࡯࡞ߣᏱ࿶㜞㉄⚛≮ᴺߩ૬↪≮ᴺߩᕆᕈᦼ⣖⯯ⴊ଻⼔૞↪ߩ⹏ଔࠍⴕ޿㧘ਔ⮎೷ߣ߽㜞㉄⚛≮ᴺߣߩ૬↪ߢ᦭ᗧߥ⣖଻⼔૞↪ࠍ␜ߔߎߣ߇᣿ࠄ߆ߣߥߞߚ㧔ጘ㒂⮎⑼ᄢ
ቇ⮎ല⸃ᨆቇ⻠ᐳߣߩ౒ห⎇ⓥ㧕‫ߚ߹ޕ‬ห᭽ߦࡑ࠙ࠬ⣖⯯ⴊࡕ࠺࡞ࠍ↪޿ߡ⣖⯯ⴊᕆᕈᦼߩ⢽⢌↱᧪ᐙ⚦⢩ߩ㕒⣂ᛩਈߦ߅ߌࠆ␹⚻଻⼔૞↪ࠍᬌ⸛ߒߚ‫ޕ‬⢽⢌↱᧪ᐙ⚦⢩ߩ㕒⣂ౝᛩਈ⟲ߢߪࠦࡦ࠻ࡠ࡯࡞⟲ߥࠄ߮ߦ㛽㜑↱᧪ᐙ⚦⢩ᛩਈ⟲ߣᲧセߒߡ᦭ᗧߥᯏ⢻੍ᓟߩᡷༀ߇ߺࠄࠇࠆߎߣ߇᣿ࠄ߆ߣߥߞߚ㧔⚦⢩ᖱႎቇ⻠ᐳߣߩ౒ห⎇ⓥ㧕‫ޕ‬േ⣂⎬ൻᕈ∔ᖚߩᴦ≮ߣ੍㒐ߦ㑐ߔࠆ⎇ⓥߣߒߡ㧘ⴊዊ᧼߆ࠄ᡼಴ߐࠇേ⣂⎬ൻߣߩ㑐ㅪ߇ᵈ⋡ߐࠇߡ޿ࠆ sCD40L ╬ߩἻ∝ᕈࠨࠗ࠻ࠞࠗࡦߩ᡼಴ᯏᐨߣฦ⒳᛫ⴊዊ᧼⮎ߩലᨐߦ㑐ߒߡ⸃ᨆࠍⴕߥߞߚ⚿ᨐ㧘᛫Ἳ∝ലᨐࠍ᦭ߔࠆࠕࠬࡇ࡝ࡦߪἻ∝ᕈࠨࠗ࠻ࠞࠗࡦߩ᡼಴ߦኻߒߡ⪺᣿ߥᛥ೙ലᨐࠍ᦭ߔࠆ߇㧘หߓ᛫ⴊዊ᧼೷ߢ߽࠴ࠛࡁࡇ࡝ࠫࡦ♽⮎೷ߪᛥ೙ലᨐࠍ߽ߚߥ޿ߎߣ߇᣿ࠄ߆ߣߥߞߚ㧔⮎ℂ∛ᘒቇ⻠ᐳߣߩ౒ห⎇ⓥ㧕‫ޕ‬ᖡᕈࠣ࡝ࠝ࡯ࡑߦ㑐ߔࠆၮ␆⎇ⓥߣߒߡ㧘ࡅ࠻ࠣ࡝ࠝ࡯ࡑᮡᧄࠍ↪޿ߡᖡᕈ⣲≌ౝࡑࠢࡠࡈࠔ࡯ࠫߣ⣲≌ߩ↥↢ߔࠆࠤࡕࠞࠗࡦߩ㑐ଥࠍ఺∉⚵❱ቇ⊛ߦ⹏ଔߒߚ⚿ᨐ㧘⣲≌ౝ߳ߩࡑࠢࡠࡈࠔ࡯ࠫߩㆆ⿛ߦ㑐ਈߔࠆࠤࡕࠞࠗࡦߣߒߡ㧘ߎࠇ߹ߢߦᜰ៰ߐࠇߡ߈ߚ MCP-1 એᄖߦ MCP-3 ߽㑐ਈߒߡ޿ࠆน⢻ᕈ߇⷗޿ߛߐࠇߚ㧔఺∉∛ℂቇ⻠ᐳߣߩ౒ห⎇ⓥ㧕‫ޕ‬ࡅ࠻ࠣ࡝ࠝ࡯ࡑߦ߅ߌࠆ⥃ᐥ⎇ⓥߣߒߡ㧘᡼኿✢ᴦ≮ᓟߦߺࠄࠇࠆ᡼኿✢უᱫߣࠣ࡝ࠝ࡯ࡑౣ⊒ߣࠍ
PET ↹௝ࠍ↪޿ߡ㐓೎ߔࠆᣇᴺࠍᬌ⸛ߒߚ‫ޕ‬CHO㧔choline㧕-PET ߦࠃߞߡ᳞߼ࠄࠇࠆⴊᵹᚑಽࠍ MET
㧔methionine㧕-PET ↹௝߆ࠄᏅߒᒁ޿ߚᄌ឵↹௝ߦࠃࠅ᡼኿✢უᱫߣ⣲≌ౣ⊒ࠍⷞⷡ⊛ߦ᣿⍎ߦ⼂೎ߢ߈ࠆน⢻ᕈ߇␜ߐࠇߚ㧔ਛㇱ≮⼔࠮ࡦ࠲࡯ߦ߅ߌࠆ⎇ⓥ㧕
‫ޕ‬
2㧚ฬ★
ᢎ᝼㧦
ಎᢎ᝼㧦
⻠Ꮷ㧦
⻠Ꮷ㧦
⥃ᐥ⻠Ꮷ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦

ጤ㑆 ੧
ศ᧛⚩৻
⍫㊁ᄢੳ
ᄢᳯ⋥ⴕ
ਛጊೣਯ
㊁ਛ⵨ᐽ
⍹㤥శ♿
᭑ᧄ↱⾆ሶ
ጟ↰ ⺈
ጊ↰ᷡᢥ
ᳰ੉↱㚅
ጊౝ࿻ᄥ
ㄞᧄ⌀▸

Toru Iwama
Shin-ichi Yoshimura
Hirohito Yano
Naoyuki Ohe
Noriyuki Nakayama
Yuko Nonaka
Mitsunori Ishiguro
Yukiko Enomoto
Makoto Okada
Kiyofumi Yamada
Yuka Ikegame
Keita Yamauchi
Masanori Tsujimoto3㧚⎇ⓥᚑᨐߩ⊒⴫⪺ᦠ㧔๺ᢥ㧕
1㧕 ጤ㑆 ੧㧚⣖␹⚻ᄖ⑼⥃ᐥߦ߅ߌࠆ PET, SPECT ⸻ᢿ ᧲ർ⣖ SPECT ⎇ⓥળ⻠Ṷ㓸 2006 ᐕ㧦15 Ꮞ㧧7㧙12.
2㧕 ศ᧛⚩৻㧘ർፉ⧷⤿㧘ጊ↰ᷡᢥ㧘ᳰ੉↱㚅㧘᭑ᧄ↱⾆ሶ㧘቟⮮ᒄ㆏㧘⍫㊁ᄢੳ㧘ጤ㑆 ੧㧚⣖ਥᐙേ⣂㐽Ⴇߦࠃࠆㅴⴕᕈ⣖තਛ-Perfusion CT ߦࠃࠆ੍᷹ߣᕆᕈᦼࡃࠗࡄࠬߩೋᦼᴦ≮ᚑ❣-㧦⣖තਛߩ࠴࡯ࡓක≮-EC-IC ࡃࠗࡄࠬߩᄛ᣿ߌ-㧧╙ 24 ࿁ The Mt. Fuji Workshop on CVD ⻠Ṷ㓸㧘᧲੩㧦ߦࠀ࡯ࠈࠎ␠㧧2006ᐕ㧦85㧙89.
3㧕 ◉↰ ᷕ㧘ᅏ᧛ ᱠ㧘⍫㊁ᄢੳ㧘ጤ㑆 ੧㧚ᚻⴚว૬∝ߩ㗫ᐲߣߘߩኻ╷㧙࠹ࡦ࠻਄㜑ౝ⣲≌㧙㧦㤥ጤᢅᒾ✬㧚⣖⣲≌ߩᄖ⑼㧙ว૬∝ߩߥ޿⣖⣲≌ߩᄖ⑼ࠍ⋡ᜰߒߡ̅㧘ᄢ㒋㧦ࡔ࠺ࠖࠞ಴ 㧧2007 ᐕ㧦80㧙89㧚
4㧕 ศ᧛⚩৻㧚ᬁ㛽േ⣂࡮㎮㛽ਅേ⣂ߦኻߔࠆⴊ▤ᒻᚑⴚ㧦⩵ᳰ᥍ᒾ✬㧚⣖␹⚻ⴊ▤ౝᴦ≮ߩߔߴߡ㧙ᦨᣂ∝଀߆ࠄቇ߱㧙㧘᧲੩㧦ߦࠀ࡯ࠈࠎ␠㧧2007 ᐕ㧦176㧙179㧚
5㧕 ศ᧛⚩৻㧚ᬁ㛽േ⣂⿠ᆎㇱ⁜⓰ߦኻߔࠆⴊ▤ᒻᚑⴚ㧦⩵ᳰ᥍ᒾ✬㧚⣖␹⚻ⴊ▤ౝᴦ≮ߩߔߴߡ㧙ᦨᣂ∝଀߆ࠄቇ߱㧙㧘᧲੩㧦ߦࠀ࡯ࠈࠎ␠㧧2007 ᐕ㧦286㧙287㧚
6㧕 ศ᧛⚩৻㧚CAS ߩㆡᔕߣ⑌ᔊ㧦ਛේ৻㇢✬㧘Ṛ ๺ᦶ⋙ୃ㧚㗪േ⣂ࠬ࠹ࡦ࠻⇐⟎ⴚ -Carotid Artery
Srenting(CAS)ߩߔߴߡ-㧘᧲੩㧦ࡔࠫࠞ࡞ࡆࡘ࡯␠㧧2008 ᐕ㧦45㧙50.

㧙㧙7㧕 ⍫㊁ᄢੳ㧘ᄢᳯ⋥ⴕ㧘ਛጊೣਯ㧘ศ᧛⚩৻㧘ጤ㑆 ੧㧚⣖ᷓㇱ⣲≌៰಴ⴚߦ߅ߌࠆⴚਛ Fluorescein-Na㕒⣂ౝᛩਈߩ᦭↪ᕈߦߟ޿ߡ㧦↲᧛⧷ੑ✬㧚⣖⣲≌ߩᄖ⑼࡯ၮᧄߣ᜸ᚢ࡯ 2008 ᐕ㧦77㧙86.
8㧕 ጊ↰ᷡᢥ㧘ศ᧛⚩৻㧚VH-IVUS㧦㗪േ⣂ࠬ࠹ࡦ࠻⇐⟎ⴚ㧦ਛේ৻㇢✬㧘Ṛ ๺ᦶ⋙ୃ㧚-Carotid Artery
Srenting(CAS)ߩߔߴߡ- 2008 ᐕ㧧80㧙81.
9㧕 ᨋ⌀৻㇢㧘ศ᧛⚩৻㧚╙ 4 ┨ ⥃ᐥᔕ↪ߩㅴ߻ⴊ▤㑐ㅪߩౣ↢කቇⴊ▤ߩౣ↢㧦᫪ਅ┥৻✬⪺㧚ⴊ▤ౣ↢කቇߩᄛ᣿ߌ-ㄭߠߊታ↪ൻ-㧘᧲੩㧦⌀⥝੤ᤃ(ᩣ)කᦠ಴ ㇱ㧧2008 ᐕ㧦154г161.
⪺ᦠ㧔᰷ᢥ㧕
1㧕 Uchiyama Y, Yamauchi M, Ando H, Yokoyama R, Hara T, Fujita H, Iwama T. Automated Classificationof Cerebral Arteries in MRA Images and Its Application to Maximum Intensity Projection. Proc of 28th
Annual International Conference of the IEEE Engineering In Medicine and Biology Society.
2006:4865-4868.
2㧕 Uchiyama Y, Yokoyama R, Fujita H, Hara T, Zhou X, Hayashi Y, Ando H, Iwama T, Asano T, Kato H,
Hoshi H. Development of CAD Scheme for Detection of Unruptured Intracranial Aneurysms in MRA
images. Innervision. 2006;21:76-77.
3㧕 Uchiyama Y, Yokoyama R, Ando H, Asano T, Kato H, Yamakawa H, Yamakawa H, Hara T, Iwama T,
Hoshi H Fujita H. Improvement of automated detection method of lacunar infarcts in brain MR
images. In: Conf Proc IEEE Eng Med Biol Soc, CA: The printing House Inc; 2007:1599-1602.
4㧕 Yamauchi M, Uchiyama Y, Yokoyama R, Hara T, Fujita H, Ando H, Yamakawa H, Iwama T, Hoshi H.
Computerized scheme for detection of arterial occlusion in brain MRA images. In: Proc. SPIE Medical
Imaging, Proc. SPIE Medical Imaging, pt6514, WA: The international Society for Optical Engineering;
2007:65142C-1-65142C-9.
5㧕 Uchiyama Y, Kunieda T, Hara T, Fujita H, Ando H, Yamakawa H, Asano T, Kato H, Iwama T,
Kanematu M, Hoshi H. Automatic segmentation of different-sized leukoaraiosis regions in brain MR
images. In: Giger ML, Karssemeijer N , ed. Proc. of SPIE Medical Imaging: Computer-aided diagnosis,
2008:69151S-1-69151S-8.
6㧕 Uchiyama Y, Gao X, Hara T, Fujita H, Ando H, Yamakawa H, Asano T, Kato H, Iwama T, Kanematu M,
Hoshi H. Computerized detection of unruptured aneurysms in MRA images: Reduction of false
positives using anatomical location feature. In: Giger ML, Karssemeijer N.ed. Proc. of SPIE Medical
Imaging: Computer-aided diagnosis, 2008:69151Q-1-69151Q-8.
✚⺑㧔๺ᢥ㧕
1㧕 ጤ㑆 ੧㧚ᄖ⑼⊛ᴦ≮ߦᔅⷐߥ↹௝⸻ᢿߩㅴᱠ㧘⣖ߣᓴⅣ 2006 ᐕ㧧11 Ꮞ㧦43㧙48.
2㧕 ጤ㑆 ੧㧚߽߿߽߿∛ߦኻߔࠆᄖ⑼ᴦ≮ߩታ㓙ߣⷐὐ㧘Neurological Surgery 2006 ᐕ㧧34 Ꮞ㧦557㧙564.
3㧕 ศ᧛⚩৻㧘ጤ㑆 ੧㧚⣖៊்ᓟߩ Neurogenesis ೙ᓮᯏ᭴ߩ⸃ᨆ—ౣ↢ක≮߳ߩዷᦸ—㧘⣖ᓴⅣઍ⻢ 2006
ᐕ㧧18 Ꮞ㧦176㧙179.
4㧕 ጤ㑆 ੧㧚⣖േ㕒⣂ᄸᒻߩᚻⴚ㧚⑳ߩᚻⴚᚢ⇛㧘⣖␹⚻ᄖ⑼ㅦႎ 2007 ᐕ㧧17 Ꮞ㧦284㧙294㧚
5㧕 ጤ㑆 ੧㧘ศ᧛⚩৻㧘⍫㊁ᄢੳ㧘ᄢᳯ⋥ⴕ㧘┻ਛరᐽ㧘㘵↰ብ᮸㧚᧻ᨐ૕∛ᄌߦኻߔࠆ infratentorial
supracerebellar approach㧘⣖␹⚻ᄖ⑼ 2007 ᐕ㧧35 Ꮞ㧦453㧙466㧚
6㧕 ጤ㑆 ੧㧚ᚺ㧙ᅏⓄ㜞ጪᄐጊ⸻≮ᚲ߳ߩ㆏㧙㧘⣖␹⚻ᄖ⑼ 2007 ᐕ㧧35 Ꮞ㧦961㧙962㧚
7㧕 ጤ㑆 ੧㧚Editorial Comment: ㆊἠᵹ∝୥⟲ߦኻߔࠆ⓫㗡ਅ⚻㗡⬄࠼ࡊ࡜ࡕ࠾࠲࡝ࡦࠣ㧘⣖ᄖ⹹ 2007
ᐕ㧧16 Ꮞ㧦798㧚
8㧕 ጊᎹᤐ᮸㧘ጤ㑆 ੧㧚ᦨᣂߩࠛࡆ࠺ࡦࠬᄖ⑼♽ԝ MASH: ߊ߽⤑ਅ಴ⴊᓟߩㆃ⊒ᕈ␹⚻⣕⪭∝⁁ߦኻߔࠆࠕࠬࡇ࡝ࡦߩᛥ೙ലᨐߦ㑐ߔࠆ࡜ࡦ࠳ࡓൻᲧセ⹜㛎㧦ಽሶ⣖ⴊ▤∛ 2007 ᐕ㧧6 Ꮞ㧦219㧙222㧚
9㧕 ጊౝᐽ㓶㧘ጤ㑆 ੧㧘ᣂ੗ ৻㧚ᐳ㐳✚᜝ ࠪࡦࡐࠫ࠙ࡓ 1 ੑಽ⣄ᬁ‫ޟ‬ᚑ㐳㧘⊒㆐ߦ઻߁໧㗴ߣߘߩኻ╷‫ޠ‬㧘ዊఽߩ⣖␹⚻ 2007 ᐕ㧧32 Ꮞ㧦302㧙303㧚
10㧕 ጤ㑆 ੧㧚⣖␹⚻∔ᖚߦⴕࠊࠇࠆᚻⴚߣᴦ≮৻ⷩ㧦ࡉ࡟ࠗࡦ࠽࡯ࠪࡦࠣ 2008 ᐕ㧧24 Ꮞ㧦932.
11㧕 ጤ㑆 ੧㧚㗡⬄ຜ㗡⣲ߦኻߔࠆ pterional approach ࠍၮᧄߣߒߚ஥ᣇ߆ࠄߩࠕࡊࡠ࡯࠴㧘⣖␹⚻ᄖ⑼ㅦႎ
2008 ᐕ㧧18 Ꮞ㧦278㧙286.
12㧕 ศ᧛⚩৻㧘ጤ㑆 ੧㧚㗪േ⣂ࠬ࠹ࡦ࠻⇐⟎ⴚ -ߘߩ⃻⁁ߣዷᦸ-㧘⣖ߣᓴⅣ 2008 ᐕ㧧13 Ꮞ㧦21㧙25.
13㧕 ⍫㊁ᄢੳ㧚᡼኿✢ᴦ≮㧦ࡉ࡟ࠗࡦ࠽࡯ࠪࡦࠣ 2008 ᐕ㧧24 Ꮞ㧦978㧙981.
14㧕 ᄢᳯ⋥ⴕ㧚ⴊ⣲㒰෰ⴚ㨪ౝⷞ㏜/ቯ૏⣖ᚻⴚࠍ฽߻㨪㧦ࡉ࡟ࠗࡦ࠽࡯ࠪࡦࠣ 2008 ᐕ㧧24 Ꮞ㧦944㧙946.
15㧕 ዊ⼱ཅೣ㧚㐿㗡ⴚ৻⥸㧦ࡉ࡟ࠗࡦ࠽࡯ࠪࡦࠣ 2008 ᐕ㧧24 Ꮞ㧦933㧙935.
16㧕 ਛጊೣਯ㧚ᄖᷫ࿶ⴚ㨪ᕆᕈ⎬⤑ਅⴊ⣲㧘⣖ᝂ்㨪㧦ࡉ࡟ࠗࡦ࠽࡯ࠪࡦࠣ 2008 ᐕ㧧24 Ꮞ㧦951㧙954.
17㧕 㜞ᧁବ▸㧘ศ᧛⚩৻㧚㜞㦂⠪ߦ߅ߌࠆᕆᕈᦼ⣖᪪Ⴇᴦ≮㧦ಽሶᔃⴊ▤∛ 2008 ᐕ㧧9 Ꮞ㧦166㧙169.
✚⺑㧔᰷ᢥ㧕
ߥߒේ⪺㧔๺ᢥ㧕
1㧕 ศ᧛⚩৻㧘ጊ↰ Ả㧘⍹Ỉ㍤ੑ㧘Ỉ↰రผ㧘ㇳ ᵏᒾ㧘ጤ㑆 ੧㧚㜞㦂⠪㊀∝ߊ߽⤑ਅ಴ⴊߦኻߔࠆᕆᕈ
ᦼ⣖ⴊ▤ౝᚻⴚߩᴦ≮ᚑ❣㧘⣖තਛߩᄖ⑼ 2006 ᐕ㧧34 Ꮞ㧦86㧙90.
2㧕 ട⮮⾆ਯ㧘౎චᎹ㓶࿑㧘ᅏ᧛ ᱠ㧘◉↰ ᷕ㧘ਛጊೣਯ㧘ጤ㑆 ੧㧚㗡ㇱᄖ்ᘟᕈᦼߦ߅ߌࠆ⣖♧ઍ⻢ߩ㧙㧙⛔⸘ቇ⊛↹௝⸃ᨆ㧘␹⚻ᄖ் 2006 ᐕ㧧29 Ꮞ㧦15㧙19㧚
3㧕 ᧻੗ ◊㧘ౝጊ⦟৻㧘ᮮጊ㦖ੑ㇢㧘ේ ᱞผ㧘๟ ะᩕ㧘⮮↰ᐢᔒ㧘቟⮮ᒄ㆏㧘ጤ㑆 ੧㧘ട⮮ඳၮ㧘ᵻ
㊁㓉ᒾ㧘ᤊ ඳᤘ㧚⣖ MR ↹௝ࠍ↪޿ߚ࡜ࠢ࠽᪪Ⴇᬌ಴ߩᡰេ⸻ᢿࠪࠬ࠹ࡓߩ㐿⊒㧘ାቇᛛႎ 2006 ᐕ㧧
107 Ꮞ㧦25㧙28㧚
4㧕 ᧻੗ ◊㧘ౝጊ⦟৻㧘ᮮጊ㦖ੑ㇢㧘ේ ᱞผ㧘๟ ะᩕ㧘⮮↰ᐢᔒ㧘቟⮮ᒄ㆏㧘ጤ㑆 ੧㧘ട⮮ඳၮ㧘ᵻ
㊁㓉ᒾ㧘ᤊ ඳᤘ㧚⣖ MR ↹௝ࠍ↪޿ߚ࡜ࠢ࠽᪪Ⴇᬌ಴ߩᡰេ⸻ᢿࠪࠬ࠹ࡓߩ㐿⊒㧘㔚ሶᖱႎㅢାቇળᛛ
ⴚ⎇ⓥႎ๔㧘㔚ሶᖱႎㅢାቇળᛛⴚ⎇ⓥႎ๔(IEICE Technical Report) 2006 ᐕ㧧105 Ꮞ㧦25㧙28㧚
5㧕 ⨹ᧁ᦭ਃ㧘㊁ୖብᤩ㧘દ⮮ Პ㧘ฎᏒ᣽ብ㧘ጤ↰ㄖᄦ㧘ጤ㑆 ੧㧚ᱜਛ⣖᪞േ⣂㐽Ⴇߦࠃࠆో⣖᪞᪪Ⴇߩ1 ଀㧘⣖තਛ 2007 ᐕ㧧3 Ꮞ㧦463㧙468㧚
6㧕 ጤ㑆 ੧㧘ศ᧛⚩৻㧘቟⮮ᒄ㆏㧘᭑ᧄ↱⾆ሶ㧚቟ో‫⏕ޔ‬ታߥ⣖േ⣂≜ᚻⴚߩᚻ㗅ߣᎿᄦ㧙േ⣂≜ᚻⴚߩᦨ⚳Ბ㓏ߦ߅ߌࠆ dome puncture ߩᓎഀ㧙㧘⣖තਛߩᄖ⑼ 2007 ᐕ㧧35 Ꮞ㧦411㧙416㧚
7㧕 ጊ↰ታ⾆ੱ㧘⼾↰ ᴰ㧘ศ᧛⚩৻㧘ጤ㑆 ੧㧘ᅏኹ ᢘ㧘ዊୖ⌀ᴦ㧚⣖තਛᢇᕆߦ߅ߌࠆ⣖තਛೋᦼ⸻≮(ISLS)
ࠦ࡯ࠬߩ㊀ⷐᕈ㧘⣖␹⚻ᄖ⑼ㅦႎ 2007 ᐕ㧦945㧙952㧚
8㧕 ጊౝ዁ผ, ౝጊ⦟৻, ዊ᫾ Ả, ᮮጊ㦖ੑ㇢, ේ ᱞผ, ቟⮮ᒄ㆏, ጊᎹᒄ଻, ጤ㑆 ੧, ᤊ ඳᤘ, ⮮↰ᐢᔒ㧚
MRA ↹௝ߦ߅ߌࠆ⣖ⴊ▤ฬߩ⥄േኻᔕઃߌᚻᴺߩ㐿⊒㧘↢૕කᎿቇ 2007 ᐕ㧧45 Ꮞ㧦27㧙35㧚
9㧕 ዊ᫾ Ả, ౝጊ⦟৻, ጊౝ዁ผ, ᮮጊ㦖ੑ㇢, ේ ᱞผ, ጊᎹᒄ଻, ቟⮮ᒄ㆏, ጤ㑆 ੧, ᤊ ඳᤘ, ⮮↰ᐢᔒ㧚ࡌࠢ࠻࡞㓸ਛᐲࡈࠖ࡞࠲ࠍ↪޿ߚ MRA ↹௝ߦ߅ߌࠆ⣖േ⣂≜ߩᬌ಴ᴺ㧘ක↪↹௝ᖱႎቇળ㔀⹹ 2007
ᐕ㧧24 Ꮞ㧦84㧙89㧚
10㧕 ౝጊ⦟৻㧘᧻੗ ◊㧘ᮮጊ㦖ੑ㇢㧘๟ ะᩕ㧘ේ ᱞผ㧘቟⮮ᒄ㆏㧘ᵻ㊁㓉ᒾ㧘ട⮮ඳၮ㧘ጤ㑆 ੧㧘ᤊ ඳᤘ㧘⮮↰ᐢᔒ㧚⣖ MR ↹௝ߦ߅ߌࠆ࡜ࠢ࠽᪪Ⴇߩᬌ಴ᴺ㧘㔚ሶᖱႎㅢାቇળ⺰ᢥ⹹ 2007 ᐕ㧧J90㧙D㧦1820
㧙1829㧚
11㧕 ศ᧛⚩৻, ጊ↰ᷡᢥ, ᭑ᧄ↱⾆ሶ, ਛጊೣਯ, ᄢᳯ⋥ⴕ, ⍫㊁ᄢੳ, ጤ㑆 ੧㧚⎕ⵚ⣖േ⣂≜ߦ߅ߌࠆ EBM
ߩ⸃㉼ߣᴦ≮ㆬᛯ, ⣖␹⚻ᄖ⑼ࠫࡖ࡯࠽࡞ 2008 ᐕ㧧17 Ꮞ㧦805㧙854.
12㧕 ศ᧛⚩৻, ጊ↰ᷡᢥ, ᭑ᧄ↱⾆ሶ, ਛጊೣਯ, ᄢᳯ⋥ⴕ, ⍫㊁ᄢੳ, ጤ㑆 ੧. ⎕ⵚ⣖േ⣂≜ߦ߅ߌࠆ EBM
ߩ⸃㉼ߣᴦ≮ㆬᛯ⎕ⵚ⣖േ⣂≜ߦ߅ߌࠆ EBM ߩ⸃㉼ߣᴦ≮ㆬᛯ, ⣖␹⚻ᄖ⑼ࠫࡖ࡯࠽࡞೎ౠ ․㓸‫ޟ‬⣖ⴊ▤㓚ኂߦ߅ߌࠆ EBM‫ޠ‬17 Ꮞ㧘᧲੩㧦ਃベᦠᐫ㧧2008 ᐕ㧧850㧙854.
13㧕 ⍫㊁ᄢੳ, ᪢᧛ ᷕ, ਛጊೣਯ, ᄢᳯ⋥ⴕ, ౎චᎹ㓶࿑, ᨋ ␭৻, ଻૑ ഞ, ጤ㑆 ੧㧚᷆⫷⃿ౝ▵ೝỗⴚ߇ᄼഞߒߚ᦭᫚⿒ⴊ⃿⥰〯∛ߩ 1 ଀㧘ᣣᧄቯ૏࡮ᯏ⢻␹⚻ᄖ⑼ቇળᯏ㑐⹹ ᯏ⢻⊛⣖␹⚻ᄖ⑼㧘2008 ᐕ㧧
47 Ꮞ㧦114㧙118.
14㧕 ᭑ᧄ↱⾆ሶ㧚㗪ㇱ㗪േ⣂ࠬ࠹ࡦ࠻⇐⟎ⴚߦ߅ߌࠆⴚ೨ⴊዊ᧼ಝ㓸⢻᷹ቯߩ᦭↪ᕈ㧘⣖␹⚻ⴊ▤ౝᴦ≮ 2008
ᐕ㧧2 Ꮞ㧦188㧙192.
15㧕 ጊ↰ᷡᢥ, ศ᧛⚩৻, ጊᎹᤐ᮸, ጤ㑆 ੧㧚⣖᪪Ⴇࠍ᧪ߒ㗪േ⣂ߦนേᕈࡊ࡜࡯ࠢࠍ⹺߼ߚᧄᘒᕈⴊዊ᧼ⴊ
∝ߩ 1 ଀㧘Journal of neuroendovascular therapy ⣖␹⚻ⴊ▤ౝᴦ≮㧘2008 ᐕ㧧2 Ꮞ㧦62㧙67.
16㧕 ࿡ᨑ℉਽, ౝጊ⦟৻, ේ ᱞผ, ⮮↰ᐢᔒ, ട⮮ඳၮ, ᵻ㊁㓉ᒾ, ᤊ ඳᤘ, ጊᎹᒄ଻, ቟⮮ᒄ㆏, ጤ㑆 ੧㧚ࠢ࡜ࠬ࠲࡝ࡦࠣࠍ↪޿ߚ⣖࠼࠶ࠢ MR ↹௝ߦ߅ߌࠆή∝୥ᕈᄢ⣖⊕⾰∛ᄌߩᬌ಴ᴺ㧘Medical Imaging
Technology 2008 ᐕ㧧26 Ꮞ㧦39㧙47.
ේ⪺㧔᰷ᢥ㧕
1㧕 Yoshimura S, Enomoto Y, Kitajima H, Yamada J, Kaku Y, Iwama T. Carotid-compression technique forthe insertion of guiding catheters. Am J Neuroradiol. 2006;27:1710-1711.
IF
2㧕 Yamakawa H, Yamada K, Sumi K, Iida H, Iwama T. Preoperative assessment of microvascularcompression of cranial nerve XI and X using 3D fast imaging employing steady-state acquisition
magnetic resonance imaging in glossopharyngeal neuralgia. Neurosurg Quart. 2006;16:166-168.
IF
3㧕 Nakayama N, Okumura A, Shinoda J, Nakashima T, Iwama T. Relationship between regional cerebral
metabolism and consciousness disturbance in traumatic diffuse brain injury without large focal
lesions㧦an FDG-PET study with statistical parametric mapping analysis. J Neurol Neurosur Psych.
2006;77:856-862.
IF
4㧕 Nakayama N, Okumura A, Shinoda J, Yasokawa Y, Miwa K, Yoshimura S, Iwama T. Evidence forwhite matter disruption in traumatic brain injury without macroscopic lesions. J Neurol Neuros Psych.
2006;77:850-855.
IF
5㧕 Shimamura M, Sato N, Yoshimura S, Kaneda Y, Morishita R. HVJ-based non-viral gene transfer
method: successful gene therapy using HGF and VEGF genes in experimental ischemia. Front Biosci.
2006;11:753-759.
IF
6㧕 Otani N, Muroi C, Yano H, Khan N, Pangalu A, Yonekawa Y. Surgical management of tuberculum
sellae meningioma 㧦 Role of selective extradural anterior clinoidectomy. Brit J Neurosurg.
2006;20:129-138.
IF
7㧕 Uchiyama Y, Matsui A, Yokoyama R, Fujita H, Hara T, Zhou X, Ando H, Iwama T, Asano T, Kato H,
Hoshi H. CAD Scheme for Detection of Lacunar infarcts in Brain MR images. Int J Com Assist Radiol
Surg. 2006;1:382-385.
8㧕 Nakashima T, Nakayama N, Miwa K, Okumura A, Soeda A, Iwama T. Focal brain glucose
hypometabolism in patients with neuropsychologic deficits after diffuse axonal injury. Am J
Neuroradiol. 2007;28:236-242.
IF
9㧕 Yamakawa H, Kato M, Yoshimura S. Vertebral arteriovenous fistula following attempt at central line

㧙㧙

2.338

0.073

3.857

3.857

2.989

0.542

2.338

placement and successfully treated with sequential endovascular coil embolization. Neurosurg Q.
2007;17:138-141.
10㧕 Miwa K, Shinoda J, Yano H, Iwama T. Relatively decreased 11C-methionine uptake within theanaplastic component of a mixed-grade oligodendroglioma: a case study. Am J Neuroradiol.
2007;28:2005-2007.
11㧕 Kato T, Nakayama N, Yasokawa Y, Okumura A, Shinoda J, Iwama T. Statistical image analysis of
cerebral glucose metabolism in patients with cognitive impairment following diffuse traumatic brain
injury. J Neurotrauma. 2007;24:919-926.
12㧕 Kotani Y, Morimoto N, Oida Y, Tamura Y, Tamura S, Inoue T, Shimazawa M, Yoshimura S, Iwama T,
Hara H. Prevention of in vitro and in vivo acute ischemic neuronal damage by (2S)-1-(4-amino-2, 3,5-trimethylphenoxy)-3-{4-[4-(4-fluorobenzyl)phenyl]-1-piperazinyl}-2-propanol
dimethanesulfonate(SUN N8075), a novel neuroprotective agent with antioxidant properties. Neuroscience.
2007;149:779-788.
13㧕 Nakagawa J, Saio M, Tamakawa N, Suwa T, Frey AB, Nonaka K, Umemura N, Imai H, Ouyang GF,
Ohe N, Yano H, Yoshimura S, Iwama T, Takami T. TNF expressed by tumor-associated macrophages,
but not microglia, can eliminate glioma. Int J Oncol. 2007;30:803-811.
14㧕 Yasokawa YT, Shinoda J, Okumura A, Nakayama N, Miwa K, Iwama T. Correlation between
diffusion-tensor magnetic resonance imaging and motor-evoked potential in chronic severe diffuse
axonal injury. J Neurotrauma. 2007;24:163-173.
15㧕 Yamashita K, Kotani Y, Nakajima Y, Shimazawa M, Yoshimura S, Nakashima S, Iwama T, Hara H.
Fasudil, a Rho Kinase(ROCK)inhibitor, protects against ischemic neuronal damage in vitro and in vivo
by acting directly on neurons. Brain Res. 2007;1154:215-224.
16㧕 Yamashita K, Ohe N, Yoshimura S, Iwama T. Intracranial Pial Arteriovenous Fistula. Neurologia
medico-chirurgica. 2007;47:550-554.
17㧕 Oka N, Soeda A, Inagaki A, Onodera M, Maruyama H, Hara A, Kunisada T, Mori H, Iwama T. VEGF
promotes tumorigenesis and angiogenesis of human glioblastoma stem cells. Biochem Biophys Res
Commun. 2007;360:553-559.
18㧕 Inagaki A, Soeda A, Oka N, Kitajima H, Nakagawa J, Motohashi T, Kunisada T, Iwama T. Long-term
maintenance of brain tumor stem cell properties under at non-adherent and adherent culture
conditions. Biochem Biophys Res Commun. 2007;361:586-592.
19㧕 Uchiyama Y, Yokoyama R, Ando H, Asano T, Kato H, Yamakawa H, Yamakawa H, Hara T, Iwama
T,Hoshi H, Fujita H. Computer-aided diagnosis scheme for detection of lacunar infarcts on MR images.
Acad Radiol. 2007;14:1554-1561.
20㧕 Yokoyama R, Zhang X, Uchiyama Y, Fujita H, Hara T, Zhou X, Kanematsu M, Asano T, Kondo H,
Goshima S, Hoshi H, Iwama T. Development of an automated method for the detection of chronic
lacunar infarct regions in brain MR images. IEICE Trans Inf & Syst. 2007;E90-D:943-954.
21㧕 Ogawa A, Mori E, Minematsu K, Taki W, Takahashi A, Nemoto S, Miyamoto S, Sasaki M, Inoue T, The
MELT Japan Study Group. Randomized traial of intraarterial infusion of urokinase within 6 hours of
middle cerebral artery stroke. The middle cerebral artery embolism local fibrinolytic intervention trial(MELT) Japan. Stroke. 2007;38:2633-2639.
22㧕 Uchiyama Y, Yokoyama R, Asano T, Kato H, Yamakawa H, Ando H, Yamakawa H, Hara T, Iwama T,
Hoshi H, Fujita H. Performance of computer-aided diagnosis for detection of lacunar infarcts on brain
MR images: ROC analysis of radiologists̉detection. Int J Computer Assisted Radiology and Surgery.
2007;2:S395-S397.
23㧕 Yoshimura S, Enomoto Y, Yamada K, Iwama T. Initial experience of balloon catheter disruption of thethrombus in an unrecanalized intracranial artery after intravenous recombinant tissue plasminogenactivator. JNET. 2008;2:207-211.
24㧕 Yamakawa H, Ohe N, Yano H, Yoshimura S, Iwama T. Venous drainage patterns in perimesencephalicnonaneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg. 2008;110:587-591.
25㧕 Yamakawa H, Yoshimura S, Enomoto Y, Nakayama N, Iwama T. Aneurysm arising from the corticalsegment of the superior cerebellar artery: a case report and reveiw of the literatures. Surgi Neurol.
2008;70:421-424.
26㧕 Miwa K, Matsuo M, Shinoda J, Oka N, Kato T, Okumura A, Ueda T, Yokoyama K, Yamada J, Yano H,
Yoshimura S, Iwama T. Simultaneous integrated boost technique by helical tomotherapy for thetreatment of glioblastoma multiforme with (11)C-methionine PET: report of three cases. J Neurooncol.
2008;87:333-339.
27㧕 Soeda A, Inagaki A, Oka N, Ikegame Y, Aoki H, Yoshimura S, Nakashima S, Kunisada T, Iwama T.
Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells.
J Biol Chem. 2008;83:10958-10966.
28㧕 Kotani Y, Nakajima Y, Hasegawa T, Satoh M, Nagase H, Shimazawa M, Yoshimura S, Iwama T, Hara
H. Propofol exerts greater neuroprotection with disodium edetate than without it. J Cereb Blood Flow
Metab. 2008;28:354-366.
29㧕 Kotani Y, Shimazawa M, Yoshimura S, Iwama T, Hara H. The experimental and clinical pharmacology㧙㧙

IF 0.073

IF 2.338

IF 3.640

IF 3.352

IF 2.295

IF 3.640

IF 2.218
IF 0.473

IF 2.749

IF 2.749

IF 2.094

IF 0.245

IF 6.296

IF 1.553

IF 1.112

IF 1.856

IF 5.581

IF 5.147

of propofol, an anesthetic agent with neuroprotective properties. CNS Neurosci Ther. 2008;14:95-106.
30㧕 Kato T, Shinoda J, Nakayama N, Miwa K, Okumura A, Yano H, Yoshimura S, Maruyama T, Muragaki
Y, Iwama T. Metabolic Assessment of Gliomas Using 11C-Methionine, [18F] Fluorodeoxyglucose, and11C-Choline Positron-Emission Tomography. Am J Neuroradiol. 2008;29:1176-1182.
IF 2.338
31㧕 Yamada K, Yoshimura S, Enomoto Y, Yamakawa H, Iwama T. Effectiveness of combining continuous
cerebrospinal drainage and intermittent intrathecal urokinase injection therapy in preventing
symptomatic vasospasm following aneurysmal subarachonoid haemorrhage. British journal of
Neurosurgery. 2008;22:649-653.
IF 0.542

4㧚⎇ⓥ⾌₪ᓧ⁁ᴫ
1㧕┹੎⊛⾗㊄1㧕 ⎇ⓥઍ⴫⠪㧦ศ᧛⚩৻㧘⎇ⓥಽᜂ⠪㧦ጤ㑆 ੧㧘⍫㊁ᄢੳ㧘ᄢᳯ⋥ⴕ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⾌⵬ഥ㊄ၮ⋚⎇ⓥ(B)(2)㧦㗡ㇱᄖ்‫ޔ‬⣖⯯ⴊᓟߩ neurogenesis ೙ᓮᯏ᭴ߩ⸃ᨆ㧦␹⚻ᩕ㙃࿃ሶߣߩ㑐ㅪ㧧
ᐔᚑ 16㧙18 ᐕᐲ㧧10,500 ජ౞(5,000㧦3,300㧦2,200 ජ౞)
2㧕 ⎇ⓥઍ⴫⠪㧦ጤ㑆 ੧㧧ጘ㒂ᄢቇᵴᕈൻ⎇ⓥ⾌㧦⣖⣲≌⎇ⓥࡕ࠺࡞ߩ⏕┙ߣ࠹࡯࡜࡯ࡔࠗ࠼ᴦ≮߳ߩᔕ↪㧧ᐔᚑ 18 ᐕᐲ㧧1,200 ජ౞3㧕 ⎇ⓥઍ⴫⠪㧦ጤ㑆 ੧㧘⎇ⓥಽᜂ⠪㧦ศ᧛⚩৻㧘ጊਅஜᄥ㇢㧧ጘ㒂ᄢቇᄢቇ㒮කቇ♽⎇ⓥ⑼ߩ⎇ⓥ
ᵴᕈൻ(ක)⎇ⓥ⾌㧦⣖⯯ⴊߦ߅ߌࠆฦ⒳ᐙ⚦⢩ߩಽൻ‫⚦߮ࠃ߅ޔ‬⢩⒖ᬀߦࠃࠆ␹⚻ⴊ▤ౣ↢ᴦ≮ᴺߩ
⏕┙㧧ᐔᚑ 18 ᐕᐲ㧧1,000 ජ౞4㧕 ⎇ⓥઍ⴫⠪㧦೽↰᣿↵㧧ጘ㒂ᄢቇᄢቇ㒮කቇ♽⎇ⓥ⑼ߩ⎇ⓥᵴᕈൻ(ක)⎇ⓥ⾌㧦⣖⣲≌ᐙ⚦⢩ߦၮߠߊ⣖⣲≌ᴦ≮㧧ᐔᚑ 18 ᐕᐲ㧧200 ජ౞5㧕 ⎇ⓥઍ⴫⠪㧦ጊਅஜᄥ㇢㧧ጘ㒂ᄢቇᄢቇ㒮කቇ♽⎇ⓥ⑼ߩ⎇ⓥᵴᕈൻ(ක)⎇ⓥ⾌㧦⣖៊்߳ߩ␹⚻ⴊ▤ౣ↢≮ᴺߩ⏕┙̆⢽⢌↱᧪㑆⪲♽ᐙ⚦⢩ߩ᦭↪ᕈߩᬌ⸛̆㧧ᐔᚑ 18 ᐕᐲ㧧200 ජ౞6㧕 ⎇ⓥઍ⴫⠪㧦ጤ㑆 ੧㧘⎇ⓥಽᜂ⠪㧦೽↰᣿↵㧧⁛┙ⴕ᡽ᴺੱᣣᧄቇⴚᝄ⥝ળ⑼ቇ⎇ⓥ⾌⵬ഥ㊄⪚⧘⎇ⓥ㧦EGF, EGFR ߇⣖⣲≌ᐙ⚦⢩ߦ෸߷ߔᓇ㗀㧧ᐔᚑ 19㧙20 ᐕᐲ㧧3,300 ජ౞(1,700㧦1,600
ජ౞)7㧕 ⎇ⓥઍ⴫⠪㧦ศ᧛⚩৻㧘⎇ⓥಽᜂ⠪㧦ጤ㑆 ੧, ᄢᳯ⋥ⴕ, ᭑ᧄ↱⾆ሶ, ጊ↰ᷡᢥ㧧⁛┙ⴕ᡽ᴺੱᣣ
ᧄቇⴚᝄ⥝ળ⑼ቇ⎇ⓥ⾌⵬ഥ㊄⪚⧘⎇ⓥ㧦⢽⢌↱᧪㑆⪲♽ᐙ⚦⢩ࠍ↪޿ߚ⣖⯯ⴊߦኻߔࠆ⒖ᬀౣ↢≮ᴺߩ⏕┙㧧ᐔᚑ 19㧙21 ᐕᐲ㧧3,200 ජ౞(1,000㧦1,300㧦900 ජ౞)
8㧕 ⎇ⓥઍ⴫⠪㧦ਛጊೣਯ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄⧯ᚻ⎇ⓥ(B)㧦⣖⣲≌ᐙ⚦⢩ߩዪ࿷ߩ⸃᣿㧧ᐔᚑ
19㧙20 ᐕᐲ㧧3,300 ජ౞(1,700㧦1,600 ජ౞)
9㧕 ⎇ⓥઍ⴫⠪㧦ศ᧛⚩৻㧧⎇ⓥ⑼㐳࡮කቇㇱ㐳ⵙ㊂⚻⾌ߦࠃࠆ⎇ⓥ⾌(ක)㧦⢽⢌⚵❱↱᧪㑆⪲♽ᐙ⚦⢩ߣ␹⚻ᩕ㙃࿃ሶࠍ↪޿ߚᣂߒ޿␹⚻∔ᖚᴦ≮ᴺߩ㐿⊒㧧ᐔᚑ 19 ᐕᐲ㧧100 ජ౞
10㧕 ⎇ⓥઍ⴫⠪㧦ጊ↰ᷡᢥ㧧ᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⵬ഥ㊄⧯ᚻ⎇ⓥ(B)㧦⣖⣲≌ߩ࡞࡯࠷㧧ᐔᚑ 20㧙21 ᐕᐲ㧧2,210 ජ౞(1,700㧦510 ජ౞)
11㧕 ઍ⴫⎇ⓥ⠪㧦ጟ↰ ⺈㧧ᵴᕈൻ⚻⾌㧦㕖ਛᨔ␹⚻⚵❱ࡑࠢࡠࡈࠔ࡯ࠫߦࠃࠆᖡᕈ␹⚻⤔⣲⹺⼂⢻ജߩᏅ⇣ߩᬌ⸛㧧ᐔᚑ 20 ᐕᐲ㧧890 ජ౞
12㧕 ઍ⴫⎇ⓥ⠪㧦᭑ᧄ↱⾆ሶ㧧ᐔᚑ 20 ᐕᐲ⎇ⓥ⑼㐳࡮කቇㇱ㐳ⵙ㊂⚻⾌㧦㗖േ⣂ࠬ࠹ࡦ࠻⇐⟎ⴚ(CAS)ߩ๟ⴚᦼ᛫ⴊዊ᧼≮ᴺߦ߅ߌࠆ⥋ㆡ᛫ⴊዊ᧼⮎࡮⥋ㆡᛩਈ㊂߅ࠃ߮ࡕ࠾࠲࡝ࡦࠣᴺߩ⏕┙㧧ᐔᚑ 20
ᐕᐲ㧧250 ජ౞
13㧕 ઍ⴫⎇ⓥ⠪㧦ᳰ੉↱㚅㧧ANGPT1 ߣ⚵❱ᐙ⚦⢩ࠍ೑↪ߒߚ⯯ⴊᕈ⣖ⴊ▤∔ᖚߦኻߔࠆᣂߒ޿ᴦ≮ᴺߩ㐿⊒㧧ᐔᚑ 20 ᐕᐲ㧧250 ජ౞
2㧕ฃ⸤⎇ⓥ1㧕 ጤ㑆 ੧㧦࡜ࠫࠞ࠶࠻ᵈ ․ቯᚑ❣૶↪⺞ᩏ(ዊఽߦኻߔࠆ⺞ᩏ)㧧ᐔᚑ 18 ᐕᐲ㧧31,500 ౞㧦ਃ⪉࠙ࠚ࡞ࡈࠔ࡯ࡑ(ᩣ)
2㧕 ጤ㑆 ੧㧦PAV ≮ᴺ ૶↪ᚑ❣⺞ᩏ㧧ᐔᚑ 18 ᐕᐲ㧧105 ජ౞㧦ਛᄖ⵾⮎(ᩣ)
3㧕 ጤ㑆 ੧㧦ࠣ࡞࠻ࡄᵈ(⯯ⴊᕈ⣖ⴊ▤㓚ኂᕆᕈᦼ)૶↪ᚑ❣⺞ᩏ㧧ᐔᚑ 17㧙19 ᐕᐲ㧧315 ජ౞㧦ਃ⪉࠙ࠚ࡞ࡈࠔ࡯ࡑ(ᩣ)
4㧕 ጤ㑆 ੧㧦ࠪࡠࠬ࠲࠱࡯࡞ߩᏒ⽼ᓟ⥃ᐥ⹜㛎̆⣖᪪Ⴇߦኻߔࠆࠕࠬࡇ࡝ࡦߣߩᲧセߦ߅ߌࠆᬌ⸽⊛⹜㛎࡯㧧ᐔᚑ 16㧙20 ᐕᐲ㧧4,066,560 ౞㧦ᄢႦ⵾⮎(ᩣ)
5㧕 ጤ㑆 ੧㧦࠹ࡕ࠳࡯࡞ࠞࡊ࠮࡞ో଀⺞ᩏ(․ቯ૶↪ᚑ❣⺞ᩏ)㧧ᐔᚑ 18㧙20 ᐕᐲ㧧1,417,500 ౞㧦ࠪࠚ࡝ࡦࠣࡊ࡜࠙(ᩣ)
6㧕 ศ᧛⚩৻㧦⣖േ⣂≜↪ࠬ࠹ࡦ࠻ߩ㐿⊒㧧ᐔᚑ 18 ᐕᐲ㧧1,050 ජ౞㧦(ᩣ)ࠞࡀࠞ

㧙㧙7㧕 ጤ㑆 ੧㧦ࠣ࡞࠻ࡃᵈ(⯯ⴊᕈ⣖ⴊ▤㓚ኂᕆᕈᦼ)૶↪ᚑ❣⺞ᩏ㧧ᐔᚑ 17㧙19 ᐕᐲ㧧315 ජ౞(105㧦
210㧦0 ජ౞)㧦ਃ⪉࠙ࠚ࡞ࡈࠔ࡯ࡑ(ᩣ)
8㧕 ጤ㑆 ੧㧦ࠟࡃࡍࡦ㍤૶↪ᚑ❣⺞ᩏ㧧ᐔᚑ 19㧙21 ᐕᐲ㧧210 ජ౞(210㧦0㧦0 ජ౞)㧦ࡈࠔࠗࠩ࡯⵾⮎(ᩣ)
9㧕 ጤ㑆 ੧㧦㗪േ⣂↪ࡊ࡝ࠨࠗࠬ࡮ࠕࡦࠫࠝࠟ࡯࠼ XP ૶↪ᚑ❣⺞ᩏ㧧ᐔᚑ 20㧙22 ᐕᐲ㧧420 ජ౞㧦࡚ࠫࡦ࠰ࡦ࡮ࠛࡦ࠼࡮࡚ࠫࡦ࠰ࡦ(ᩣ)
10㧕 ศ᧛⚩৻㧦㗪േ⣂ࠬ࠹ࡦ࠻⇐⟎ⴚᓟߩⴊ▤ࠗࡌࡦ࠻ߩ⊒∝ߦ㑐ߔࠆ೨ะ߈ⷰኤ⎇ⓥ(IDEALCAST)㧧
ᐔᚑ 20㧙22 ᐕᐲ㧧726,900 ౞㧦⽷࿅ᴺੱవ┵ක≮ᝄ⥝⽷࿅
3㧕౒ห⎇ⓥߥߒ
5㧚⊒᣿࡮․⸵಴㗿⁁ᴫ
1㧕 ⮮↰ᐢᔒ㧘ౝጊ⦟৻㧘ጤ㑆 ੧㧘቟⮮ᒄ㆏㧦ක↪↹௝ಣℂⵝ⟎෸߮↹௝ಣℂᣇᴺ㧘PCT ಴㗿㧘
PCT/JP2006/316595(․⸵)㧧ᐔᚑ 18 ᐕᐲ
2㧕 ⮮↰ᐢᔒ㧘ౝጊ⦟৻㧘ጤ㑆 ੧㧘቟⮮ᒄ㆏㧘ੑ᧛ ੳ㧦ක↪↹௝ಣℂⵝ⟎㧧ᐔᚑ 18 ᐕᐲ(․㗿
2007-533204)
6㧚ቇળᵴേ
1㧕ቇળᓎຬ
ጤ㑆 ੧㧦
1㧕 ␠࿅ᴺੱᣣᧄ⣖␹⚻ᄖ⑼ቇળ⹏⼏ຬ(㨪⃻࿷)2㧕 ᣣᧄ⣖තਛቇળ⹏⼏ຬ(㨪⃻࿷)3㧕 ␠࿅ᴺੱᣣᧄ⣖␹⚻ᄖ⑼ቇળઍ⼏ຬ(㨪⃻࿷)4㧕 ᣣᧄ⣖තਛߩᄖ⑼ቇળㆇ༡ᆔຬ(㨪⃻࿷)5㧕 ␠࿅ᴺੱᣣᧄ⣖␹⚻ᄖ⑼ቇળਛㇱᡰㇱℂ੐(㨪⃻࿷)6㧕 ᣣᧄዊఽ␹⚻ᄖ⑼ቇળ਎⹤ੱ(㨪⃻࿷)7㧕 ᣣᧄ⣖⣲≌ߩᄖ⑼ቇળ⹏⼏ຬ(㨪⃻࿷)8㧕 ᣣᧄ⣖࠼࠶ࠢቇળ⹏⼏ຬ(㨪⃻࿷)9㧕 ᣣᧄ⣖␹⚻ᄖ⑼ࠦࡦࠣ࡟ࠬㆇ༡ᆔຬ(ᐔᚑ 18 ᐕ 5 ᦬㨪⃻࿷)ศ᧛⚩৻㧦
1㧕 ᣣᧄ⣖␹⚻ⴊ▤ౝᴦ≮ቇળㆇ༡ᆔຬ(㨪⃻࿷)2㧕 ␠࿅ᴺੱᣣᧄ⣖␹⚻ᄖ⑼ቇળ⹏⼏ຬ(㨪⃻࿷)⍫㊁ᄢੳ㧦1㧕 ␠࿅ᴺੱᣣᧄ⣖␹⚻ᄖ⑼ቇળ⹏⼏ຬ(ᐔᚑ 19 ᐕ 9 ᦬㨪⃻࿷)2㧕ቇળ㐿௅
1㧕 ጤ㑆 ੧㧦ᣣᧄ⣖␹⚻ᄖ⑼ቇળਛㇱᡰㇱቇⴚ㓸ળ(ᐔᚑ 19 ᐕ 4 ᦬)
3㧕ቇⴚ㔀⹹
ጤ㑆 ੧㧦
1㧕 ⣖␹⚻ᄖ⑼㧧✬㓸หੱ(㨪⃻࿷)2㧕 ⣖␹⚻ᄖ⑼ࠫࡖ࡯࠽࡞㧧✬㓸ᆔຬ(ᐔᚑ 18 ᐕ 5 ᦬㨪⃻࿷)3㧕 Neurologia medico-chirurgica㧧Review Board(ᐔᚑ 18 ᐕ 5 ᦬㨪⃻࿷)4㧕 ⣖ߣᓴⅣ㧧✬㓸ࠕ࠼ࡃࠗࠩ࡯(ᐔᚑ 19 ᐕ 1 ᦬㨪⃻࿷)ศ᧛⚩৻㧦
1㧕 Neurotrauma Research㧧Editional Board(㨪⃻࿷)2㧕 Journal of Neuroendovascular Therapy㧧✬㓸ᆔຬ(ᐔᚑ 19 ᐕ 4 ᦬㨪⃻࿷)3㧕 Neurologia medico-chirurgica㧧Review Board(ᐔᚑ 19 ᐕ 11 ᦬㨪⃻࿷)㧙㧙

7㧚ቇળ᜗ᓙ⻠Ṷ㧘᜗ᓙࠪࡦࡐࠫࠬ࠻㧘ᐳ㐳ጤ㑆 ੧㧦
1㧕 The 4th International Mt. BANDAI Symposium for Neuroscience&The 5th Pan-Pacific
Neurosurgery Congress (2006.01, Hawaii, Ischemia and Cerebrovascular surgery-2. joint
Neurosurgical Convention 2006; ᐳ㐳)2㧕 ╙ 26 ࿁ᣣᧄ⣖␹⚻ᄖ⑼ࠦࡦࠣ࡟ࠬ✚ળ(ᐔᚑ 18 ᐕ 5 ᦬㧘᧲੩㧘ࡕ࡯࠾ࡦࠣ࠮ࡒ࠽࡯‫ޟ‬STA-MCA
bypass.ⴊⴕౣᑪⴚߩၮᧄᚻᛛ‫ޠ‬Ṷ⠪)3㧕 3th European-Japanese Joint Conference for Stroke Surgery and Satellite Symposium on
Moyamoya Angiopathy (2006.07, Zurich, Moyamoya symposium; ᐳ㐳)4㧕 3th European-Japanese Joint Conference for Stroke Surgery and Satellite Symposium on
Moyamoya Angiopathy (2006.07, Zurich, Moyamoya disease: Present status in Japan; ࠪࡦࡐࠫࠬ࠻)5㧕 The 8th Korean and Japanese Friendship Conference on Surgery for Cerebral Stroke(2006.08,
Sendai, EC-IC bypass; ᐳ㐳)
6㧕 ╙ 27 ࿁ᣣᧄ⣖␹⚻ᄖ⑼ࠦࡦࠣ࡟ࠬ✚ળࡂࡦ࠭ࠝࡦࠦ࡯ࠬ(ᐔᚑ 19 ᐕ 5 ᦬㧘઄บ㧘ࡒ࠾࡟ࠢ࠴ࡖ࡯‫ޟ‬⣖ⴊⴕౣᑪߩ᭎ᔨ㧙ⴊ▤่ว‫ޠ‬Ṷ⠪)7㧕 ╙ 27 ࿁ ᣣ ᧄ ⣖ ␹ ⚻ ᄖ ⑼ ࠦ ࡦ ࠣ ࡟ ࠬ ✚ ળ ( ᐔ ᚑ 19 ᐕ 5 ᦬ 㧘 ઄ บ 㧘 ࡕ ࡯ ࠾ ࡦ ࠣ ࠮ ࡒ ࠽ ࡯‫ޟ‬Interhemispheric approach ߩ㐳ᚲߣ⍴ᚲ㧙೨੤ㅢേ⣂≜ߩၮᧄ‫ޠ‬Ṷ⠪)8㧕 ╙ 35 ࿁ᣣᧄዊఽ␹⚻ᄖ⑼ቇળ(ᐔᚑ 19 ᐕ 5 ᦬㧘ᧁᦝᵤ㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬ੑಽ⣄ᬁ㧧ᚑ㐳, ⊒㆐ߦ઻߁໧㗴ߣߘߩኻ╷‫ޠ‬ᐳ㐳)
9㧕 Congress of Neurological Surgeons 2007 Annual Meeting(ᐔᚑ 19 ᐕ 9 ᦬, San Diego, Luncheon
Seminar‫ޟ‬Cerebral ischemic disease: current management strategies‫ޠ‬Ṷ⠪)10㧕 ╙ 66 ࿁␠࿅ᴺੱᣣᧄᣣᧄ⣖␹⚻ᄖ⑼ቇળ✚ળ(ᐔᚑ 19 ᐕ 10 ᦬㧘᧲੩㧘ᢎ⢒࠮ࡒ࠽࡯‫ޟ‬㐽Ⴇᕈ⣖ⴊ▤㓚ኂߩ⸻ᢿ࡮ᴦ≮㧦EC-IC ࡃࠗࡄࠬⴚߩၮᧄᚻᛛ‫ޠ‬Ṷ⠪)11㧕 ╙ 66 ࿁␠࿅ᴺੱᣣᧄᣣᧄ⣖␹⚻ᄖ⑼ቇળ✚ળ(ᐔᚑ 19 ᐕ 10 ᦬㧘᧲੩㧘࡜ࡦ࠴࡚ࡦ࠮ࡒ࠽࡯‫ޟ‬⣖ⴊ▤㓚ኂߩᴦ≮ᚢ⇛㧦⎕ⵚ⣖േ⣂≜ߦኻߔࠆᴦ≮ᚢ⇛‫ޠ‬Ṷ⠪)12㧕 ╙ 6 ࿁ᣣᧄᢇᕆකቇળਛㇱ࿾ᣇળ(ᐔᚑ 19 ᐕ 11 ᦬㧘ጘ㒂㧘࡜ࡦ࠴࡚ࡦ࠮ࡒ࠽࡯‫ޟ‬⣖තਛߩᕆᕈᦼᴦ
≮‫ޠ‬Ṷ⠪)
13㧕 The 12th Asian Australasian Congress of Neurosurgical Societies/World Federation of
Neurosurgical Societies, 13th Interim Meeting(ᐔᚑ 19 ᐕ 11 ᦬, Nagoya, Luncheon Seminar‫ޟ‬Endarterectomy: indication, technique, complication.‫ޠ‬Ṷ⠪)
14㧕 The 12th Asian Australasian Congress of Neurosurgical Societies/World Federation of
Neurosurgical Societies, 13th Interim Meeting(ᐔᚑ 19 ᐕ 11 ᦬, Nagoya, Evening Video Seminar‫ޟ‬Management of Low Grade Gliomas: Current Strategies and Dilemmas.‫ޠ‬ᐳ㐳)15㧕 Memorial International Neuro-Oncology Forum in Nagoya 2007(ᐔᚑ 19 ᐕ 11 ᦬, Nagoya, ᐳ㐳)
16㧕 ╙ 40 ࿁ਛㇱ⣄㜑ᄖ⑼ࡢ࡯࡚ࠢࠪ࠶ࡊ(ᐔᚑ 20 ᐕ 3 ᦬㧘ฬฎደ㧘․೎⻠Ṷ‫ޟ‬⣄㜑ᄖ⑼ߦ߅ߌࠆⴚਛࡕ
࠾࠲࡝ࡦࠣ ၮ␆ߣ⥃ᐥ‫ޠ‬ᐳ㐳)17㧕 ╙ 28 ࿁ᣣᧄ⣖␹⚻ᄖ⑼ࠦࡦࠣ࡟ࠬ✚ળ(ᐔᚑ 20 ᐕ 5 ᦬㧘ᮮᵿ㧘ࡊ࡟࠽࡝࡯࠮࠶࡚ࠪࡦ‫ోޟ‬り⣂▤∛ߣߒߡߩ⣖තਛ‫ޠ‬ᐳ㐳)18㧕 ╙ 36 ࿁ᣣᧄዊఽ␹⚻ᄖ⑼ቇળ(ᐔᚑ 20 ᐕ 5 ᦬㧘᧲੩㧘‫▤ⴊޟ‬㓚ኂ‫ޠ‬ᐳ㐳)19㧕 ╙ 13 ࿁ᣣᧄ⣖⣲≌ߩᄖ⑼ቇળ(ᐔᚑ 20 ᐕ 10 ᦬㧘ᄢ㒋㧘ࠪࡦࡐࠫ࠙ࡓ 6‫ޟ‬Tentorial Meningioma ߩᴦ≮ᚢ⇛‫ޠ‬ᐳ㐳)ศ᧛⚩৻㧦
1㧕 ╙ 35 ࿁ᣣᧄ⣖තਛߩᄖ⑼ቇળ(ᐔᚑ 18 ᐕ 3 ᦬㧘ᮮᵿ㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬ᕆᕈᦼ⎕ⵚ⣖േ⣂≜ߩᴦ≮ㆬᛯߩ⃻⁁‫ޠ‬Ṷ⠪)2㧕 Complex Catheter Therapeutics(CCT2006)(ᐔᚑ 18 ᐕ 9 ᦬㧘␹ᚭ㧘᜗ᓙ⻠Ṷ‫ޟ‬CAS ᓟ Hyperperfusion㧦ߘߩ੍⍮ߣኻ╷‫ޠ‬Ṷ⠪)3㧕 Complex Catheter Therapeutics (CCT2006)(ᐔᚑ 18 ᐕ 9 ᦬㧘␹ᚭ㧘᜗ᓙ⻠Ṷ‫ޟ‬Proximal protection in
the CAS Parodi ᴺ㧦ㆡᔕߣ೑ὐ࡮ᰳὐ‫ޠ‬Ṷ⠪)
4㧕 ╙ 9 ࿁ᣣᧄᩖሶᬌ಴ߣᴦ≮ቇળ(ࠛࡦࡏ࡜ࠬቇળ)(ᐔᚑ 18 ᐕ 11 ᦬㧘੩ㇺ㧘ࠪࡦࡐࠫ࠙ࡓ‫ⴚޟ‬೨ࡊ࡜࡯ࠢ⸻ᢿߣႧᩖᕈว૬∝‫ޠ‬Ṷ⠪)5㧕 The 4th international Intracranial Stent Meeting(ᐔᚑ 19 ᐕ 4 ᦬㧘Kyoto㧘ᐳ㐳)㧙㧙6㧕 ╙ 66 ࿁␠࿅ᴺੱᣣᧄᣣᧄ⣖␹⚻ᄖ⑼ቇળ✚ળ(ᐔᚑ 19 ᐕ 10 ᦬㧘᧲੩㧘ࠗࡉࠗࡦࠣ࠮ࡒ࠽࡯‫ⴚޟ‬⠪ᢎ⢒ߩࠦ࠷ߣ㔍ߒߐ‫ޠ‬Ṷ⠪)7㧕 ╙ 23 ࿁ᣣᧄ⣖␹⚻ⴊ▤ౝᴦ≮ቇળ✚ળ(ᐔᚑ 19 ᐕ 11 ᦬㧘␹ᚭ㧘࡜ࡦ࠴࡚ࡦ࠮ࡒ࠽࡯‫ޟ‬㗪േ⣂⁜⓰∝ᴦ≮ߩᦨ೨✢㧦ว૬∝࠯ࡠࠍ⋡ᜰߒߚ CAS ߣ best medical treatment‫ޠ‬Ṷ⠪)8㧕 ╙ 23 ࿁ᣣᧄ⣖␹⚻ⴊ▤ౝᴦ≮ቇળ✚ળ(ᐔᚑ 19 ᐕ 11 ᦬㧘␹ᚭ㧘ࠪࡦࡐࠫ࠙ࡓ 4‫ޟ‬CAS ᤨઍࠍㄫ߃
ߚ㗪േ⣂⁜⓰⸽ߩᴦ≮ᚢ⇛㧙ࠃࠅ቟ోߥⴊⴕౣᑪࠍ⋡ᜰߒߡ‫ޠ‬ᐳ㐳)9㧕 The 12th Asian Australasian Congress of Neurosurgical Societies/World Federation of
Neurosurgical Societies, 13th Interim Meeting(ᐔᚑ 19 ᐕ 11 ᦬, Nagoya, Luncheon Seminar‫ ޟ‬Management of Unruptured Intracranial Aneurysms: Understanding and Developing
Treatment Options/ Clipping, coiling, and their combinations for unruptured intracranial
aneurysms ‫ޠ‬Ṷ⠪)8㧚ቇⴚ⾨╬ߩฃ⾨⁁ᴫ1㧕 ᭑ᧄ↱⾆ሶ㧦╙ 5 ࿁ᣣᧄ㗖ㇱ⣖ⴊ▤ᴦ≮ቇળఝ⑲ࡐࠬ࠲࡯⾨(ᐔᚑ 18 ᐕᐲ)
2㧕 ጊ↰ᷡᢥ㧦╙ 71 ࿁ᣣᧄ⣖␹⚻ᄖ⑼ቇળਛㇱᡰㇱળఝ⑲⺰ᢥ⾨(ᐔᚑ 18 ᐕᐲ)
9㧚␠ળᵴേ
ጤ㑆 ੧㧦
1㧕 ጘ㒂ഭ௛ዪ࿾ᣇഭἴකຬ(㨪⃻࿷)2㧕 ጘ㒂⋵කᏧળᄖ⑼කㇱળ㘈໧(㨪⃻࿷)3㧕 ጘ㒂⋵කᏧળഭἴᜰቯකㇱળ㘈໧(㨪⃻࿷)4㧕 ጘ㒂⋵ᚑੱ∛ᬌ⸻▤ℂᜰዉද⼏ળᓴⅣེ∔ᖚ╬ᆔຬળᆔຬ(㨪⃻࿷)5㧕 ጘ㒂࿾ᣇⵙ್ᚲᚲዻኾ㐷ᆔຬ(㨪⃻࿷)6㧕 ਛㇱ≮⼔࠮ࡦ࠲࡯౉㒮ክᩏᆔຬળᆔຬ㐳(㨪⃻࿷)7㧕 ⁛┙ⴕ᡽ᴺੱ⥄േゞ੐᡿ኻ╷ᯏ᭴㊀ᐲᓟㆮ㓚ኂ⹺ቯክᩏᆔຬળ࿾ᣇᆔຬ(㨪ᐔᚑ 19 ᐕ 3 ᦬)
8㧕 ␠࿅ᴺੱᣣᧄ⣖තਛදળጘ㒂⋵ᡰㇱᡰㇱ㐳(㨪⃻࿷)9㧕 ጘ㒂ᄢቇකቇㇱห⓹ળℂ੐(ળ⸘)(ᐔᚑ 18 ᐕ 5 ᦬㨪ᐔᚑ 20 ᐕ 5 ᦬)
10㧕 ጘ㒂⋵┙∛㒮ක≮੐᡿ክᩏᆔຬળᆔຬ(㨪⃻࿷)11㧕 ⑺↰⋵┙⣖ⴊ▤⎇ⓥ࠮ࡦ࠲࡯⎇ⓥᄖㇱ⹏ଔᆔຬ(㨪⃻࿷)ศ᧛⚩৻㧦1㧕 ␠࿅ᴺੱᣣᧄ⣖තਛදળጘ㒂⋵ᡰㇱ೽ᡰㇱ㐳(㨪⃻࿷)10㧚ႎ๔ᦠ
1㧕 ศ᧛⚩৻㧦㗡ㇱᄖ்‫ޔ‬⣖⯯ⴊᓟߩ neurogenesis ೙ᓮᯏ᭴ߩ⸃ᨆ㧦␹⚻ᩕ㙃࿃ሶߣߩ㑐ㅪ㧦ᐔᚑ 16ᐕᐲ㧙ᐔᚑ 18 ᐕᐲᢥㇱ⑼ቇ⋭⑼ቇ⎇ⓥ⾌⵬ഥ㊄ၮ⋚⎇ⓥ(B)(2)⎇ⓥᚑᨐႎ๔ᦠ(2007 ᐕ 3 ᦬)
11㧚ႎ㆏1㧕 ೽↰᣿↵㧦‫ࠎ߇ޟ‬ᐙ⚦⢩‫⎇ޠ‬ⓥᵴ⊒ߦ㧦ᣣᧄ⚻ᷣᣂ⡞(2006 ᐕ 9 ᦬ 18 ᣣ)
2㧕 ೽↰᣿↵㧦߇ࠎߦૃߖߚ⚵❱߇ࠎᐙ⚦⢩߆ࠄ૞⵾㧦ᣣ⚻↥ᬺᣂ⡞(2006 ᐕ 9 ᦬ 22 ᣣ)
3㧕 ೽↰᣿↵㧦21 ਎♿ߩ᳇㍈ ᚻⴚቶߣ⎇ⓥቶᯅᷰߒ㧦ᣣ⚻↥ᬺᣂ⡞(2006 ᐕ 11 ᦬ 30 ᣣ)
12㧚⥄Ꮖ⹏ଔ
⹏ଔᕆᕈᦼ⣖⯯ⴊߦኻߔࠆฦ⒳⮎೷ߥࠄ߮ߦ⢽⢌⚵❱↱᧪ᐙ⚦⢩ᛩਈߦ߅ߌࠆ⣖଻⼔ലᨐߦ㑐ߒߡᣂߚߥ
⍮⷗߇ᓧࠄࠇ㧘੹ᓟߐࠄߥࠆ⊒ዷߣ⥃ᐥ߳ߩᔕ↪߇ᦼᓙߐࠇࠆ‫ⴊޕ‬ዊ᧼᡼಴࿃ሶߣേ⣂⎬ൻߣߩ㑐ㅪ㧘ߥࠄ߮ߦฦ⒳᛫ⴊዊ᧼೷ߩᓇ㗀ߦ㑐ߔࠆ⎇ⓥߦ߅޿ߡ߽⥃ᐥᔕ↪ߦ⋥⚿ߔࠆᚑᨐ߇ᓧࠄࠇߡ޿ࠆ‫ޕ‬ᖡᕈ⣖⣲≌ߩౣ⊒ߣ᡼኿✢უᱫߩ㐓೎ߦ㑐ߔࠆ⥃ᐥ⎇ⓥߦ߅޿ߡᣂߚߥ⸻ᢿᴺ߇㐿⊒ߐࠇߟߟ޽ࠆ‫ޕ‬⃻⁁ߩ໧㗴ὐ෸߮ߘߩኻᔕ╷ߘࠇߙࠇߩ࠹࡯ࡑߦ߅޿ߡᦝߥࠆ⎇ⓥߩዷ㐿߇ᦼᓙߐࠇࠆਛߢ㧘⃻࿷ߩᦨᄢߩ໧㗴ὐߪ⎇ⓥੱຬߩਇ⿷ߣ⎇ⓥ૕೙ߩ⏕┙ߦ޽ࠆ‫ޕ‬⎇ⓥੱຬߩჇടࠍ⍴ᦼ㑆ߦ㆐ᚑߔࠆ੐ߪ࿎㔍ߢ޽ࠆߚ߼㧘㐳ᦼ⊛ዷᦸߦ┙ߞߡ⎇ⓥ⠪ࠍ⢒ᚑߒߡ޿ߊ

㧙㧙ᔅⷐ߇޽ࠆ‫ߚ߹ޕ‬㧘⃻࿷ߘࠇߙࠇ⇣ߥߞߚၮ␆⻠ᐳߣߩ౒ห⎇ⓥ߇ਥ૕ߣߥߞߡ޿ࠆ߇㧘࠻࡜ࡦࠬ࡟࡯
࡚ࠪ࠽࡞࡝ࠨ࡯࠴ࠍߐࠄߦㅴ߼ࠆߚ߼ߦ߽㧘⣖␹⚻ᄖ⑼ߦᚲዻߔࠆ⥃ᐥක㧘ၮ␆⎇ⓥ⠪߇Ᏹߦ㗻ࠍวࠊߖߡ⎇ⓥߦ㑐ߔࠆ⸛⺰߇⥄ὼߦ↢߹ࠇࠆߎߣ߇ᄢಾߢ㧘⎇ⓥ᜚ὐࠍ⣖␹⚻ᄖ⑼ౝߦ⸳┙ߔߴߊᢛ஻ࠍㅴ
߼ߡ޿ࠆ‫ޕ‬੹ᓟߩዷᦸ⃻࿷ߥ߅ᴦ≮ᚑ❣߇ਇ⦟ߢ޽ࠆᖡᕈ⣖⣲≌ߣ㧘߹ߔ߹ߔߩჇട߇੍ᗐߐࠇࠆ⣖⯯ⴊߦኻߔࠆᣂߚߥᴦ
≮ᴺߩ㐿⊒ߪ㧘⣖␹⚻ᄖ⑼ቇ㗔ၞߦ߅޿ߡ੹ᓟ߽㊀ⷐߥ⺖㗴ߢ޽ࠆ‫ޕ‬ᖡᕈ⣖⣲≌ߩ⥃ᐥ⊛ᴦ≮ᚑ❣ߪ⛔ว⊛↹௝⸻ᢿߩᔕ↪ߢዋߒߕߟㅴᱠߒߡ޿ࠆ߇㧘ᦝߥࠆᴦ≮ലᨐࠍᓧࠆߚ߼ߦߪ఺∉≮ᴺ㧘⣖≌ᐙ⚦⢩ߩಽ㔌ࠍၮߦߒߚ࠹࡯࡜࡯ࡔ࡯࠼ᴦ≮ߥߤ߇ᔅⷐߢ޽ࠅ㧘ၮ␆⎇ⓥ
ߣߣ߽ߦ⥃ᐥᔕ↪ࠍ⋡ᜰߒߚ࠻࡜ࡦࠬ࡟࡯࡚ࠪ࠽࡞࡝ࠨ࡯࠴ࠍߐࠄߦㅴ߼ࠆᔅⷐ߇޽ࠆ‫ޕ‬⣖⯯ⴊߩᴦ≮ߦ㑐ߒߡߪ㧘ߎࠇ߹ߢߩ⯯ⴊߦኻߔࠆ⣖଻⼔ߣ޿߁ฃേ⊛ⷰὐ߆ࠄ㧘㓚ኂߐࠇߚᯏ⢻ࠍขࠅᚯߔߣ޿߁ౣ↢ක≮ߩዉ౉㧘ߐࠄߦߪ㧘⣖⯯ⴊߩේ࿃ߢ޽ࠆ⣖േ⣂⎬ൻࠍⓍᭂ⊛ߦᛥ೙ߔࠆߣ޿߁
ᚢ⇛ߩࠪࡈ࠻߇੍ᗐߐࠇࠆ‫ޕ‬⣖⯯ⴊ଻⼔ߦ㑐ߔࠆߎࠇ߹ߢߩ⎇ⓥᚑᨐߩ⥃ᐥᔕ↪ࠍㅴ߼ࠆߣหᤨߦ㧘␹⚻ౣ↢㧘⣖േ⣂⎬೙ᓮࠍ⋡ᜰߒߚၮ␆⊛㧘⥃ᐥ⊛⎇ⓥߦขࠅ⚵ࠎߢ޿߈ߚ޿‫ޕ‬㧙㧙㧔7㧕⡊㥦ຜ༄⑼ቇಽ㊁1㧚⎇ⓥߩ᭎ⷐ
1㧕߼߹޿࡮ᐔⴧ㓚ኂߦ㑐ߔࠆ߽ߩ߼߹޿࡮ᐔⴧ㓚ኂᖚ⠪ߦฦ⒳ᐔⴧᯏ⢻ᬌᩏࠍⴕ޿㧘∔ᖚߩ⚛࿃߿∛௝㧘߼߹޿ᐔⴧ㓚ኂߩ⥃ᐥ⊛∛ᘒࠍߣࠄ߃㧘ߘߩᚑᨐࠍᴦ≮ߦࡈࠖ࡯࠼ࡃ࠶ࠢߒߡ޿ࠆ‫ޕ‬㕒⊛ᐔⴧᯏ⢻ᬌᩏߩ৻ߟߢ޽ࠆ㊀ᔃേំᬌᩏߢߪᐔ
ⴧ㓚ኂߩ∛Ꮍ⸻ᢿ♖ᐲะ਄ߩߚ߼㧘ࡑࡂ࡜ࡁࡆࠬ࡮࠲ࠣ࠴ᴺ߿ᦨᄢ࡝ࠕࡊࡁࡈᜰᢙߦࠃࠆ⸃ᨆ⹏ଔࠍ⹜ߺ
ߡ޿ࠆ‫ޕ‬േ⊛ᐔⴧᯏ⢻ᬌᩏߩ⿷〯ߺᬌᩏߢߪ㧘ࡈࠜ࡯ࠬࡊ࡟࡯࠻ࠍዉ౉ߒ⿷ᐩ࿶ᄌൻߣ〯ߺᦧ߃࡝࠭ࡓߩ
⹏ଔࠍน⢻ߣߒߚ‫ޕ‬ᱠⴕ೙ᓮᯏ⢻⸃ᨆߦ߽ᔕ↪น⢻ߢ޽ࠆ‫ߚ߹ޕ‬㧘㔍ᴦߥᐔⴧ㓚ኂᖚ⠪ߦߪᐔⴧ⸠✵ࠍ࿖ౝߢߪ޿ߜᣧߊዉ౉ߒ㧘ߘߩ⥃ᐥ⊛࠺࡯࠲ࠍಽᨆ⹏ଔߒߥ߇ࠄ㧘᦭ലߥ⸠✵ᣇᴺ㧘⹏ଔᣇᴺࠍ⎇ⓥߒߡ޿ࠆ‫ޕ‬┙૏ᤨߩり૕േំࠍ᷹ቯߒ㧘ࡃࠗࠝࡔࠞ࠾ࠞ࡞ࡕ࠺࡞ࠍ᭴▽ߒ㧘り૕േំߩ␹⚻೙ᓮᯏ᭴ࠍ PID
㧔proportional integral derivative㧕೙ᓮᣇᑼࠍណ↪ߒߡᬌ⸽ߒߡ޿ࠆ‫ࠆࠃߦࠇߎޕ‬ฦ⒳ࡄ࡜ࡔ࡯࠲࡯ࠍ↪
޿ߡ∛Ꮍ⸻ᢿߦᔕ↪ߒߡ޿ࠆ‫ߚ߹ޕ‬㧘ᒰ⑼ߢⓍᭂ⊛ߦขࠅ౉ࠇߡ޿ࠆ̌߼߹޿࡝ࡂࡆ࡝࠹࡯࡚ࠪࡦ̍ߩᴦ
≮ലᨐ್ቯߦ⥃ᐥᔕ↪ߒ㧘ߘߩ᦭↪ᕈࠍᬌ⸽ߒߡ޿ࠆ‫ޕ‬߹ߚ㧘ࡔ࠾ࠛ࡯࡞∛ߩ∛ᘒߢ޽ࠆౝ࡝ࡦࡄ᳓⣲ߦ㑐ㅪᕈ߇޽ࠆ᳓ઍ⻢♽ࡎ࡞ࡕࡦߩࡃ࠱ࡊ࡟࠶ࠪࡦߦߟ
޿ߡ⎇ⓥߒߡ޿ࠆ‫∝⊒ޕ‬࿃ሶߣߒߡߩᓎഀ߿㧘ࡔ࠾ࠛ࡯࡞∛ߩ⊒∝࿃ሶߥࠄ߮ߦ੍ᓟ࿃ሶߣߒߡߩᓎഀߦ
ߟ޿ߡ㧘⥃ᐥ߅ࠃ߮ၮ␆⎇ⓥࠍⴕߞߡ޿ࠆ‫ߡߒߣ࡯࠲࡯ࡔ࡜ࡄࠍࡦࠪ࠶࡟ࡊ࠱ࡃޕ‬㧘ౝ⡊࿶೙ᓮࠍ⋡⊛ߦߒߚ㥏⤑࠴ࡘ࡯ࡉ⇐⟎ⴚ߅ࠃ߮ਛ⡊ട࿶ᴦ≮ࠍⴕ޿㧘⦟ᅢߥ⚿ᨐࠍᓧߡ޿ࠆ‫ޕ‬⿠┙ᕈᓴⅣ⺞▵ߦߪ࿶ฃኈེ෻኿ߦࠃࠆࡀࠟ࠹ࠖࡉࡈࠖ࡯࠼ࡃ࠶ࠢᯏ᭴߇㊀ⷐߢ޽ࠆ߇㧘೨ᐸེߦࠃࠆ
ࡈࠖ࡯࠼ࡈࠜࡢ࡯࠼♽೙ᓮߢ޽ࠆ೨ᐸ੤ᗵ␹⚻෻኿߇㑐ਈߒߡ޿ࠆߎߣࠍႎ๔ߒߚ‫ߚ߹ޕ‬㧘߼߹޿∝଀߇ߒ߫ߒ߫⸷߃ࠆ⿠┙ᕈ⺞▵㓚ኂߦ߅ߌࠆ೨ᐸ੤ᗵ␹⚻෻኿ߩ㑐ਈࠍᬌ⸽ߔࠆߣ߽ߦ㧘೨ᐸ㔚᳇ೝỗߦࠃࠆ߼߹޿ᴦ≮ߩ⥃ᐥᔕ↪ࠍᬌ⸛ߒߡ޿ࠆ‫ޕ‬⠧ൻଦㅴࡑ࠙ࠬࠍ↪޿㧘⠧ੱᕈ㔍⡬ߥࠄ߮ߦ⠧ൻߦߣ߽ߥ߁ᐔⴧ㓚ኂߩ⊒↢ᯏᐨߥࠄ߮ߦ⊒↢੍㒐ߦߟ޿ߡౝಽᴲࡎ࡞ࡕࡦߥߤߩⷰὐ߆ࠄᬌ⸛ߒߡ޿ࠆ‫ޕ‬߼߹޿࡮ᐔⴧකቇߩലᨐ⊛ߥත೨ᢎ⢒ࠍ࠴ࡘ࠻࡯࡝ࠕ࡞ࠦ࡯ࠬߣ⥃ᐥታ⠌ߦ߅޿ߡታ⃻ߔࠆᣇᴺࠍ⎇ⓥߒߡ޿ࠆ‫ޕ‬2㧕㗡㗪ㇱ⣲≌ߦ㑐ߔࠆ߽ߩ㗡㗪ㇱ≸ߦኻߔࠆൻቇ᡼኿✢ᴦ≮ߩ᦭ലᕈ㧘቟ోᕈߦ㑐ߒߡ㧘ߥࠄ߮ߦᯏ⢻᷷ሽߦ㑐ߒߡ㧘⥃ᐥᬌ⸛ࠍⴕߞߡ޿ࠆ‫ޕ‬㗡㗪ㇱ≸ᚻⴚⴚᓟߩᖚ⠪ߩ QOL ૐਅߩ㒐ᱛߦ㑐ߒߡ㧘ౣᑪⴚᑼߩ⥃ᐥ⊛ᬌ⸛ࠍⴕߞߡ޿ࠆ‫ޕ‬
2㧚ฬ★
ᢎ᝼㧦
ಎᢎ᝼㧦
⻠Ꮷ㧦
⻠Ꮷ㧦
⻠Ꮷ㧦
⥃ᐥ⻠Ꮷ㧦
⥃ᐥ⻠Ꮷ㧦
⥃ᐥ⻠Ꮷ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦

દ⮮౎ᰴ
᳓↰໪੺
㕍ᧁశᐢ
ਭ਎ᢥ਽
ട⮮ਭ๺
ጊ↰ධᤊ
಴ේ໪৻
㕍ᧁ㚅❱
⷏ၳਂ⚐
ᨋ ኼశ
ᵻ੗㓷ᐘ
ဈ੗↰⼑
ട⮮ผ㐷

Yatsuji Ito
Keisuke Mizuta
Mitsuhiro Aoki
Bunya Kuze
Hisakazu Kato
Nansei Yamada
Keiichi Izuhara
Kaori Aoki
Takesumi Nishihori
Hisamitsu Hayashi
Masayuki Asai
Yuzuru Sakaida
Shimon Kato

3㧚⎇ⓥᚑᨐߩ⊒⴫⪺ᦠ㧔๺ᢥ㧕
1㧕 ᳓↰໪੺㧚೽㥦⣧๟ㄝ⣲≌(⠢ญ⬄┃࡮஥㗡ਅ┃⣲≌)߳ߩࠕࡊࡠ࡯࠴㧦␹ፒੳ✬㧚⡊㥦ຜ༄⑼࡮㗡㗪ㇱᄖ⑼⸻≮ߩࠦ࠷ߣ⪭ߣߒⓣ 2 㥦࡮೽㥦⣧∔ᖚ㧘᧲੩㧦ਛጊᦠᐫ㧧2006 ᐕ㧦152㧙153㧚
2㧕 ᳓↰໪੺㧘᧛੗㆏ౖ㧚ᶐẢဳ೽㥦⣧⌀⩶∝ߩᴦ≮㧦␹ፒੳ✬㧚⡊㥦ຜ༄⑼࡮㗡㗪ㇱᄖ⑼⸻≮ߩࠦ࠷ߣ⪭ߣ
ߒⓣ 2 㥦࡮೽㥦⣧∔ᖚ㧘᧲੩㧦ਛጊᦠᐫ㧧2006 ᐕ㧦88㧙89㧚
3㧕 દ⮮౎ᰴ㧚ᬁ㛽⣖ᐩേ⣂ᓴⅣਇో㧦᫪ጊኡ㧘ጯᧄ⺈ม㧘ዊᨋବశ㧘Ꮉౝ⑲ਯ✬㧚੹ᣣߩ⡊㥦ຜ༄⑼࡮㗡㗪ㇱᄖ⑼ᴦ≮ᜰ㊎ ╙ 3 㧘᧲੩㧦කቇᦠ㒮㧧2008 ᐕ㧦185㧚㧙㧙⪺ᦠ㧔᰷ᢥ㧕ߥߒ✚⺑㧔๺ᢥ㧕
1㧕 દ⮮౎ᰴ㧚㜞㦂⠪ߩ߼߹޿㧘ᣣᧄ⡊㥦ຜ༄⑼ቇળኾ㐷කㅢା 2006 ᐕ㧧86 Ꮞ㧦6㧙7㧚
2㧕 દ⮮౎ᰴ㧚MLF syndrome㧘⡊㥦ຜ༄⑼࡮㗡㗪ㇱᄖ⑼ 2006 ᐕ㧧78 Ꮞ㧦186㧚
3㧕 દ⮮౎ᰴ㧚Moebius syndrome㧘⡊㥦ຜ༄⑼࡮㗡㗪ㇱᄖ⑼ 2006 ᐕ㧧78 Ꮞ㧦187㧚
4㧕 ᳓↰໪੺㧚߼߹޿ᄖ᧪ߦභ߼ࠆ BPPV ߩታᘒ㧘ENTONI 2006 ᐕ㧧60 Ꮞ㧦1㧙6㧚
5㧕 ᳓↰໪੺㧚ᓟඨⷙ▤ဳ BPPV ߩ⸻ᢿߣᴦ≮̆㗡૏ᕈ߼߹޿ࠍ߼ߋߞߡ㧘JOHNS 2006 ᐕ㧧22 Ꮞ㧦167㧙
171㧚
6㧕 દ⮮౎ᰴ㧚ᕆᕈ߼߹޿ߣᘟᕈ߼߹޿㧙⸻ᢿ࡮ᴦ≮ߩᏅ㧙 ✬㓸ડ↹㧘ENTONI 2007 ᐕ㧧75 Ꮞ㧦1㧚
7㧕 દ⮮౎ᰴ㧚ട㦂ߦࠃࠆᄌൻߣߘߩࠕࡦ࠴ࠛࠗࠫࡦࠣ ᐔⴧⷡ㧘JOHNS 2007 ᐕ㧧23 Ꮞ㧦1551㧙1553㧚
8㧕 ᳓↰໪੺㧚ౝ࡝ࡦࡄ᳓⣲ࠍ߈ߚߔ∔ᖚ㧘ENTONI 2007 ᐕ㧧81 Ꮞ㧦67㧙72㧚
9㧕 ᳓↰໪੺㧚߼߹޿㧘⡊㥦ຜ༄⑼ߦ߅ߌࠆዊఽ߳ߩᛩ⮎㧘ENTONI 2007 ᐕ㧧79 Ꮞ㧦39㧙44㧚
10㧕 㕍ᧁశᐢ㧚߼߹޿࡝ࡂࡆ࡝࠹࡯࡚ࠪࡦߣ EBM ⹏ଔ ᕆᕈ߼߹޿ߣᘟᕈ߼߹޿㧙⸻ᢿ࡮ᴦ≮ߩᏅ㧙㧘
ENTONI 2007 ᐕ㧧75 Ꮞ㧦45㧙49㧚
11㧕 દ⮮౎ᰴ㧚㊀ᔃേំᬌᩏ㧘⥃ᐥᬌᩏ 2008 ᐕ㧧52 Ꮞ㧦1465㧙1470㧚
✚⺑㧔᰷ᢥ㧕
ߥߒේ⪺㧔๺ᢥ㧕
1㧕 ᳓↰໪੺㧘቟⮮ஜ৻㧘ਭ਎ᢥ਽㧘᧛੗㆏ౖ㧘ᮮ↰㓁৻㧘ጊ↰ධᤊ㧘㕍ᧁశᐢ㧘દ⮮౎ᰴ㧚߼߹޿ᖚ⠪ߩᄢ⣖ MRI ⊹⾰ਅ⊕⾰ᄌൻߩᬌ⸛㧘Equilibrium Res 2006 ᐕ㧧65 Ꮞ㧦181㧙185㧚
2㧕 ᳓↰໪੺㧘ᤨ↰ ༜㧘ਭ਎ᢥ਽㧘᧛੗㆏ౖ㧘ᮮ↰㓁৻㧘ጊ↰ධᤊ㧘㕍ᧁశᐢ㧘દ⮮౎ᰴ㧚㜞㦂߼߹޿ᖚ⠪ߦ߅ߌࠆᄢ⣖ MRI ⊹⾰ਅ⊕⾰ᄌൻߣ㊀ᔃേំ㧘Equilibrium Res 2006 ᐕ㧧65 Ꮞ㧦186㧙190㧚
3㧕 ᳓↰໪੺㧘⮮၂ ᾊ㧘ᄢ੗⋉৻㧘᦯ㇱᓀ᮸㧘᫜ᯅ⡨ሶ㧘⷏ၳਂ⚐㧘↰ਛ㓶৻㧘ᮮ↰ ᣿㧘ᩊ↰ᐽᚑ㧘ᷰㄝᔘᒾ㧘દ⮮౎ᰴ㧘┻ౝ⑲ⴕ㧘ጊፒ ᄥ㧘ዊᧁᦥᱜノ㧘㜞ᯅᐢᔒ㧘ർ᧛ᵏብ㧚ጘ㒂⋵ߦ߅ߌࠆ 2005 ᐕߩࠬࠡ⧎☳㘧ᢔ⁁ᴫߣ 2006 ᐕߩࠬࠡ⧎☳㘧ᢔ੍ᗐ㧘᧲ᶏ⧎☳∝ 2006 ᐕ㧧17 Ꮞ㧦24㧙27㧚
4㧕 㕍ᧁశᐢ㧚ࡔ࠾ࠛ࡯࡞∛ᴦ≮ߦ߅ߌࠆ᦯⮎ࠦࡦࡊ࡜ࠗࠕࡦࠬߩᡷༀ㧘ࡔ࠺ࠖࠞ࡞࠻࡝ࡆࡘ࡯ࡦ 2006 ᐕ㧧
39 Ꮞ㧦29㧚5㧕 㕍ᧁశᐢ㧘ᮮ↰㓁৻㧘቟⮮ஜ৻㧘ᵻ੗㓷ᐘ㧘᳓↰໪੺㧘દ⮮౎ᰴ㧚㜞቟േ⣂Ἳ∝଀ߦኻߔࠆੱᎿౝ⡊ᚻⴚ㧘⡊㥦⥃ᐥ 2006 ᐕ㧧99 Ꮞ㧦275㧙278㧚
6㧕 㕍ᧁశᐢ㧚ࡅ࠻ߢߩ㊀ജฃኈེ♽੤ᗵ␹⚻෻኿ߩᬌ⸛㧘ቝቮ⥶ⓨⅣႺකቇ 2006 ᐕ㧧43 Ꮞ㧦205㧚
7㧕 ਭ਎ᢥ਽㧘ᮮ↰㓁৻㧘ᵻ੗㓷ᐘ㧚ᒰ⑼ߦ߅ߌࠆ㥏⤑࡮㥏ቶᒻᚑⴚߩⴚᓟᚑ❣㧘㜞ጊ⿒චሼ∛㒮♿ⷐ 2006
ᐕ㧧30 Ꮞ㧦13㧙17㧚
8㧕 ᤨ↰ ༜㧘દ⮮౎ᰴ㧘᳓↰໪੺㧚⋥┙೙ᓮ♽ߩ⸃ᨆ㧙ⶄ㔀♽ߩⷰὐࠃࠅ㧙㧘Equilibrium Res 2007 ᐕ㧧
66 Ꮞ㧦17㧙25㧚
9㧕 ᳓↰໪੺㧚ዊఽ߼߹޿ߩขࠅᛒ޿㧘⡊㥦⥃ᐥ 2007 ᐕ㧧100 Ꮞ㧦506㧙507㧚
10㧕 ᳓↰໪੺㧘ᤨ↰ ༜㧘᫪ ⧐㇢㧘⷏ၳਂ⚐㧘቟⮮ஜ৻㧘ਭ਎ᢥ਽㧘᧛੗㆏ౖ㧘ᮮ↰㓁৻㧘㕍ᧁశᐢ㧘દ⮮౎ᰴ㧚ੱ㑆࠼࠶ࠢஜ⸻⠪ߦ߅ߌࠆᄢ⣖ MRI ⊹⾰ਅ⊕⾰ᄌൻߣ㊀ᔃേំᚑ❣㧘Equilibrium Res 2007 ᐕ㧧
66 Ꮞ㧦110㧙115㧚
11㧕 ᳓↰໪੺㧘⮮၂ ᾊ㧘ᄢ੗⋉৻㧘᦯ㇱᓀ᮸㧘᫜ᯅ⡨ሶ㧘⷏ၳਂ⚐㧘ᮮጊᄈ৻㧘↰ਛ㓶৻㧘ᮮ↰ ᣿㧘ᩊ↰ᐽᚑ㧘ᷰㄝᔘᒾ㧘દ⮮౎ᰴ㧘ጊፒ ᄥ㧘↰ਛቁᴦ㧘ዊᧁᦥᱜノ㧘㜞ᯅᐢᔒ㧘ർ᧛ᵏብ㧚ጘ㒂⋵ߦ߅ߌࠆ 2006ᐕߩࠬࠡ⧎☳㘧ᢔ⁁ᴫߣ 2007 ᐕߩࠬࠡ⧎☳㘧ᢔ੍ᗐ㧘᧲ᶏ⧎☳∝ 2007 ᐕ㧧18 Ꮞ㧦21㧙24㧚
12㧕 㕍ᧁశᐢ㧘቟⮮ஜ৻㧘ጊ↰ධᤊ㧘᧛੗㆏ౖ㧘㕍ᧁ⻞ᄥ㧘᳓↰໪੺㧘દ⮮౎ᰴ㧚ⲕ‐⡊⎬ൻ∝ߦኻߔࠆੱᎿ
ౝ⡊ߩ໧㗴㧘ᣣᧄ⡊㥦ຜ༄⑼ቇળળႎ 2007 ᐕ㧧110 Ꮞ㧦752㧙757㧚
13㧕 ጊ↰ධᤊ㧘દ⮮౎ᰴ㧚వᄤᕈ㗻㕙␹⚻㤗∽ߩ 2 ∝଀㧘FACIAL NERVE RESEARCH JAPAN 2007 ᐕ㧧
27 Ꮞ㧦225㧙228㧚
14㧕 ട⮮ඳၮ㧘ᤊ ඳᤘ㧘ጊ↰ධᤊ㧘㕍ᧁ⻞ᄥ㧘᳓↰໪੺㧘દ⮮౎ᰴ㧘᧻᳗⎇๋㧘ᑝἑༀା㧚৻஥⡊ਅ⣼ߦ⊒↢ߒߚᄙ⊒⡊ਅ⣼ౝ␹⚻㕽⣲ߩ 1 ଀㧘⥃ᐥ᡼኿✢ 2007 ᐕ㧧52 Ꮞ㧦312㧙317㧚
15㧕 ㊁‫↰ޘ‬ጪᄦ㧘಴ේ໪৻㧘ᄢᯅᢅల㧘ᄢ⷏዁⟤㧘ጊ↰ධᤊ㧚ᕆᕈߦ⊒∝ߒߚ≚∥ᕈ㘃ᄤ∊≙଀㧘⡊㥦⥃ᐥ 2007
ᐕ㧧100 Ꮞ㧦579㧙585㧚
16㧕 ᳓↰໪੺㧘⮮၂ ᾊ㧘ᄢ੗⋉৻㧘᦯ㇱᓀ᮸㧘᫜ᯅ⡨ሶ㧘ട⮮ᵗᴦ㧘↰ਛ㓶৻㧘ᮮ↰ ᣿㧘ᩊ↰ᐽᚑ㧘ᷰㄝᔘᒾ㧘દ⮮౎ᰴ㧘┻ౝ⑲ⴕ㧘ጊፒ ᄥ㧘↰ਛቁᴦ㧘ዊᧁᦥᱜノ㧘㜞ᯅᐢᔒ㧘ർ᧛ᵏብ㧚ጘ㒂⋵ߦ߅ߌࠆ 2007ᐕࠬࠡ࡮ࡅࡁࠠ⧎☳㘧ᢔ⚿ᨐߣ 2008 ᐕߩࠬࠡ㘧ᢔ੍᷹㧘᧲ᶏ⧎☳∝ 2008 ᐕ㧧19 Ꮞ㧦22㧙25㧚
17㧕 㕍ᧁశᐢ㧚ࡔ࠾ࠛ࡯࡞∛⊒∝ߦ߅ߌࠆࡃ࠱ࡊ࡟࠶ࠪࡦߩ㑐ਈ ጘ㒂කቇᅑബ⾨㧘ጘ㒂ᄢቇකቇㇱห⓹ળ⹹
2008 ᐕ㧧87 Ꮞ㧦7㧙8㧚
18㧕 㕍ᧁశᐢ㧚߼߹޿ᴦ≮ߣߒߡߩᐔⴧ࡝ࡂࡆ࡝࠹࡯࡚ࠪࡦ ߼߹޿ߩᴦ≮ᚢ⇛㧘Medical View Points 2008ᐕ㧧29 Ꮞ㧦1㧙3㧚
19㧕 㕍ᧁశᐢ㧚߼߹޿⊒∝ߩᯏᐨ ⥄ᓞ␹⚻⇣Ᏹߩ㑐ਈ㧘Equilibrium Res 2008 ᐕ㧧67 Ꮞ㧦234㧙241㧚
20㧕 㕍ᧁ㚅❱㧘᳓↰໪੺㧘દ⮮౎ᰴ㧚㗪ㇱ⤥≌∝଀ߩᬌ⸛㧘ᣣᧄ⡊㥦ຜ༄⑼ᗵᨴ∝⎇ⓥળ⹹ 2008 ᐕ㧧26 Ꮞ㧦
247㧙250㧚㧙㧙ේ⪺㧔᰷ᢥ㧕1㧕 Kato Y, Shibata T, Yamashita T, Kobayashi A, Yonemoto K, Makita H, Mizuta K, Hayashi S, Toida M.
Parapharyngeal and retropharyngeal space infection of odontogenic origin. Asian J Oral Maxillofac
Surg. 2006;18:224-227.
2㧕 Matsuo M, Hayashi S, Maeda S, Tanaka O, Mizuta K, Shibata T, Ito Y, Hoshi H. 4 Gy single fraction
palliative radiotherapy for the treatment of painful recurrent soft plate carcinoma by high-dose-ratemold brachytherapy: A case of report. Oral Oncol. 2006;42:305-307.
3㧕 Aoki M, Yokota Y, Kuze B, Mizuta K, Ito Y. Disorder of the saliva melatonin circardian rhythm inpatients with Meniere’s disease. Acta Neurol Scand. 2006;113:256-261.
4㧕 Iwata H, Itokazu M, Shirahashi K, Matsumoto S, Mizuta K, Takemura H. Sterilization using
Antibiotic-impregnated Porous Hydroxyapatite Block for Osteomyelitis of Rib and Sternum: A Case
Report. J Jpn Coll Surg. 2007;32:150-152.
5㧕 Kato H, Kanematsu M, Kusunoki Y, Shibata T, Murakami H, Mizuta K, Ito Y, Hirose Y. Nasoalveolar
cyst: imaging findings in three cases. Clin Imag. 2007;31:206-209.
6㧕 Kato H, Kanematsu M, Ando K, Mizuta K, Ito Y, Hirose Y, Hoshi H. Ossifying pleomorphic adenoma of
the parotid gland: a case report and review. Australas Radiol. 2007;51:B173-175.
7㧕 Aoki M, Asai M, Nishihori T, Mizuta K, Ito Y, Ando K. The relevance of an elevation in the plasma
vasopressin levels to the pathogenesis of Meniere’s attack. J Neuroendocrinol. 2007;19:901-906.
8㧕 Funato M, Kaneko H, Ozeki M, Kanda K, Fukao T, Mizuta K, Kondo N. Pediatric synovial sarcoma of
the right masseter muscle: A case report. Int J Pediat Otorhinolaryngol. 2008;3:105-108.
9㧕 Kato H, Kanematsu M, Mizuta K, Ito Y, Hirose Y. Carcinoma ex pleomorphic adenoma of the parotid
gland: radiologic-pathologic correlation with MR imaging including diffusion-weighted imaging. Am J
Neuroradiol. 2008;29:865-867.
10㧕 Hayashi H, Kunisada T, Takakura N, Aoki M, Mizuta K, Ito Y. Involvement of platelet-derived growth
factor receptor- in maintenance of mesenchyme and sensory epithelium of the neonatal mouse innerear. Hear Res. 2008;245:73-81.

IF 2.569
IF 2.099

IF 0.742

IF 2.588
IF 0.851

IF 2.338

IF 2.0624㧚⎇ⓥ⾌₪ᓧ⁁ᴫ
1㧕┹੎⊛⾗㊄1㧕 ⎇ⓥઍ⴫⠪㧦㕍ᧁశᐢ㧧ਛጊ㓳㓶⑼ቇᛛⴚᢥൻ⽷࿅ ⎇ⓥ㐿⊒ഥᚑ A㧦ࠥ࡯ࡓ㈮޿ߩቯ㊂⊛⹏ଔ㨪੍㒐ࠪࠬ࠹ࡓߩ㐿⊒ߩߚ߼ߦ㨪㧧ᐔᚑ 18 ᐕᐲ㧧800 ජ౞2㧕 ⎇ⓥઍ⴫⠪㧦㕍ᧁ⻞ᄥ㧧⑼ቇ⎇ⓥ⾌⵬ഥ㊄⧯ᚻ⎇ⓥ(B)㧦㗡㗪ㇱᚳᐔ਄⊹≸ߦኻߔࠆ᛫≸೷ߩ⠴ᕈࡔࠞ࠾࠭ࡓ㧧ᐔᚑ 17㧙18 ᐕᐲ㧧3,500 ජ౞(2,100㧦1,400 ජ౞)
3㧕 ⎇ⓥઍ⴫⠪㧦ᨋ ኼశ㧘౒ห⎇ⓥ⠪㧦቟⮮ஜ৻㧘⷏ၳਂ⚐㧧ጘ㒂ᄢቇᵴᕈൻ⚻⾌(⎇ⓥ)㧦⠧ੱᕈ㔍⡬∛ᘒ⸃᣿ߦะߌߚ p16INK4a ߩౝ⡊߅ߌࠆᓎഀ㧧ᐔᚑ 19 ᐕᐲ㧧270 ජ౞4㧕 ⎇ⓥઍ⴫⠪㧦㕍ᧁశᐢ㧧⑼ቇ⎇ⓥ⾌⵬ഥ㊄ၮ⋚⎇ⓥ(C)㧦ࠨ࡯ࠞ࠺ࠖࠕࡦ࡝࠭ࡓ߆ࠄߺߚࡔ࠾ࠛ࡯࡞
∛∛ᘒߩ⸃᣿㧧ᐔᚑ 20㧙22 ᐕᐲ㧧3,220 ජ౞(1,820㧦800㧦600 ජ౞)
5㧕 ⎇ⓥ⽿છ⠪㧦㕍ᧁశᐢ㧘⎇ⓥᜂᒰ⠪㧦᫪↰໪ਯ㧘↰ਛ㇌ᒾ㧘ဈ੗↰⼑㧧ጘ㒂ᄢቇᄢቇ㒮කቇ⎇ⓥ⑼㐳ⵙ㊂⚻⾌ߦࠃࠆ⎇ⓥ⾌㧦ౝ⡊∔ᖚ∝଀ߦ߅ߌࠆ೨ᐸ̆േ⣂ⴊ࿶⺞▵♽ߦ㑐ߔࠆ⎇ⓥ㧧ᐔᚑ 20 ᐕᐲ㧧500 ජ౞6㧕 ⎇ⓥઍ⴫⠪㧦ᧄᯅജ㧘ᨋኼశ㧧ጘ㒂ᄢቇᄢቇ㒮කቇ⎇ⓥ⑼㐳ⵙ㊂⚻⾌ߦࠃࠆ⎇ⓥ⾌㧦ᚑ૕⚵❱ߦሽ࿷ߔࠆᄙಽൻ⢻ࠍ᦭ߔࠆ␹⚻ႇ⚦⢩ߩหቯ߅ࠃ߮ߘߩ⸃ᨆ㧧ᐔᚑ 20 ᐕᐲ㧧500 ජ౞
2㧕ฃ⸤⎇ⓥ1㧕 ᳓↰໪੺㧦㗡㗪ㇱᚳᐔ਄⊹≸ᩮᴦᴦ≮ᓟߩ TS-1 ⵬ഥൻቇ≮ᴺߩᬌ⸛㧧ᐔᚑ 18㧙24 ᐕᐲ㧧1,365 ජ౞㧦⽷࿅ᴺੱవ┵ක≮ᝄ⥝⽷࿅
3㧕౒ห⎇ⓥߥߒ
5㧚⊒᣿࡮․⸵಴㗿⁁ᴫߥߒ
6㧚ቇળᵴേ
1㧕ቇળᓎຬદ⮮౎ᰴ㧦
1㧕 ᣣᧄ߼߹޿ᐔⴧකቇળℂ੐(㨪ᐔᚑ 19 ᐕ 11 ᦬)㧙㧙

2㧕 ᣣᧄ⡊㥦ຜ༄⑼ቇળ⹏⼏ຬ(㨪⃻࿷)3㧕 ᣣᧄ߼߹޿ᐔⴧකቇળ⹏⼏ຬ(㨪⃻࿷)4㧕 ᣣᧄ⡊⑼ቇળ⹏⼏ຬ(㨪⃻࿷)5㧕 ᣣᧄ㥦⑼ቇળ⹏⼏ຬ(㨪⃻࿷)6㧕 ᣣᧄ᳇▤㘩㆏⑼ቇળ⹏⼏ຬ(㨪⃻࿷)7㧕 ⡊㥦ຜ༄⑼⥃ᐥቇળㆇ༡ᆔຬ(㨪⃻࿷)8㧕 ᣣᧄ⡊㥦ຜ༄⑼఺∉ࠕ࡟࡞ࠡ࡯ቇળ⹏⼏ຬ(㨪⃻࿷)9㧕 ᣣᧄญ⣧࡮ຜ㗡⑼ቇળ⹏⼏ຬ(㨪⃻࿷)10㧕 ᣣᧄ༄㗡⑼ቇળ⹏⼏ຬ(㨪⃻࿷)11㧕 ᣣᧄྚਅකቇળ⹏⼏ຬ(㨪⃻࿷)᳓↰໪੺㧦1㧕 ᣣᧄ⡊㥦ຜ༄⑼ቇળ⹏⼏ຬ(㨪⃻࿷)2㧕 ᣣᧄ߼߹޿ᐔⴧකቇળ⹏⼏ຬ(㨪⃻࿷)3㧕 ᣣᧄ᳇▤㘩㆏⑼ቇળ⹏⼏ຬ(㨪⃻࿷)㕍ᧁశᐢ㧦1㧕 ᣣᧄ߼߹޿ᐔⴧකቇળ⹏⼏ຬ(㨪⃻࿷)2㧕ቇળ㐿௅દ⮮౎ᰴ㧦
1㧕 ╙ 31 ࿁ᣣᧄ⡊㥦ຜ༄⑼ቇળጘ㒂⋵࿾ᣇㇱળ✚ળߥࠄ߮ߦቇⴚ⻠Ṷળ(ᐔᚑ 18 ᐕ 5 ᦬㧘ጘ㒂)2㧕 ╙ 36 ࿁ᣣᧄ߼߹޿ᐔⴧකቇળᐔⴧᯏ⢻ᬌᩏᛛⴚ⻠⠌ળ(ᐔᚑ 18 ᐕ 7 ᦬㧘ጘ㒂)
3㧕 ╙ 32 ࿁ᣣᧄ⡊㥦ຜ༄⑼ቇળጘ㒂⋵࿾ᣇㇱળ✚ળߥࠄ߮ߦቇⴚ⻠Ṷળ(ᐔᚑ 19 ᐕ 5 ᦬㧘ጘ㒂)
4㧕 ╙ 129 ࿁ᣣᧄ⡊㥦ຜ༄⑼ቇળ᧲ᶏ࿾ᣇㇱળㅪว⻠Ṷળ(ᐔᚑ 19 ᐕ 6 ᦬㧘ጘ㒂)
5㧕 ╙ 33 ࿁ᣣᧄ⡊㥦ຜ༄⑼ቇળጘ㒂⋵࿾ᣇㇱળ✚ળߥࠄ߮ߦቇⴚ⻠Ṷળ(ᐔᚑ 20 ᐕ 6 ᦬㧘ጘ㒂)
6㧕 ╙ 56 ࿁ᣣᧄ⡊㥦ຜ༄⑼ቇળਛㇱ࿾ᣇㇱળㅪวળ(ᐔᚑ 20 ᐕ 7 ᦬㧘ጘ㒂)
3㧕ቇⴚ㔀⹹
દ⮮౎ᰴ㧦
1㧕 Equilibrium Research㧦ળႎᜂᒰℂ੐(㨪ᐔᚑ 19 ᐕ 11 ᦬)
7㧚ቇળ᜗ᓙ⻠Ṷ㧘᜗ᓙࠪࡦࡐࠫࠬ࠻㧘ᐳ㐳દ⮮౎ᰴ㧦
1㧕 ╙ 31 ࿁ᣣᧄ⡊㥦ຜ༄⑼ቇળጘ㒂⋵࿾ᣇㇱળ✚ળ(ᐔᚑ 18 ᐕ 5 ᦬㧘ጘ㒂㧘․೎⻠Ṷ‫ޟ‬ᚳ᩶ߣ IgA ⣢∝‫ޠ‬ᐳ㐳)
2㧕 ╙ 32 ࿁ᣣᧄ⡊㥦ຜ༄⑼ቇળᄐᦼ⻠⠌ળ(ᐔᚑ 18 ᐕ 7 ᦬㧘ᄢ㒋㧘․೎⻠Ṷ‫⦟ޟ‬ᕈ⊒૞ᕈ㗡૏߼߹޿∝‫ޠ‬มળ)
3㧕 Baylor Oto-Research-Conference(ᐔᚑ 18 ᐕ 7 ᦬, ᧲੩, ᜗ᓙ⻠Ṷ‫ޟ‬૕ᐔⴧ⎇ⓥߣߩઃ߈ว޿‫ޠ‬Ṷ⠪)
4㧕 ╙ 36 ࿁ᣣᧄ߼߹޿ᐔⴧකቇળᐔⴧᯏ⢻ᬌᩏᛛⴚ⻠⠌ળ(ᐔᚑ 18 ᐕ 7 ᦬㧘ጘ㒂㧘․೎⻠Ṷ‫ޟ‬㊀ᔃേំᬌᩏ‫ޠ‬Ṷ⠪)5㧕 ╙ 23 ࿁ᣣᧄ߼߹޿ᐔⴧකቇળකᏧ⻠⠌ળ(ᐔᚑ 18 ᐕ 7 ᦬, ೨ᯅ, ․೎⻠Ṷ‫޿߹߼ޟ‬ᬌᩏ࡮⸻ᢿߩㅴ
߼ᣇ‫ޠ‬Ṷ⠪)6㧕 ╙ 32 ࿁ᣣᧄ⡊㥦ຜ༄⑼ቇળጘ㒂⋵࿾ᣇㇱળ✚ળ(ᐔᚑ 19 ᐕ 5 ᦬㧘ጘ㒂㧘․೎⻠Ṷ‫ ࠕ࡟ࡈޟ‬MRI ߢⷰኤߒߚౝ⡊∔ᖚ‫ޠ‬ᐳ㐳)7㧕 ╙ 24 ࿁ᣣᧄ߼߹޿ᐔⴧකቇળකᏧ⻠⠌ળ(ᐔᚑ 19 ᐕ 6 ᦬㧘ᄢ㒋㧘․೎⻠Ṷ‫ޟ‬૕ᐔⴧߩࡔࠞ࠾࠭ࡓ‫ޠ‬Ṷ⠪)8㧕 ╙ 33 ࿁ᣣᧄ⡊㥦ຜ༄⑼ቇળᄐᦼ⻠⠌ળ(ᐔᚑ 19 ᐕ 7 ᦬㧘᧲੩㧘․೎⻠Ṷ‫ޟ‬ENG ߩၮᧄᚻᛛߣᣣᏱ
ߢࠃߊ⷗ࠄࠇࠆ⌒ᝄ‫ޠ‬มળ)9㧕 ╙ 33 ࿁ᣣᧄ⡊㥦ຜ༄⑼ቇળጘ㒂⋵࿾ᣇㇱળ✚ળ(ᐔᚑ 20 ᐕ 6 ᦬㧘ጘ㒂㧘․೎⻠Ṷ‫ߣ߃ߎ߈ޟ‬ㆮવሶ̆㔍⡬ߩㆮવሶ⸻ᢿߣㆮવࠞ࠙ࡦ࠮࡝ࡦࠣ̆‫ޠ‬ᐳ㐳)10㧕 ╙ 25 ࿁ᣣᧄ߼߹޿ᐔⴧකቇળකᏧ⻠⠌ળ(ᐔᚑ 20 ᐕ 7 ᦬㧘᧲੩㧘․೎⻠Ṷ‫ޟ‬૕ᐔⴧᯏ⢻ᬌᩏߣ㊀ᔃേំᬌᩏ‫ޠ‬Ṷ⠪)㧙㧙

11㧕 ╙ 56 ࿁ᣣᧄ⡊㥦ຜ༄⑼ቇળਛㇱ࿾ᣇㇱળㅪวળ(ᐔᚑ 20 ᐕ 7 ᦬㧘ጘ㒂㧘․೎⻠Ṷ‫⺰ޟ‬ℂ⊛ഃ⮎ᴺߩ⏕┙ߣࡊ࡝ࠝࡦ∛߳ߩᔕ↪‫ޠ‬มળ)12㧕 ╙ 34 ࿁ᣣᧄ⡊㥦ຜ༄⑼ቇળᄐᦼ⻠⠌ળ(ᐔᚑ 20 ᐕ 7 ᦬㧘ᄢ㒋㧘․೎⻠Ṷ‫ޟ‬ᚳ᩶Ἳߩᦨᣂ⍮⼂‫ޠ‬มળ)᳓↰໪੺㧦
1㧕 ╙ 36 ࿁ᣣᧄ߼߹޿ᐔⴧකቇળᐔⴧᯏ⢻ᬌᩏᛛⴚ⻠⠌ળ(ᐔᚑ 18 ᐕ 7 ᦬㧘ጘ㒂㧘․೎⻠Ṷ‫ⷞޟ‬ೝỗᬌᩏ‫ޠ‬Ṷ⠪)㕍ᧁశᐢ㧦
1㧕 ╙ 36 ࿁ᣣᧄ߼߹޿ᐔⴧකቇળᐔⴧᯏ⢻ᬌᩏᛛⴚ⻠⠌ળ(ᐔᚑ 18 ᐕ 7 ᦬㧘ጘ㒂㧘․೎⻠Ṷ‫ޟ‬ㅅ〝ೝỗᬌᩏ‫ޠ‬Ṷ⠪)2㧕 ╙ 52 ࿁ᣣᧄቝቮ⥶ⓨⅣႺකቇળ ࠪࡦࡐࠫ࠙ࡓ
‫ޟ‬ౝ⡊೨ᐸ♽ߣᓴⅣ೙ᓮ‫(ޠ‬ᐔᚑ 18 ᐕ 11 ᦬, 㠽ข, ᜗ᓙ⻠Ṷ‫ߩߢ࠻ࡅޟ‬㊀ജฃኈེ♽㧙੤ᗵ␹⚻෻኿ߩᬌ⸛‫ޠ‬Ṷ⠪)
3㧕 ╙ 66 ࿁ᣣᧄ߼߹޿ᐔⴧකቇળ✚ળ࡮ቇⴚ⻠Ṷળ(ᐔᚑ 19 ᐕ 11 ᦬㧘ᄢ㒋㧘ࠪࡦࡐࠫ࠙ࡓ‫ߩ޿߹߼ޟ‬⊒∝ᯏᐨࠍ⠨߃ࠆ‫⥄ޠ‬ᓞ␹⚻⇣Ᏹߩ㑐ਈ Ṷ⠪)
4㧕 άάΧ Barany society meeting(2008.04㧘Kyoto㧘Symposium㧦Autonomic Function and Migraine
The Influence of Vestibular Dysfunctions on Autonomic Regulation of Orthostatic Tolerance in
Human㧧Ṷ⠪)8㧚ቇⴚ⾨╬ߩฃ⾨⁁ᴫ1㧕 㕍ᧁశᐢ㧦ጘ㒂කቇᅑബ⾨(ᐔᚑ 20 ᐕᐲ)
9㧚␠ળᵴേદ⮮౎ᰴ㧦
1㧕 ጘ㒂⋵␠ળ⑔␩ክ⼏ળᆔຬ(㨪⃻࿷)2㧕 ጘ㒂⋵⧎☳∝ኻ╷ᆔຬળᆔຬ(㨪ᐔᚑ 19 ᐕᐲ)
3㧕 ጘ㒂⋵ᣂ↢ఽ⡬ⷡᬌᩏ੐ᬺᬌ⸛ᆔຬળᆔຬ(㨪⃻࿷)4㧕 ጘ㒂Ꮢ␠ળ⑔␩ክ⼏ળᆔຬ(㨪⃻࿷)5㧕 㔍∛ක≮࠹࡟ࡈࠜࡦ࡮ࡔ࡯࡞ࠨ࡯ࡆࠬ‫(ޠߤߥ∛࡞࡯ࠛ࠾ࡔޟ‬ᐔᚑ 19 ᐕ 11 ᦬ 30 ᣣ)᳓↰໪੺㧦1㧕 ጘ㒂⋵⧎☳∝ኻ╷ᆔຬળᆔຬ(㨪ᐔᚑ 19 ᐕᐲ)
2㧕 ጘ㒂⋵࿖᳃ஜᐽ଻㒾⸻≮ႎ㈽ክᩏᆔຬળᆔຬ(㨪⃻࿷)⷏ၳਂ⚐㧦1㧕 ጘ㒂Ꮢ┙ᐜ⒩࿦ߎߣ߫ߩᢎቶᢎ⢒⋧⺣ᆔຬ(ᐔᚑ 19 ᐕᐲ㨪⃻࿷)10㧚ႎ๔ᦠ
1㧕 㕍ᧁశᐢ㧘቟⮮ஜ৻㧘᳓↰໪੺㧘દ⮮౎ᰴ㧦ࡔ࠾ࠛ࡯࡞∛⊒૞ߦ߅ߌࠆⴊẏ ADH㧘ࠬ࠻࡟ࠬ㧘ᔃℂ⊛஥㕙ߩ㑐ㅪᕈ㧦ෘ↢ഭ௛⑼ቇ⎇ⓥ⾌⵬ഥ㊄ 㔍ᴦᕈ∔ᖚస᦯⎇ⓥ੐ᬺ ೨ᐸᯏ⢻⇣Ᏹߦ㑐ߔࠆ⺞ᩏ⎇ⓥ ᐔᚑ 18 ᐕᐲ ✚᜝࡮ಽᜂ⎇ⓥႎ๔ᦠ㧦81㧙83(ᐔᚑ 19 ᐕ 3 ᦬)
2㧕 㕍ᧁశᐢ㧘ᵻ੗㓷ᐘ㧘㕍ᧁ㚅❱㧘᳓↰໪੺㧘દ⮮౎ᰴ㧦৻஥ᕈ೨ᐸ㓚ኂ∝଀ߦ߅ߌࠆ⿠┙ᕈ⥄ᓞ␹⚻⺞▵ߩᬌ⸛㧦ෘ↢ഭ௛⑼ቇ⎇ⓥ⾌⵬ഥ㊄ 㔍ᴦᕈ∔ᖚస᦯⎇ⓥ੐ᬺ ೨ᐸᯏ⢻⇣Ᏹߦ㑐ߔࠆ⺞ᩏ⎇ⓥ ᐔᚑ 19 ᐕᐲ ✚᜝࡮ಽᜂ⎇ⓥႎ๔ᦠ㧦181㧙182(ᐔᚑ 20 ᐕ 3 ᦬)
3㧕 㕍ᧁశᐢ㧘ᨋ ኼశ㧘᳓↰໪੺㧘દ⮮౎ᰴ㧦ᚻⴚട≮ߦߡ∝⁁ᡷༀࠍ⹺߼ߚ਄ඨⷙ▤ⵚ㓗∝୥⟲∝଀㧦ෘ↢ഭ௛⑼ቇ⎇ⓥ⾌⵬ഥ㊄ 㔍ᴦᕈ∔ᖚస᦯⎇ⓥ੐ᬺ ೨ᐸᯏ⢻⇣Ᏹߦ㑐ߔࠆ⺞ᩏ⎇ⓥ ᐔᚑ
19 ᐕᐲ ✚᜝࡮ಽᜂ⎇ⓥႎ๔ᦠ㧦201㧙203(ᐔᚑ 20 ᐕ 3 ᦬)
4㧕 㕍ᧁశᐢ㧘ᳯ ଐᴺ㧦ࠥ࡯ࡓ㈮޿ߩቯ㊂⊛⹏ଔ 㨪੍㒐ࠪࠬ࠹ࡓߩ㐿⊒ߩߚ߼ߦ㨪 ਛጊ㓳㓶⑼ቇ
ᛛⴚ⽷࿅ ⎇ⓥ㐿⊒ഥᚑ ᐔᚑ 19 ᐕᐲႎ๔ᦠ㧦24㧙25(ᐔᚑ 20 ᐕ 10 ᦬)
11㧚ႎ㆏1㧕 દ⮮౎ᰴ㧦‫ޟ‬⡊ߩᣣ‫ޠ‬㑐ㅪ⸥੐㧦ጘ㒂ᣂ⡞(2006 ᐕ 3 ᦬ 3 ᣣ)
2㧕 દ⮮౎ᰴ㧦‫ޟ‬㥦ߩᣣ‫ޠ‬㑐ㅪ⸥੐㧦ਛᣣᣂ⡞(2006 ᐕ 8 ᦬ 7 ᣣ)㧙㧙

3㧕 ᳓↰໪੺㧦‫⎇ޟ‬ⓥቶ߆ࠄᄢቇߪ޿߹‫ޠ‬㧦ጘ㒂ᣂ⡞(2006 ᐕ 12 ᦬ 12 ᣣ)
4㧕 દ⮮౎ᰴ㧦‫ޟ‬⡊ߩᣣ‫ޠ‬㑐ㅪ⸥੐㧦ጘ㒂ᣂ⡞(2007 ᐕ 3 ᦬ 3 ᣣ)
5㧕 દ⮮౎ᰴ㧦‫ޟ‬㥦ߩᣣ‫ޠ‬㑐ㅪ⸥੐㧦ਛᣣᣂ⡞(2007 ᐕ 8 ᦬ 7 ᣣ)
6㧕 દ⮮౎ᰴ㧦‫ޟ‬⡊ߩᣣ‫ޠ‬㑐ㅪ⸥੐㧦ጘ㒂ᣂ⡞(2008 ᐕ 3 ᦬ 3 ᣣ)
7㧕 દ⮮౎ᰴ㧦‫ޟ‬㥦ߩᣣ‫ޠ‬㑐ㅪ⸥੐㧦ਛᣣᣂ⡞(2008 ᐕ 8 ᦬ 7 ᣣ)
8㧕 ᳓↰໪੺㧦ࠬࠡ࡮ࡅࡁࠠ⑼⧎☳∝ߩᴦ≮ߣጘ㒂⋵ߦ߅ߌࠆࠬࠡ࡮ࡅࡁࠠ⑼㘧ᢔߩേะ㧦ጘ㒂⋵଻㒾කᣂ⡞(2008 ᐕ 3 ᦬ 10 ᣣ)
12㧚⥄Ꮖ⹏ଔ
⹏ଔ࿖ౝߢߪో࿖࡟ࡌ࡞ߩ⡊㥦ຜ༄⑼㑐ㅪቇળߢⓍᭂ⊛ߦෳട⊒⴫ߒߡ޿ࠆ‫ޕ‬ᶏᄖߢߩቇળ⊒⴫ߣ⺰ᢥᛩ
Ⓜ߇ਇ⿷ߒߡ޿ࠆ‫ޕ‬⃻⁁ߩ໧㗴ὐ෸߮ߘߩኻᔕ╷ࡠ࡯࠹࡯࠻⎇ୃ೙ᐲዉ౉ᓟߩੱຬਇ⿷߇⸃ᶖߢ߈ߡ޿ߥ޿‫⎇ޕ‬ⓥߪ⥃ᐥߣᐔⴕߦⴕߞߡ߅ࠅ㧘≸ᖚ⠪ߥߤߩ㊀∝ߥ∔ᖚߩᄙ޿∛᫟ߩᴦ≮ࠍㅴ߼ߥ߇ࠄߩ⎇ⓥߦߪ೙⚂߇ᄙ޿‫ޕ‬ᄢቇ㒮↢߽␠ળੱᄢቇ㒮↢ߣߒߡ⥃ᐥࠍ⛽ᜬߒߡ޿ࠆߩߢ㧘ၮ␆⎇ⓥߦᔅⷐߥ➙߹ߞߚᤨ㑆ࠍ⏕଻ߢ߈ߥ޿⃻⁁ߢ޽ࠆ‫ޕ‬ኻᔕ╷ߣߒߡߪ㧘ක≮⡯એᄖ߿ᄖ࿖ੱᄢቇ㒮↢߅ࠃ߮⎇ⓥ↢ߩჇຬࠍ࿑ࠅ㧘⎇ⓥߦኾᔨߢ߈ࠆੱ᧚ࠍ
⏕଻ߔࠆ‫ߪߦࠄߐޕ‬㧘ၮ␆⻠ᐳ߿ઁߩ⎇ⓥᯏ㑐ߣߩ੤ᵹࠍኒߦߒߡዋߥ޿⎇ⓥ⠪ߩࠕࠗ࠺ࠕࠍ↢߆ߖࠆࠃ߁ߦߒߚ޿‫ޕ‬੹ᓟߩዷᦸጘ㒂ᄢቇ⡊㥦ຜ༄⑼ߦ⫾Ⓧߐࠇߚ߼߹޿ᐔⴧ㓚ኂߩ⎇ⓥᚑᨐࠍၮ␆ߦ㧘߼߹޿࡮ᐔⴧ㓚ኂࠍਛᔃߣߔ
ࠆ⎇ⓥࠍ᛼ߒㅴ߼ࠆ‫ߦ∛࡞࡯ࠛ࠾ࡔޕ‬ઍ⴫ߐࠇࠆ㔍ᴦᕈ߼߹޿ᴦ≮ߦࡈࠖ࡯࠼ࡃ࠶ࠢߢ߈ࠆᚑᨐࠍ᜼ߍ㧘߼߹޿ᐔⴧ㓚ኂᖚ⠪߿㜞㦂⠪ߩり૕ᐔⴧᯏ⢻ᡷༀߦነਈߔࠆലᨐ⊛ᐔⴧ⸠✵ᣇᴺ㐿⊒ࠍ⋡ᮡߣߔࠆ‫߹ޕ‬ߚ㧘㗡㗪ㇱ߇ࠎߩᴦ≮ᚢ⇛ߦ߅ߌࠆᯏ⢻᷷ሽࠍ㊀ὐൻߒ㧘㑐ㅪߔࠆ⥃ᐥ⎇ⓥࠍㅴ߼ࠆ‫ޕ‬㧙㧙㧔8㧕⌒⑼ቇಽ㊁1㧚⎇ⓥߩ᭎ⷐ
ᒰᢎቶߪ㧘✛ౝ㓚ࠍࡔࠗࡦ࠹࡯ࡑߣߒߚၮ␆߅ࠃ߮⥃ᐥ⎇ⓥࠍਥߦⴕ޿㧘ߎߩ㗔ၞߦ߅޿ߡߪ㧘⌒࿶࡮
ⷞ㊁࡮↹௝⸃ᨆ࡮⮎‛≮ᴺ࡮ᚻⴚ≮ᴺ࡮␹⚻଻⼔࡮✂⤑ౣ↢࡮ㆮવሶ⸃ᨆߥߤ⎇ⓥߪᄙጘߦࠊߚࠆ‫ޕ‬
ⷞ㊁⸃ᨆߢߪ㧘✛ౝ㓚⸻≮ߩ⺖㗴ߩ߭ߣߟߢ޽ࠆᣧᦼ⊒⷗ࠍ߼ߑߒ㧘VERIS ࠍ↪޿ߚᄙዪᚲ✂⤑㔚࿑㧘ᄙዪᚲⷞⷡ⺃⊒㔚૏ߦࠃࠆ✛ౝ㓚⌒ߩⷰኤࠍⴕߞߡ߅ࠅ㧘ઁⷡ⊛ᬌᩏߦࠃࠆ✛ౝ㓚ᬌ಴⢻ജࠍᬌ⸛ߒߡ޿
ࠆ‫ޕ‬↹௝⸃ᨆߦ߅޿ߡߪ㧘ⷞ␹⚻੃㗡⸃ᨆⵝ⟎ߢ޽ࠆ Heidelberg Retina Tomograph㧔HRT㧕߿శᐓᷤᢿ
ጀ⸘㧔OCT㧕ࠍ↪޿ߡ㧘✛ౝ㓚⌒ߢߩⷞ␹⚻ᒻᘒ߅ࠃ߮✂⤑␹⚻✢⛽ጀෘߩ⸃ᨆࠍⴕߞߡ޿ࠆ‫ߦࠄߐޕ‬㧘⼾ንߥ⥃ᐥ∝଀ࠍၮߦ㧘⮎‛ᴦ≮ലᨐߩ್ቯ߿㧘࡟࡯ࠩ࡯ߥࠄ߮ߦᚻⴚ≮ᴺߩലᨐ್ቯ߽ⴕߞߡ޿ࠆ‫ޕ‬߹ߚၮ␆㗔ၞߦ߅޿ߡߪ㧘NMDA ⎣ሶ૕ᛩਈᓟߩ✂⤑߳ߩ ES ⚦⢩ߩ↢⌕₸㧘ಽൻࠍ⺞ߴ✂⤑ౣ↢ߩน⢻ᕈ߿㧘✛ౝ㓚㑐ㅪㆮવሶߩ⸃᣿ࠍ࠹࡯ࡑߦ⎇ⓥ߇ㆀⴕߐࠇߡ޿ࠆ‫ޕ‬ࡠ࡯ࡆ࡚ࠫࡦࠤࠕߪ㧘ⷞ⢻⸠✵჻ࠍਛᔃߦ⎇ⓥࠍⴕߞߡ߅ࠅ㧘✛ౝ㓚࡮♧ዩ∛✂⤑∝ᖚ⠪ߢߩᣣᏱ↢ᵴߢߩ Quality of Vision㧔QOV㧕ߩㆡಾߥ⹏ଔᣇᴺࠍᬌ⸛ߒߡ޿ࠆ‫ޕ‬ߘߩઁ㧘✂⤑⎣ሶ૕∔ᖚ㧘ⷺ⤑∔ᖚ㧘ᗵᨴ∝㧘߱ߤ߁⤑Ἳߥߤߦ߅޿ߡ㧘ႎ๔ߦ୯ߔࠆ∝଀ߢߪ⌕ታߦႎ๔ࠍⴕߞߡ޿ࠆ‫ޕ‬
2㧚ฬ★
ᢎ᝼㧦
ಎᢎ᝼㧦
ಎᢎ᝼㧦
⻠Ꮷ㧦
⥃ᐥ⻠Ꮷ㧦
⥃ᐥ⻠Ꮷ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦
කຬ㧦

ጊᧄື਽
Ꮉἑ๺⑲
ᦸ᦬ᷡᢥ
㕍ጊ⵨⟤ሶ
Ỉ↰ ᣿
ᧃ᫪᤯ౖ
ቝ࿯৻ᚑ
⊕ᧁ⢒⟤
ዊ࿡ ോ
ဈ 㓉⵨
ዊ᫪િ਽
ฬୖ┨ᢅ

Tetsuya Yamamoto
Kazuhide Kawase
Kiyofumi Mochizuki
Yumiko Aoyama
Akira Sawada
Shinsuke Suemori
Kazunari Udo
Ikumi Shiraki
Tsutomu Oguni
Takahiro Ban
Shinya Komori
Akitoshi Nagura

3㧚⎇ⓥᚑᨐߩ⊒⴫⪺ᦠ㧔๺ᢥ㧕
1㧕 ጊᧄື਽㧚೨ᚱ࡮㓈ⷺߩ⸻߆ߚ㧦๟ㄝⰂᓀ೨≹⌕㧘ⴊ▤ᣂ↢㧘⚿▵ߩⷰኤߣ⹏ଔ㧘⸥タᴺ㧚⌒⑼ࠗࡦࠬ࠻
࡜࡚ࠢࠪࡦࠦ࡯ࠬ 7 ✛ౝ㓚⚦㓗Ἦ㗼ᓸ㏜ቢోࡑࠬ࠲࡯㧘᧲੩㧦ࡔࠫࠞ࡞ࡆࡘ࡯㧧2006 ᐕ㧦72㧙77㧚
2㧕 ጊᧄື਽㧚✛ౝ㓚㧦⃻ઍߩ⌒⑼ቇ ᡷ⸓╙ 9  Section 10 ᧲੩㧦㊄ේ಴ 㧧2006 ᐕ㧦187㧙205㧚
3㧕 Ꮉ਄⑲ᤘ㧘ጊᧄື਽㧚⸻ኤቶ(ᄢቇ∛㒮)㧦⌒⑼ࡊ࡜ࠢ࠹ࠖࠬ 10 ⌒⑼ᄖ᧪ᔅ៤㧘᧲੩㧧ᢥశၴ㧦2006 ᐕ㧦
31㧙37㧚
4㧕 ጊᧄື਽㧚ᱜᏱ⌒࿶✛ౝ㓚㧦⌒⑼ࡊ࡜ࠢ࠹ࠖࠬ 11 ✛ౝ㓚⸻≮ߩㅴ߼߆ߚ㧘᧲੩㧦ᢥశၴ㧧2006 ᐕ㧦34
㧙37㧚
5㧕 ጊᧄື਽㧚㓈ⷺಾ㐿ⴚ㧦⌒⑼ࡊ࡜ࠢ࠹ࠖࠬ 11 ✛ౝ㓚⸻≮ߩㅴ߼߆ߚ㧘᧲੩㧦ᢥశၴ㧧2006 ᐕ㧦312㧙
313㧚
6㧕 ㄭ⮮㓶ม㧚ታ଀ߢ⷗ࠆ✛ౝ㓚ⷞ␹⚻∝ߩᒻ⁁ߣᯏ⢻(2)ᱜᏱ⌒࿶✛ౝ㓚㧦⌒⑼ࠗࡦࠬ࠻࡜࡚ࠢࠪࡦࠦ࡯ࠬ 10⸻≮ࠟࠗ࠼࡜ࠗࡦߦḰ᜚ߒߚⷞ␹⚻ߣⷞ㊁ߦࠃࠆ✛ౝ㓚⸻ᢿቢోࡑࠬ࠲࡯㧘᧲੩㧦ࡔࠫࠞ࡞ࡆࡘ࡯㧧2006ᐕ㧦146㧙149㧚
7㧕 ⍹↰ᕶሶ㧚✛ౝ㓚⌒ᐩ⺒ᓇീᒝળ࠹ࠠࠬ࠻㧘᧲੩㧦✛ౝ㓚⌒ᐩ⺒ᓇീᒝળ࠹ࠠࠬ࠻⵾૞ᆔຬળ㧧2006 ᐕ㧦
34㧙37, 82㧙83㧚
8㧕 ጊᧄື਽㧚ⷞ␹⚻๟࿐⚵❱ߩᚲ⷗ ⷞ␹⚻੃㗡಴ⴊߩ∛⊛ᗧ⟵㧦⌒⑼ࠗࡦࠬ࠻࡜࡚ࠢࠪࡦࠦ࡯ࠬ 10 ⸻≮ࠟࠗ࠼࡜ࠗࡦߦḰ᜚ߒߚⷞ␹⚻ߣⷞ㊁ߦࠃࠆ✛ౝ㓚⸻ᢿቢోࡑࠬ࠲࡯㧘᧲੩㧦ࡔࠫࠞ࡞ࡆࡘ࡯㧧2007 ᐕ
74㧙75㧚
9㧕 ጊᧄື਽㧚✛ౝ㓚㧦ࠟࠗ࠼࡜ࠗࡦᄖ᧪⸻≮ 2007㧘᧲੩㧦ᣣ⚻ࡔ࠺ࠖࠞ࡞㐿⊒㧧2007 ᐕ㧦478㧙480㧚
10㧕 ጊᧄື਽㧚ⷞ㊁ᬌᩏ㧦⌒⑼⸻≮ଢ೑ᚻᏝᡷ⸓╙ 2 㧘᧲੩㧦⸻ᢿߣᴦ≮␠㧧2007 ᐕ㧦274㧙275㧚
11㧕 Ꮉἑ๺⑲㧚‫ⷞޣ‬㊁‫߻⺒ޤ‬ὑߩၮ␆⍮⼂㧦Humphrey ⷞ㊁⸃㉼ߩၮᧄ ⷞ㊁ᬌᩏߦᓇ㗀ߔࠆ࿃ሶ ࿕ⷞਇ⦟ ⌒⑼ࡊ࡜ࠢ࠹ࠖࠬ 15㧘᧲੩㧦ᢥశၴ㧧2007 ᐕ㧦62㧙63㧚
‫ⷞޣ‬㊁‫߻⺒ޤ‬ὑߩၮ␆⍮⼂㧦Humphrey ⷞ㊁⸃㉼ߩၮᧄ ⷞ㊁ᬌᩏߦᓇ㗀ߔࠆ࿃ሶ ዮ᛬⇣Ᏹ ⌒12㧕 Ꮉἑ๺⑲㧚⑼ࡊ࡜ࠢ࠹ࠖࠬ 15㧘᧲੩㧦ᢥశၴ㧧2007 ᐕ㧦67㧙69㧚㧙㧙

13㧕 ศ᧛㐳ਭ㧘ችᧄ๺᣿㧘ጊᧄື਽㧘ਅ᧛ཅ৻㧘ਃ᧛ᴦ㧘㤥ဈᄢᰴ㇢(✬㓸)㧚࿑⸃⌒⑼ 2008㧦Σㇱ ✚⺰㧙ᯏ⢻㧙㧘੩ㇺ㧦㊄⧐ၴ㧧2008 ᐕ㧦15㧙25㧚
14㧕 ศ᧛㐳ਭ㧘ችᧄ๺᣿㧘ጊᧄື਽㧘ਅ᧛ཅ৻㧘ਃ᧛ᴦ㧘㤥ဈᄢᰴ㇢(✬㓸)㧚࿑⸃⌒⑼ 2008㧦Τㇱ ਥⷐ⌒⑼∔ᖚ㧙✛ౝ㓚㧙㧘੩ㇺ㧦㊄⧐ၴ㧧2008 ᐕ㧦96㧙103㧚
15㧕 ጊᧄື਽㧚✛ౝ㓚ᚻⴚ㧦⋴⼔ߩߚ߼ߩᦨᣂකቇ⻠ᐳ ╙ 2  ╙ 20 Ꮞ ⌒⑼∔ᖚ㧘᧲੩㧦ਛጊᦠᐫ㧧2008ᐕ㧦273㧙279㧚
16㧕 ጊᧄື਽㧚⌒࿶࡮㓈ⷺ࡮೨ᚱ࡮ᚱ᳓േᘒߩട㦂ᄌൻ㧦⌒⑼ࡊ࡜ࠢ࠹ࠖࠬ 22 ᛫ട㦂⌒⑼ቇ㧘᧲੩㧦ᢥశၴ㧧2008 ᐕ㧦40㧙43㧚
17㧕 ጊᧄື਽㧚ᱜᏱ⌒࿶✛ౝ㓚ߪᄬ᣿ᕈ⌒∔ᖚߥߩ߆㧫 ߔߴ߈⺑᣿ߣߔߴ߈ߢߥ޿⺑᣿㧦⌒⑼ࠗࡦࠬ࠻࡜ࠢ
࡚ࠪࡦࠦ࡯ࠬ 17 ⌒⑼⸻≮ߩࠬࠠ࡞ࠕ࠶ࡊ ✛ౝ㓚✬㧘᧲੩㧦ࡔࠫࠞ࡞ࡆࡘ࡯㧧2008 ᐕ㧦58㧙63㧚
18㧕 ጊᧄື਽㧚㓈ⷺᬌᩏߩᛛⴚะ਄ࠍ⋡ᜰߒߡ㧦⌒⑼⸻≮ߩࠦ࠷ߣ⪭ߣߒⓣ 3 ᬌᩏ࡮⸻ᢿ㧘᧲੩㧦ਛጊᦠᐫ㧧
2008 ᐕ㧦60㧚
19㧕 ጊᧄື਽㧚✛ౝ㓚ߩ㐓೎⸻ᢿߣߒߡߩ superior segmental optic hypoplasia㧦⌒⑼⸻≮ߩࠦ࠷ߣ⪭ߣߒⓣ
3 ᬌᩏ࡮⸻ᢿ㧘᧲੩㧦ਛጊᦠᐫ㧧2008 ᐕ㧦87㧚
20㧕 Ꮉἑ๺⑲㧚⌒⑼⸻≮ߩࠦ࠷ߣ⪭ߣߒⓣ㧦ᮘ↰ືᄦ㧘ᳯญ⑲৻㇢✬㧚ࠟ࡯࠼࠽ࠗࡈࠍ૶↪ߒߚ 2 ㊀ᒝ⤑ᑯ૞ᚑ㧘᧲੩㧦ਛጊᦠᐫ㧧2008 ᐕ㧦184㧙185㧚
21㧕 Ꮉἑ๺⑲㧚࠻࡜ࡌࠢ࡟ࠢ࠻ࡒ࡯ቢోࡑࠬ࠲࡯㧦⼱ේ⑲ା✬㧚೨ᚱ᳓߇ṳ಴ߒߡߊࠆ႐วߩ MMC ႣᏓߣઍ↪ᒝ⤑ᑯ㧘᧲੩㧦ࡔࠫࠞ࡞ࡆࡘ࡯␠㧧2008 ᐕ㧦80㧙81㧚
22㧕 Ꮉἑ๺⑲㧚ᱜᏱ⌒࿶✛ౝ㓚ߪ‫ᧄޔ‬ᒰߦ⌒࿶߇ᱜᏱ߆㧫⌒࿶ߩᄌേߣᣣౝᄌേߩᗧ⟵ߣ㒢⇇㧦⼱ේ⑲ା✬㧚⌒⑼⸻≮ߩࠬࠠ࡞ࠕ࠶ࡊ✛ౝ㓚✬㧘᧲੩㧦ࡔࠫࠞ࡞ࡆࡘ࡯␠㧧2008 ᐕ㧦64㧙69㧚
23㧕 ⍹↰ᕶሶ㧘Ꮉἑ๺⑲㧚௑ᢳ੃㗡∝୥⟲ߣ௑ᢳ੃㗡㧦Ỉ ల✬㧚‫∔⑼⌒ޣ‬ᖚࠕ࠻࡜ࠬ‫✛ޤ‬ౝ㓚 ⌒⑼ 50 Ꮞ 10ภ㧘᧲੩㧦㊄ේ಴ 㧧2008 ᐕ㧦1454㧙1455㧚
24㧕 ⍹↰ᕶሶ㧘Ꮉἑ๺⑲㧚੃㗡ࠨࠗ࠭⇣Ᏹߦว૬ߒߚ✛ౝ㓚㧦Ỉ ల✬㧚‫∔⑼⌒ޣ‬ᖚࠕ࠻࡜ࠬ‫✛ޤ‬ౝ㓚 ⌒⑼50 Ꮞ 10 ภ㧘᧲੩㧦㊄ේ಴ 㧧2008 ᐕ㧦1456㧙1457㧚
25㧕 Ꮉἑ๺⑲㧘⍹↰ᕶሶ㧘ᩮᧁᤘ✬㧚
‫‛⮎⑼⌒ޣ‬ᴦ≮ A to Z‫ ޤ‬࿑⺑૞↪ᯏᐨ ࠞ࡞ࠪ࠙ࡓᜟ᛫⮎ ⌒⑼ࡊ࡜ࠢ
࠹ࠖࠬ 23 Ꮞ㧘᧲੩㧦శᢥၴ㧧 2008 ᐕ㧦552㧙555㧚
⪺ᦠ㧔᰷ᢥ㧕
1㧕 Quigley H, Yamamoto T. Management of acute angle closure crisis. In: Weinreb RN, Friedman DS, eds.
Angle Closure and Angle Closure Glaucoma. Kugler Publications, The Hague, The Netherlands;
2006:21-26.
2㧕 Hong C, Yamamoto T, eds. Angle Closure Glaucoma. Kugler Publications, Amsterdam, The
Netherlands;2007.
3㧕 Hong C, Yamamoto T. Preface. In: Hong C, Yamamoto T, eds. Angle Closure Glaucoma. vii-viii, Kugler
Publications, Amsterdam, The Netherlands;2007.
4㧕 Kondo Y, Yamamoto T. Epidemiology of angle closure glaucoma. In: Hong C, Yamamoto T, eds. Angle
Closure Glaucoma. Kugler Publications, Amsterdam, The Netherlands;2007:11-18.
5㧕 Kondo Y, Yamamoto T. Trabeculectomy. In: Hong C, Yamamoto T, eds. Angle Closure Glaucoma. Kugler
Publications, Amsterdam, The Netherlands;2007:225-238.
✚⺑㧔๺ᢥ㧕
1㧕 ጊᧄື਽㧚✛ౝ㓚ߩዷᦸ̆2003 ᐕᐲ̆㧘⌒⑼ 2006 ᐕ㧧48 Ꮞ㧦1㧙36㧚
2㧕 ㄭ⮮㓶ม㧘ጊᧄື਽㧚✛ౝ㓚ߩᬌᩏߣᚲ⷗㧘ᣣᧄක੐ᣂႎ 2006 ᐕ㧧4268 ภ㧦33㧙36㧚
3㧕 ᦸ᦬ᷡᢥ㧘ጊᧄື਽㧘⍹↰ᕶሶ㧚ỹㆊᚻⴚᓟߩᗵᨴ∝ߩ⃻⁁ߣኻ╷㧘⌒⑼ 2006 ᐕ㧧48 Ꮞ㧦763㧙768㧚
4㧕 ⊕ᧁ⃍ሶ㧘ㄭ⮮㓶ม㧘ጊᧄື਽㧚↹௝ࡈࠔࠗ࡝ࡦࠣࠪࠬ࠹ࡓ㧘⌒⑼ 2006 ᐕ㧧48 Ꮞ㧦1131㧙1139㧚
5㧕 ᣣᧄ✛ౝ㓚ቇળ✛ౝ㓚⸻≮ࠟࠗ࠼࡜ࠗࡦ૞ᚑᆔຬળ(ၫ╩⠪㧦ጊᧄື਽㧘ઁ)㧚✛ౝ㓚⸻≮ࠟࠗ࠼࡜ࠗࡦ╙ 2 ᣣ⌒ળ⹹ 2006 ᐕ㧧110 Ꮞ㧦777㧙814㧚
6㧕 ဈ㓉⵨㧘ጊᧄື਽㧚✛ౝ㓚ߩᴦ≮㧘ᣣᧄක੐ᣂႎ 2006 ᐕ㧧4273 ภ㧦33㧙36㧚
7㧕 ㄭ⮮㓶ม㧚ỹㆊᚻⴚ ⎕უᚻⴚ߆ࠗࡦࡊ࡜ࡦ࠻ᚻⴚ߆㧘⥃ᐥ⌒⑼ 2006 ᐕ㧧60 Ꮞ㧦70㧙74㧚
8㧕 ⍹↰ᕶሶ㧚✛ౝ㓚ߣઁߩⷞ␹⚻∔ᖚߩ⌒ᐩᚲ⷗ߣⷞ␹⚻ᚲ⷗ߦࠃࠆ㐓೎, ޽ߚࠄߒ޿⌒⑼ 2006 ᐕ㧧23 Ꮞ㧦
599㧙615㧚
9㧕 Ỉ↰᣿㧘ᦸ᦬ᷡᢥ㧚✛ౝ㓚⸻≮ߩㅴ߼߆ߚΤ. ᬌᩏߩታ㓙ߣ⹏ଔߩࡐࠗࡦ࠻ 5 ߘߩઁߩⷞᯏ⢻ᬌᩏ 㔚᳇↢ℂቇ⊛ᬌᩏ ⌒⑼ࡊ࡜ࠢ࠹ࠖࠬ 11㧘᧲੩㧦ᢥశၴ㧧2006 ᐕ㧦242㧙244㧚
10㧕 Ỉ↰᣿㧚✛ౝ㓚⸻≮ߩㅴ߼߆ߚΥ. ▤ℂߩၮᧄߣⷐὐ 1 ⮎‛ᴦ≮ 2) ⮎‛ߩ․ᕈߣ૶↪਄ߩᵈᗧὐ One
Point Advice ὐ⌒ലᨐߩ⹏ଔ ⌒⑼ࡊ࡜ࠢ࠹ࠖࠬ 11㧘᧲੩㧦ᢥశၴ㧧2006 ᐕ㧦274㧙275㧚
11㧕 ጊᧄື਽㧚ේ⊒㐽Ⴇ㓈ⷺ∝ߣේ⊒㐽Ⴇ㓈ⷺ✛ౝ㓚㧙ᣂߒ޿∔ᖚ᭎ᔨߣ▤ℂၮḰࠍਛᔃߦ㧙㧘ᣣ⌒ળ⹹
2007 ᐕ㧧111 Ꮞ㧦59㧙67㧚
12㧕 ጊᧄື਽㧚ᵈ⋡ߐࠇࠆ∔ᖚ̌ᱜᏱ⌒࿶✛ౝ㓚̍ߣߪ㧫㧘Medical Practice 2007 ᐕ㧧24 Ꮞ㧦390㧙391㧚
13㧕 ጊᧄື਽㧚✛ౝ㓚ᬌ⸻㧘EBM ࠫࡖ࡯࠽࡞ 2007 ᐕ㧧8 Ꮞ㧦132㧙135㧚
14㧕 ጊᧄື਽㧚♧ዩ∛ߩ✛ౝ㓚ᴦ≮ߪ㧫㧘⢈ḩߣ♧ዩ∛ 2007 ᐕ㧧6 Ꮞ㧦213㧙215㧚
15㧕 ㄭ⮮㓶ม㧘ጊᧄື਽㧚࡟࡯ࠩ࡯Ⰲᓀಾ㐿ⴚߩㆡᔕߣ㒢⇇̆✛ౝ㓚ኾ㐷කߩ┙႐߆ࠄ̆㧘޽ߚࠄߒ޿⌒⑼
2007 ᐕ㧧24 Ꮞ㧦855㧙859㧚
16㧕 ጊᧄື਽㧚ේ⊒㐽Ⴇ㓈ⷺ✛ౝ㓚ᴦ≮ߩ╙৻ㆬᛯߪ࡟࡯ࠩ࡯Ⰲᓀಾ㐿ⴚ߆ PEA+IOL ߆㧫࡟࡯ࠩ࡯Ⰲᓀಾ㐿㧙㧙ⴚᠩ⼔ߩ┙႐߆ࠄ㧘޽ߚࠄߒ޿⌒⑼ 2007 ᐕ㧧24 Ꮞ㧦1021㧙1025㧚
17㧕 Ỉ↰ ᣿㧚೨⌒ㇱࠕ࠻࡜ࠬΦ Ⰲᓀ 㓈ⷺ ೨ᚱ 1 Ⰲᓀ 8) ᕆᕈේ⊒㐽Ⴇ㓈ⷺ✛ౝ㓚㧘⌒⑼ࡊ࡜ࠢ࠹ࠖ
ࠬ 18 2007 ᐕ㧧337㧚
18㧕 ᦸ᦬ᷡᢥ㧚ỹㆊᚻⴚᓟߩ᥅ᦼᗵᨴߩᴦ≮㧚↰㊁଻㓶✬㧦ߺࠎߥߩ⎣ሶ૕ᚻⴚ㧘⌒⑼ࡊ࡜ࠢ࠹ࠖࠬ 17 2007
ᐕ㧧298㧙300㧚
19㧕 Ꮉἑ๺⑲㧚∛᳇ߣ⮎ߩ⺑᣿ࠟࠗ࠼ 2007 ᗵེⷡ∔ᖚ ⮎‛≮ᴺ✬ ක⮎ຠᖱႎ✬ ✛ౝ㓚㧘⮎ዪ 2007 ᐕ㧧
58 Ꮞ㧦1138㧙114㧚
20㧕 Ꮉἑ๺⑲㧚✛ౝ㓚࠮ࡒ࠽࡯ "ࠟ࡯࠼ઃ߈࠽ࠗࡈ"ߦࠃࠆ 2 ㊀ᒝ⤑ᑯ૞⵾㧘ᣂߒ޿⌒⑼ 2007 ᐕ㧧24 Ꮞ㧦
1319㧙1320㧚
21㧕 Ꮉἑ๺⑲㧚೨⌒ㇱࠕ࠻࡜ࠬ ⷺ⤑ Axenfeld-Rieger ∝୥⟲㧘⌒⑼ࡊ࡜ࠢ࠹ࠖࠬ 18 2007 ᐕ㧧148㧙150㧚
22㧕 Ꮉἑ๺⑲㧚Ⰲᓀ࡮㓈ⷺ࡮೨ᚱ 㓈ⷺᚲ⷗ߩಽ㘃㧘⌒⑼ࡊ࡜ࠢ࠹ࠖࠬ 18 2007 ᐕ㧧364㧙366㧚
23㧕 ဈ㓉⵨㧘ጊᧄື਽㧚ỹㆊ⢩ᗵᨴ⺞ᩏ⎇ⓥ߆ࠄᓧࠄࠇࠆ߽ߩߪ㧫޽ߚࠄߒ޿⌒⑼⥃ᤨჇೀภ ✛ౝ㓚 Now1
2008 ᐕ㧧25(⥃Ⴧ)㧦27㧙29㧚
24㧕 ㋈ᧁᐽਯ㧘ጊᧄື਽㧘ᣂኅ⋿㧘ጤἑᗲሶ㧘ንᚲᢕ↵㧘㒙ㇱᤐ᮸㧘⊕࿯ၔᾖ㧘᪀ጊᵏ᣿㧘ਃ᎑ᒄ㧘ᷡ᳓ᒄਯ㧘౷↰೰ม㧘੗਄ᵗ৻㧘ർỈస᣿㧚ᣣᧄ✛ౝ㓚ቇળᄙᴦ⷗∉ቇ⺞ᩏ(ᄙᴦ⷗ࠬ࠲࠺ࠖ)✚᜝ႎ๔㧘ᣣ⌒ળ⹹ 2008
ᐕ㧧112 Ꮞ㧦1039㧙1058㧚
25㧕 Ỉ↰᣿㧚࿑⸃⌒⑼ Σㇱ ✚⺰ 4 ┨ ⸻ኤߣᬌᩏ 4㧙13㧚ᔀᾖᴺ㧘ᢳᾖᴺ 4㧙14㧚⚦㓗᾽㗼ᓸ㏜ᬌᩏ 4㧙15㧚೨ᚱ㓈ⷺᬌᩏ 4㧙16㧚⌒࿶ᬌᩏ 4㧙17㧚⌒ᐩᬌᩏ 4㧙18㧚㔚᳇↢ℂቇ⊛ᬌᩏ 4㧙19㧚Ⱟశ⌒ᐩㅧᓇ
ᬌᩏ 4㧙20㧚⿥㖸ᵄᬌᩏ 4㧙21㧚శᐓᷤᢿጀᴺ 4㧙22㧚CT㧘MRI ᬌᩏ㧦᧲੩㧦㊄⧐ၴ㧧2008 ᐕ㧧48㧙60㧚
26㧕 Ỉ↰᣿㧚✛ౝ㓚 Now!Τ ✛ౝ㓚ߩᬌᩏ࡮⸻ᢿ A ⌒࿶ 4. ⷺ⤑ෘߪ⌒࿶᷹ቯ୯ߦߤߩ⒟ᐲᓇ㗀ߔࠆߩ߆?㧘
޽ߚࠄߒ޿⌒⑼ 2008 ᐕ㧧25(⥃Ⴧ)㧦49㧙51.
27㧕 Ꮉἑ๺⑲㧚✛ౝ㓚 Now!㧚㧙✛ౝ㓚ߩᴦ≮ ၮᧄ⊛ᣇ㊎ ✛ౝ㓚ߩࡠ࡯ࡆ࡚ࠫࡦࠤࠕߪߤ߁ⴕ߁ߩ߆?㧘޽ߚࠄߒ޿⌒⑼ 2008 ᐕ㧧25 Ꮞ(⥃Ⴧ)㧦138㧙141㧚
28㧕 Ꮉἑ๺⑲㧚✛ౝ㓚ߩᣂಽ㘃㧘⌒⑼ᚻⴚ 2008 ᐕ㧧21 Ꮞ㧦323㧙324㧚
29㧕 㚍႐ᕺሶ㧘Ꮉἑ๺⑲㧚ࡠ࡯ࡆ࡚ࠫࡦࠤࠕ ∔ᖚ೎ ࠃߊ޽ࠆ࠾࡯࠭ߣߘߩኻᔕ 㧙✛ౝ㓚ߩᖚ⠪ߐࠎ߆ࠄ
ࠃߊ޽ࠆ࠾࡯࠭ߣߘߩኻᔕ㧘⌒⑼ࠤࠕ 2008 ᐕ㧧10 Ꮞ㧦709㧙711㧚
30㧕 Ꮉἑ๺⑲㧚ࡢࡦࡐࠗࡦ࠻ࠕ࠼ࡃࠗࠬ㧙✛ౝ㓚⌒ߢߩ⊕ౝ㓚ᚻⴚ ỹㆊ⢩ߩ޽ࠆ⌒㧘⌒⑼ᚻⴚ 2008 ᐕ㧧21
Ꮞ㧦220㧙221✚⺑㧔᰷ᢥ㧕
ߥߒේ⪺㧔๺ᢥ㧕
1㧕 ᵻ㊁♿⟤ᳯ㧘Ꮉἑ๺⑲㧘ጊᧄື਽㧚✛ౝ㓚ᖚ⠪ߩ Quality of Life ߩ⹏ଔ㧘޽ߚࠄߒ޿⌒⑼ 2006 ᐕ㧧23
Ꮞ㧦655㧙659㧚
2㧕 ⍹Ỉ⡡ሶ㧘ㄭ⮮㓶ม㧘ጊᧄື਽㧚৻ᄢቇ㒝ዻ∛㒮ߦ߅ߌࠆ✛ౝ㓚ᴦ≮⮎ㆬᛯߩታᘒ⺞ᩏ㧘⥃⌒ 2006 ᐕ㧧
60 Ꮞ㧦1679㧙1684㧚
3㧕 ਛᎹବ᣿㧘ᨋ૫ౖ㧘⇌ਛ⵨ม㧘㕍ጊ㓁㧘᳓⨲⼾㧘⮮↰᣿ብ㧘ടฎᎹᱜൎ㧘ේᱞผ㧘⮮↰ᐢᔒ㧘ጊᧄື਽㧚1
ᨎߩ 2 ᰴర⌒ᐩ↹௝ࠍ↪޿ߚ 3 ᰴర⌒ᐩ↹௝ߩ᭴▽㧘ක↪↹௝ᖱႎቇળ㔀⹹ 2006 ᐕ㧧23 Ꮞ㧦85㧙90㧚
4㧕 ਛᎹବ᣿㧘ᨋ૫ౖ㧘⇌ਛ⵨ม㧘㕍ጊ㓁㧘᳓⨲⼾㧘⮮↰᣿ብ㧘ടฎᎹᱜൎ㧘ේᱞผ㧘⮮↰ᐢᔒ㧘ጊᧄື਽㧚⌒ᐩ↹௝⸻ᢿᡰេࠪࠬ࠹ࡓߩߚ߼ߩⴊ▤ᶖ෰↹௝ࠍ↪޿ߚⷞ␹⚻੃㗡ߩ⥄േ⹺⼂෸߮ᡆૃ┙૕↹௝↢ᚑ߳ߩᔕ↪㧘㔚ሶᖱႎㅢାቇળ⺰ᢥ⹹ 2006 ᐕ㧧J89-D㧦2491㧙2501㧚
5㧕 ၷ↰೑ᒾ㧘Ꮉ਄⑲ᤘ㧘ਤ⠀⟵᣿㧘ᦸ᦬ᷡᢥ㧘㐳㊁ഞ㧘㜞ᯅఝਃ㧚᭽‫⥃ߥޘ‬ᐥ௝ࠍ๒ߒߚ⌒࠻ࠠ࠰ࠞ࡜∝ߩ
6 ଀㧘⌒⑼⥃ᐥකႎ 2006 ᐕ㧧100 Ꮞ㧦580㧙586㧚
6㧕 ᾢ↰㓷ሶ㧘⍹Ỉ⡡ሶ㧘Ꮉ਄⑲ᤘ㧘㋈ᧁፏ㧘ᦸ᦬ᷡᢥ㧚Group B Streptococcus ߦࠃࠆౝ࿃ᕈ⌒ౝἻߩ 1 ଀㧘޽ߚࠄߒ޿⌒⑼ 2006 ᐕ㧧23 Ꮞ㧦1377㧙1380㧚
7㧕 ጊᧄື਽㧘ࠞ࡞࠹ࠝࡠ࡯࡞ᜬ⛯ᕈὐ⌒ᶧ⎇ⓥળ㧚Ⴎ㉄ࠞ࡞࠹ࠝࡠ࡯࡞ 1㧑ᜬ⛯ᕈὐ⌒ᶧߩ⌒࿶ਅ㒠ലᨐߩᬌ⸛́Ⴎ㉄ࠞ࡞࠹ࠝࡠ࡯࡞ 1㧑ὐ⌒ᶧࠍᲧセኻᾖߣߒߚ㜞⌒࿶ᖚ⠪ߦ߅ߌࠆή૞ὑൻੑ㊀⋤ᬌ╙Υ⋧⥃ᐥ⹜㛎́㧘ᣣ⌒ળ⹹ 2007 ᐕ㧧111 Ꮞ㧦463㧙472㧚
8㧕 ᵻ㊁⧷ੑ㇢㧘ᦸ᦬ᷡᢥ㧘Ỉ↰᣿㧘㐳ဈ⧷৻㇢㧘ㄭ⮮㓶ม㧘ጊᧄື਽㧚ᱜᏱ⌒࿶✛ౝ㓚ߦ߅ߌࠆᄙዪᚲⷞⷡ
⺃⊒㔚૏㧘޽ߚࠄߒ޿⌒⑼ 2007 ᐕ㧧24 Ꮞ㧦1653㧙1659㧚
9㧕 ᧛ἑኡ♿㧘ၳ↱⿠ሶ㧘ၷ↰೑ᒾ㧘᧲᧻ᢕሶ㧘ᦸ᦬ᷡᢥ㧘ᄥ↰ବᴦ㧘ጊ↰ାੑ㧘Ỉ↰᣿㧘ਃ㡞ᑝ❥㧚ᣂ↢ఽࠢ࡜ࡒࠫࠕ⚿⤑Ἳ 8 ଀ߩᬌ⸛㧘⥃ᐥ⌒⑼ 2007 ᐕ㧧61 Ꮞ㧦1431㧙1435㧚
10㧕 ᦸ᦬ᷡᢥ㧘ㄭ⮮િᒾ㧘᫪⦟㓶㧘ጊ↰ቁብ㧘᫪㊁ᶈᄥ㇢㧚஥㗡േ⣂Ἳߦࠃࠆ೨ㇱ⯯ⴊᕈⷞ␹⚻∝ߩ 1 ଀㧘⌒⑼ 2007 ᐕ㧧49 Ꮞ㧦1851㧙1856㧚
11㧕 ᧛ἑኡ♿㧘ၳ↱⿠ሶ㧘ᦸ᦬ᷡᢥ㧘ᄥ↰ବᴦ㧘㜞ᧁᢕᔒ㧘દ⮮✍ሶ㧘ጊ↰ାੑ㧘ጊጯ↱૫㧘ਃ㡞ᑝ❥㧚ሶች㗪▤ࠬࠢ࡝࡯࠾ࡦࠣᬌᩏᓟߦ⊒∝ߒߚᣂ↢ఽࠢ࡜ࡒࠫࠕ⚿⤑Ἳߩ 2 ଀㧘⥃⌒ 2007 ᐕ㧧61 Ꮞ㧦2037㧙
2042㧚
12㧕 ዊ࿡ോ㧘Ꮉἑ๺⑲㧚࠻ࠠ࠰ࡊ࡜࠭ࡑߦࠃࠆ੃㗡㓞ធ✂⣂⛊⤑Ἳ(Edmund-Jensen)ߩ 1 ଀㧘⌒⑼⥃ᐥක 2007
ᐕ㧧101 Ꮞ㧦786㧙789㧚
13㧕 ၳ↱⿠ሶ㧘ᦸ᦬ᷡᢥ㧘ᧃ᧻ኡਯ㧘⷏᧛๺ሶ㧚Paecilomyces lilacinus ߦࠃࠆⷺ⤑⌀⩶∝ߩ 1 ଀㧘޽ߚࠄߒ޿⌒⑼ 2008 ᐕ㧧25 Ꮞ㧦1139㧙1142㧚
14㧕 ၳ↱⿠ሶ㧘ᦸ᦬ᷡᢥ㧚✛ౝ㓚ࠍ઻ߞߡஜᏱᚑੱߦ⊒∝ߒߚࠨࠗ࠻ࡔࠟࡠ࠙ࠗ࡞ࠬ✂⤑Ἳߩ 1 ଀㧘޽ߚࠄߒ㧙㧙޿⌒⑼ 2008 ᐕ㧧25 Ꮞ㧦1315㧙1318㧚
15㧕 ᧛ἑኡ♿㧘ᦸ᦬ᷡᢥ㧘Ỉ↰᣿㧘㋈ᧁፏ㧘Ꮉ਄⑲ᤘ㧚⧯ᐕ↵ᕈߩਔ⌒ߦჇᱺᄌൻࠍ߈ߚߒߚ Eales ∛ߩ 1 ଀㧘޽ߚࠄߒ޿⌒⑼ 2008 ᐕ㧧25 Ꮞ㧦1731㧙1735㧚
16㧕 ဈ㓉⵨㧘ᾢ↰㓷ሶ㧘Ꮉἑ๺⑲㧚MMC ✢⛽ᩇᏪಾ㒰ⴚᓟߩᒝ⤑Ⲣ⸃ߦኻߔࠆ಄ಓ଻ሽⷺ⤑ ߦࠃࠆỹㆊ⢩ߩୃᓳ㧘⌒⑼⥃ᐥ♿ⷐ 2008 ᐕ㧧1 Ꮞ㧦569㧙572㧚
ේ⪺㧔᰷ᢥ㧕
1㧕 Kondo N, Sawada A, Yamamoto T, Taniguchi T. Correlation between individual differences inintraocular pressure reduction and outflow facility due to latanoprost in normal-tension glaucoma
patients. Jpn J Ophthalmol. 2006;50:20-24.
IF2㧕 Miyake T, Sawada A, Yamamoto T, Miyake K, Sugiyama K, Kitazawa Y. The incidence of dischemorrhage in open-angle glaucoma before and after trabeculectomy. J Glaucoma. 2006;15:164-171.
IF
3㧕 Hara A, Niwa M, Kumada M, Aoki H, Kunisada T, Oyama T, Yamamoto T, Kozawa O, Mori H.
Intraocular injection of folate antagonist methotrexate induces neuronal differentiation of embryonicstem cells transplanted in the adult mouse retina. Brain Res. 2006;1085:33-42.
IF
4㧕 Karim MZ, Sawada A, Kawakami H, Yamamoto T, Taniguchi T. A new calcium channel antagonist,
lomerizine, alleviates secondary retinal ganglion cell death after optic nerve injury in the rat. Curr
Eye Res. 2006;31:273-283.
IF5㧕 Iwase A, Araie M, Tomidokoro A, Yamamoto T, Shimizu H, Kitazawa Y. Tajimi Study Group:
Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study.
Ophthalmology. 2006;113:1354-1362.
IF
6㧕 Suemori S, Shimazawa M, Kawase K, Satoh M, Nagase H, Yamamoto T, Hara H. Metallothionein, an
endogenous antioxidant, protects against retinal neuron damage in mice. Invest Ophthalmol Vis Sci.
2006;47:3975-3982.
IF7㧕 Suzuki Y, Iwase A, Araie M, Yamamoto T, Abe H, Shirato S, Kuwayama Y, Mishima HK, Shimizu H,
Tomita G, Inoue Y, Kitazawa Y. Tajimi Study Group: Risk factors for open-angle glaucoma in a
Japanese population. The Tajimi Study. Ophthalmology. 2006;113:1613-1617.
IF
8㧕 Hasegawa K, Ishida K, Sawada A, Kawase K, Yamamoto T. Diurnal variation of intraocular pressure
in suspected normal-tension glaucoma. Jpn J Ophthalmol. 2006;50:449-454.
IF
9㧕 Hara A, Niwa M, Aoki H, Kumada M, Kunisada T, Oyama T, Yamamoto T, Kozawa O, Mori H. A newmodel of retinal photoreceptor cell degeneration induced by a chemical hypoxia-mimicking agent,cobalt chloride. Brain Res. 2006;1109:192-200.
IF
10㧕 Ishida K, Netland PA. Ahmed Glaucoma Valve Implantation in African-American and CaucasianPatients. Arch Ophthalmol. 2006;124:800-806.
IF
11㧕 Ishida K, Netland PA, Costa VP, Shiroma L, Khan B, Ahmed IIK: Comparison of polypropylene andsilicone Ahmed Glaucoma Valves. Ophthalmology. 2006;113:1320-1326.
IF
12㧕 Karim MZ, Sawada A, Kawakami H, Yamamoto T. A new calcium channel antagonist, lomerizine,
alleviates secondary retinal ganglion cell death after optic nerve injury in the rat. Current Eye
Research. 2006;31:273-283.
IF
13㧕 Mochizuki K, Murase H, Imose M, Kawakami H, Sawada A. Improvement of scotopic
electroretinograms and night blindness with recovery of serum zinc levels. Jpn J Ophthalmol.
2006;50:532-536.
IF
14㧕 Suemori S, Shimazawa M, Kawase K, Satoh M, Nagase H, Yamamoto T, Hara H. Metallothionein, an
Endogenous Antioxidant, Protects against Retinal Neuron Damage in Mice. Invest Ophthalmol Vis Sci.
2006;47:3975-3982.
IF
15㧕 Hewitt AW, Bennett SL, Richards JE, Dimasi DP, Booth AP, Inglehearn C, Anwar R, Yamamoto T,
Fingert JH, Héon E, Craig JE, Mackey DA. The Myocilin Gly252Arg mutation and glaucoma ofintermediate severity in Caucasians individuals. Arch Ophthalmol. 2007;125:98-104.
IF
16㧕 Nakagawa T, Hayashi Y, Hatanaka Y, Aoyama A, Hara T, Fujita A, Kakogawa M, Fujita H, Yamamoto
T. Three-dimensional reconstruction of optic nerve head from stereo fundus images and its
quantitative estimation. Proceedings of the 29th Annual International Conference of the IEEE EMBS
2007;6747-6750.
17㧕 Sawada A, Aoyama A, Yamamoto T, Takatsuka N. Long-term therapeutic outcome of acute primary
angle closure in Japanese. Jpn J Ophthalmol. 2007;51:353-359.
IF
18㧕 Asano E, Mochizuki K, Sawada A, Nagasaka E, Kondo Y, Yamamoto T. Decreased nasal-temporal
asymmetry of the second-order kernel response of multifocal electroretinograms in eyes withnormal-tension glaucoma. Jpn J Ophthalmol. 2007;51:379-389㧚
IF
19㧕 Mochizuki K, Murase, H, Sawada A, Suzuki T. Detection of Staphylococcus Species by Polymerase
Chain Reaction in Late Onset Endophthalmitis after Cataract Surgery and Posterior Capsulotomy.
Clin Exp Ophthalmol. 2007;35:873-875.
IF
20㧕 Takashi Suzuki, Nobuhide Hori, Tomoko Miyake, Yukiko Hori, Kiyofumi Mochizuki. Keratitis Caused
by a Rare Fungus, Malassezia restricta. Jpn J Ophthalmol. 2007;51:292-294.
IF
21㧕 Sawada A, Tomidokoro A, Araie M, Iwase A, Yamamoto T. Tajimi Study Group. Refractive errors in an

㧙㧙

0.888
0.207

2.218

1.443

4.621

3.528

4.621
0.888

2.218
2.984
4.621

1.443

0.888

3.528

2.984

0.888

0.888

1.253
0.888

elderly Japanese population. The Tajimi Study. Ophthalmol. 2008;115:363-370.
22㧕 Akiyama M, Yatsu K, Ota M, Katsuyama Y, Kashiwagi K, Mabuchi F, Iijima H, Kawase K, Yamamoto
T, Nakamura M, Negi A, Sagara T, Kumagai N, Nishida T, Inatani M, Tanihara H, Ohno S, Inoko H,
Mizuki N. Microsatellite analysis of the GLC1B locus on chromosome 2 points to NCK2 as a new
candidate gene for normal tension glaucoma. Br J Ophthalmol. 2008;92:1293-1296.
23㧕 Mochizuki K, Katada T, Kawakami H, Sawada A, Mikamo H. Polymicrobial endogenous
endophthalmitis. Retinal Cases & Brief Reports. 2008;2:342-343.
24㧕 Mochizuki K, Yamada T, Mori Y, Sawada A, Mori I, Ohnishi Y. Case of atypical fibroxanthoma in thepalpebral conjunctiva. Jpn J Ophthalmol. 2008;52:404-406.
25㧕 Kawase K, Tomidokoro A, Araie M, Iwase A, Yamamoto T. Tajimi Study Group; Japan Glaucoma
Society. Ocular and systemic factors related to intraocular pressure in Japanese adults:the Tajimi
study. Br J Ophthalmol. 2008;92:1175-1179.

IF 4.621

IF 2.689
IF 0.888
IF 0.888

IF 2.6894㧚⎇ⓥ⾌₪ᓧ⁁ᴫ
1㧕┹੎⊛⾗㊄1㧕 ⎇ⓥઍ⴫⠪㧦ጊᧄື਽㧘⎇ⓥಽᜂ⠪㧦Ꮉἑ๺⑲㧘㕍ጊ⵨⟤ሶ㧘ㄭ⮮㓶ม㧘ᧃ᫪᤯ౖ㧘Ỉ↰᣿㧘⍹↰ᕶሶ㧘㕍ጊ㓁㧧⑼ቇ⎇ⓥ⵬ഥ㊄ၮ⋚⎇ⓥ(C)(2)㧦✛ౝ㓚േ‛ࡕ࠺࡞ߦࠃࠆᣂⷙ⮎‛ᴦ≮ߩ㐿⊒ߣ⃻࿷ߩ✛ౝ㓚⸻≮ߩวℂᕈߩᬌ⸛㧧ᐔᚑ 17㧙19 ᐕᐲ㧧4600 ජ౞(1,700㧦700㧦2,200 ජ౞)
2㧕 ⎇ⓥઍ⴫⠪㧦⼱ේ⑲ା(ᾢᧄᄢቇකቇㇱ)㧘⎇ⓥಽᜂ⠪㧦ጊᧄື਽㧘߶߆㧧ෘ↢ഭ௛⑼ቇ⎇ⓥ⾌⵬ഥ㊄(ᗵེⷡ㓚ኂ⎇ⓥ੐ᬺ)㧦ᱜᏱ⌒࿶✛ౝ㓚ߦኻߔࠆᣧᦼ⊒⷗ߩࠬࠢ࡝࡯࠾ࡦࠣࠪࠬ࠹ࡓ᭴▽ߣᦨㆡൻߐ
ࠇߚ⸻≮ᜰ㊎ߩ⏕┙ߦ㑐ߔࠆ⎇ⓥ㧧ᐔᚑ 17㧙19 ᐕᐲ㧧9,600 ජ౞(4,800㧦2,800㧦2,800 ජ౞)
3㧕 ⎇ⓥઍ⴫⠪㧦Ỉ↰᣿㧧⑼ቇ⎇ⓥ⾌⵬ഥ㊄⧯ᚻ⎇ⓥ(B)㧦࡜࠶࠻ⷞ␹⚻ᝂṌࡕ࠺࡞ߦ߅ߌࠆ࠾ࡊ࡜ࠫࡠ
࡯࡞ߩ␹⚻଻⼔ലᨐ㧧ᐔᚑ 17㧙19 ᐕᐲ㧧3,700 ජਁ౞(3,100㧦300㧦300 ජ౞)
4㧕 ⎇ⓥ⠪ઍ⴫㧦⍹↰ᕶሶ㧧⑼ቇ⎇ⓥ⾌⵬ഥ㊄⧯ᚻ⎇ⓥ(B)㧦⋡ᮡ⌒࿶ߩౣ⹏ଔߣᣂߒ޿ⷞ㊁ࡊࡠࠣ࡜ࡓ
෸߮ࠗࡦࡊ࡜ࡦ࠻ᚻⴚߩน⢻ᕈߦߟ޿ߡ㧧ᐔᚑ 18㧙20 ᐕᐲ㧧3,500 ජਁ౞(1,900㧦1,200㧦400 ජ౞)
2㧕ฃ⸤⎇ⓥߥߒ
3㧕౒ห⎇ⓥߥߒ
5㧚⊒᣿࡮․⸵಴㗿⁁ᴫߥߒ
6㧚ቇળᵴേ
1㧕ቇળᓎຬጊᧄື਽㧦
1㧕 ᣣᧄ⌒⑼ቇળℂ੐(ᐔᚑ 19 ᐕ 6 ᦬㨪⃻࿷)2㧕 ᣣᧄ⌒⑼ቇળ⹏⼏ຬ(㨪⃻࿷)3㧕 ᣣᧄ⌒⑼ቇળኾ㐷ක೙ᐲ↢ᶦᢎ⢒ᆔຬળᆔຬ㐳(ᐔᚑ 19 ᐕ 6 ᦬㨪⃻࿷)
4㧕 ᣣᧄ⌒⑼ቇળኾ㐷ක೙ᐲᆔຬળᆔຬ(㨪⃻࿷)5㧕 ᣣᧄ⌒⑼ቇળኾ㐷೎⎇ⓥળ⹏ଔᆔຬળᆔຬ(ᐔᚑ 18 ᐕ 8 ᦬㨪⃻࿷)
6㧕 ᣣᧄ⌒⑼ቇળ✚㓸ળࡊࡠࠣ࡜ࡓᆔຬળᆔຬ(㨪ᐔᚑ 19 ᐕ 10 ᦬)
7㧕 ᣣᧄ✛ౝ㓚ቇળℂ੐(㨪⃻࿷)8㧕 ᣣᧄ✛ౝ㓚ቇળ⹏⼏ຬ(㨪⃻࿷)9㧕 ᣣᧄ✛ౝ㓚ቇળ࠺࡯࠲⸃ᨆᆔຬળᆔຬ(㨪⃻࿷)10㧕 ᣣᧄ⌒⑼ᚻⴚቇળℂ੐(㨪⃻࿷)11㧕 ᣣᧄ⌒⮎ℂቇળ⹏⼏ຬ(㨪⃻࿷)12㧕 Glaucoma Research Society, Executive Committee Member(ᐔᚑ 20 ᐕ 2 ᦬㨪⃻࿷)
13㧕 World Glaucoma Association, Cochairman of the WGA Committee on Global Research andScreening(ᐔᚑ 20 ᐕ 4 ᦬㨪⃻࿷)
14㧕 World Glaucoma Association, Member of the WGA Code of Practice Committee(ᐔᚑ 20 ᐕ 4 ᦬㨪⃻࿷)
15㧕 Asian Angle-closure Glaucoma Club, President(ᐔᚑ 20 ᐕ 9 ᦬㨪⃻࿷)㧙㧙

16㧕 Asian Angle-closure Glaucoma Club, Vice-President(㨪ᐔᚑ 20 ᐕ 9 ᦬)Ꮉἑ๺⑲㧦
1㧕 ᣣᧄ✛ౝ㓚⹏⼏ຬ(ᐔᚑ 19 ᐕ 6 ᦬㨪⃻࿷)2㧕ቇળ㐿௅ጊᧄື਽㧦
1㧕 ╙ 18 ࿁ᣣᧄ✛ౝ㓚ቇળ(ᐔᚑ 19 ᐕ 9 ᦬㧘ጘ㒂)2㧕 The 5th Meeting of the Asian Angle㧙Closure Glaucoma Club(ᐔᚑ 19 ᐕ 9 ᦬㧘ጘ㒂)
3㧕 ╙ 417 ࿁᧲ᶏ⌒⑼ቇળ(ᐔᚑ 20 ᐕ 5 ᦬㧘ጘ㒂)
3㧕ቇⴚ㔀⹹
ጊᧄື਽㧦
1㧕 Japanese Journal of Ophthalmology; Glaucoma Section Chief (㨪⃻࿷)2㧕 Asian Journal of Ophthalmology; editor (㨪⃻࿷)3㧕 ޽ߚࠄߒ޿⌒⑼㧧✬㓸ᆔຬ(ᐔᚑ 19 ᐕ 10 ᦬㨪⃻࿷)4㧕 ጘ㒂⋵කᏧળකቇ㔀⹹㧧✬㓸ᆔຬ(ᐔᚑ 20 ᐕ 4 ᦬㨪⃻࿷)7㧚ቇળ᜗ᓙ⻠Ṷ㧘᜗ᓙࠪࡦࡐࠫࠬ࠻㧘ᐳ㐳ጊᧄື਽㧦
1㧕 ╙ 29 ࿁ᣣᧄ⌒⑼ᚻⴚቇળ(ᐔᚑ 18 ᐕ 1 ᦬㧘᧲੩㧘ᢎ⢒࠮ࡒ࠽࡯5‫࡯ࡒ࠻ࠢ࡟ࠢࡌ࡜࠻ޟ‬1 ⴚᑼߣㆡᔕ㧚✛ౝ㓚㧙ઍ⴫⊛ߥⴚᑼߩㆡᔕߣၮᧄᚻᛛ‫ޠ‬ᐳ㐳)2㧕 ╙ 29 ࿁ᣣᧄ⌒⑼ᚻⴚቇળ(ᐔᚑ 18 ᐕ 1 ᦬㧘᧲੩㧘ᢎ⢒࠮ࡒ࠽࡯5‫࡯ࡒ࠻ࠢ࡟ࠢࡌ࡜࠻ޟ‬1 ⴚᑼߣㆡᔕ㧚✛ౝ㓚㧙ઍ⴫⊛ߥⴚᑼߩㆡᔕߣၮᧄᚻᛛ‫ޠ‬Ṷ⠪)
3㧕 World Ophthalmology Congress 2006(2006.02, Sao Paulo, Brazil, My choice of therapy.
Symposium “Practical Strategies in Glaucoma Managemenťinvited speaker)
4㧕 World Ophthalmology Congress 2006(2006.02, Sao Paulo, Brazil, Etiology of open-angle
glaucoma: Importance of disc hemorrhage. Symposium “Basic and Clinical Aspects ofOpen-angle Glaucoma” invited speaker )5㧕 World Ophthalmology Congress 2006(2006.02, Sao Paulo, Brazil, Surgical options and outcomesof angle-closure glaucoma. Angle-closure Glaucoma - APAO ;Symposium)
6㧕 The 3rd Global AIGS Consensus Meeting.(2006.05, Hollywood, USA Consensus report on
management of acute angle closure crisis. invited speaker)
7㧕 The 21st Congress of the Asia-Pacific Academy of Ophthalmology Symposium 21 – Glaucoma“Glaucoma Challenges in the Asia Pacific(2006.06 , Singapore, Is Japanese glaucoma different?
invited speaker)
8㧕 ╙ 17 ࿁ᣣᧄ✛ౝ㓚ቇળ(ᐔᚑ 18 ᐕ 9 ᦬㧘␹ᚭ㧘ࠪࡦࡐࠫ࠙ࡓ 2 ⋡ᮡ⌒࿶ߩ᦭↪ᕈߣ㒢⇇㧦㐳ᦼ⚻ㆊ߆ࠄ⷗ߚ⠨ኤ‫ޠ‬ᐳ㐳)9㧕 ╙ 60 ࿁ᣣᧄ⥃ᐥ⌒⑼ቇળ(ᐔᚑ 18 ᐕ 10 ᦬㧘੩ㇺ㧘ࠗࡦࠬ࠻࡜࡚ࠢࠪࡦࠦ࡯ࠬ IC2-20‫ޟ‬ᱜᏱ⌒࿶✛ౝ㓚ߩ⸻ᢿߣ▤ℂ 2006‫)࡯࠲ࠢ࡜࠻ࠬࡦࠗޠ‬10㧕 ╙ 60 ࿁ᣣᧄ⥃ᐥ⌒⑼ቇળ(ᐔᚑ 18 ᐕ 10 ᦬㧘੩ㇺ㧘ࠪࡦࡐࠫ࠙ࡓ 14‫✛ޟ‬ౝ㓚ᬌᩏߪߤߎ߹ߢᔅⷐ߆‫ޠ‬ᐳ㐳)
11㧕 AAO 2006 instruction course #268 Office Management of Asian Glaucoma Update. (2006.11. Las
Vegas, USA)Course chairman)
12㧕 The 6th WHO Inter-country Workshop(2006.11, Korat, Thailand Current status of PACG
management and prevention of blindness - Japan & the World)13㧕 ╙ 30 ࿁ᣣᧄ⌒⑼ᚻⴚቇળ(ᐔᚑ 19 ᐕ 1 ᦬㧘੩ㇺ㧘ࠪࡦࡐࠫ࠙ࡓ 1‫Ⰲ࡯ࠩ࡯࡟ޟ‬ᓀಾ㐿ⴚߩഞ⟋‫ޠ‬ᐳ㐳)
14㧕 ╙ 30 ࿁ᣣᧄ⌒⑼ᚻⴚቇળ(ᐔᚑ 19 ᐕ 1 ᦬㧘੩ㇺ㧘ࡄࡀ࡞࠺ࠖࠬࠞ࠶࡚ࠪࡦ‫ޟ‬ᚻⴚߩಽጘὐ㧙޽ߥߚߥࠄߤ߁ߔࠆ㧫ߎߩ∝଀‫ޠ‬ᐳ㐳)15㧕 Asia ARVO Meeting 2007(2007.03, Singapore, Symposium 5 Ocular Epidemiology/International
Ophthalmology: Rates and causes of visual impairment in Japan; Symposist)16㧕 The 4th Global AIGS Consensus Meeting(2007.05, Ft. Lauderdale USA, Consensus report on
IOP as risk factor for glaucoma development and progression invited speaker)

㧙㧙

17㧕 WGC 2007 (2007.07, Singapore, Didactic Morning Session 3+4. IOP consensus:invited
Epidemiology of intraocular pressure (IOP); Speaker)
18㧕 WGC 2007(2007.07, Singapore, Course 27. Impact of Western clinical trials : Impact ofCollaborative Normal-tension Glaucoma Study on glaucoma management in Japan ; Current
medical treatment for glaucoma in Japan)
19㧕 WGC 2007(2007.07, Singapore, Symposium 21: Normal pressure glaucoma; Symposist)20㧕 WGC 2007(2007.07, Singapore, Course 53. Secondary open angle glaucoma: Introduction anddiagnostic tips for SOAG; Invited speaker)
21㧕 WGC 2007(2007.07, Singapore, Course 69. Normal pressure glaucoma: Ocular hypotensive
therapy for normal-tension glaucoma; Invited speaker)
22㧕 Glaucoma Summer Camp(2007.08, Awajishima, What can we expect following successful
trabeculectomy in NTG cases?; Invited speaker)
23㧕 The 12th Congress of Chinese Ophthalmological Society(2007.08, Zhengzhou, China, The firstJapan-China Glaucoma Symposium: Current medical treatment for glaucoma in Japan ; Invited
symposist)24㧕 ╙ 18 ࿁ᣣᧄ✛ౝ㓚ቇળ(ᐔᚑ 19 ᐕ 9 ᦬㧘ጘ㒂㧘․೎ડ↹✛ౝ㓚ࠝ࡯࡞ࠬ࠲࡯࠭ 2007 ᐳ㐳)
25㧕 ╙ 18 ࿁ᣣᧄ✛ౝ㓚ቇળ(ᐔᚑ 19 ᐕ 9 ᦬㧘ጘ㒂㧘․೎ડ↹✛ౝ㓚ࠝ࡯࡞ࠬ࠲࡯࠭ 2007 ᱜᏱ⌒࿶✛ౝ㓚ߩ㐓೎∔ᖚߣߒߡߩ superior segmental optic hypoplasia ߩ㊀ⷐᕈ㧚Ṷ⠪)26㧕 ╙ 18 ࿁ᣣᧄ✛ౝ㓚ቇળ࡮╙ 5 ࿁ࠕࠫࠕ㐽Ⴇ㓈ⷺ✛ౝ㓚ࠢ࡜ࡉળ⼏(ᐔᚑ 19 ᐕ 9 ᦬㧘ጘ㒂㧘วหࠪࡦࡐࠫ࠙ࡓ ̌Primaru angle-closure ̄ Asian view̍ᐳ㐳)27㧕 ╙ 61 ࿁ᣣᧄ⥃ᐥ⌒⑼ቇળ(ᐔᚑ 19 ᐕ 10 ᦬㧘੩ㇺ㧘ࠪࡦࡐࠫ࠙ࡓ‫⌒ޟ‬࿶ߩ⠨߃ᣇߩㅴᱠ‫ޠ‬ᐳ㐳)28㧕 The Asian Oceanic Glaucoma Society Meeting 2007(2007.12, Bangkok Thailand, Modern
management of primary angle-closure; Invited speaker)
29㧕 The Asian Oceanic Glaucoma Society Meeting 2007(2007.12, Bangkok Thailand , Glaucoma risk
reduction in PACG and NTG; Invited speaker)
30㧕 The Asian Oceanic Glaucoma Society Meeting 2007(2007.12, Bangkok Thailand, Current
management strategy for open-angle glaucoma in Japan; Invited speaker)
31㧕 ╙ 31 ࿁ᣣᧄ⌒⑼ᚻⴚቇળ(ᐔᚑ 20 ᐕ 2 ᦬㧘ᢎ⢒࠮ࡒ࠽࡯16 ᮮᵿ࠻࡜ࡌࠢ࡟ࠢ࠻ࡒ࡯ߩว૬∝ኻ╷㧚‫✛ޟ‬ౝ㓚ᚻⴚ㧙࠻࡜ࡉ࡞ࠪࡘ࡯࠹ࠖࡦࠣ‫ޠ‬Ṷ⠪)32㧕 ╙ 112 ࿁ᣣᧄ⌒⑼ቇળ✚ળ(ᐔᚑ 20 ᐕ 4 ᦬㧘ᮮᵿ㧘ࠪࡦࡐࠫ࠙ࡓ‫ޟ‬ᄙᣉ⸳ᄢⷙᮨ⥃ᐥ⎇ⓥ‫ޠ‬ᣣᧄ✛ౝ㓚ቇળ‫ޟ‬ỹㆊ⢩ᗵᨴߦ㑐ߔࠆ೨ะ߈⺞ᩏ⎇ⓥ‫ޠ‬Ṷ⠪)33㧕 ╙ 112 ࿁ᣣᧄ⌒⑼ቇળ✚ળ(ᐔᚑ 20 ᐕ 4 ᦬㧘ᮮᵿ㧘࠮ࡒ࠽࡯‫✛ޟ‬ౝ㓚ᕈⷞ␹⚻∝ࡑࠬ࠲࡯ࠦ࡯ࠬ‫ޠ‬ᐳ㐳)34㧕 ╙ 112 ࿁ᣣᧄ⌒⑼ቇળ✚ળ(ᐔᚑ 20 ᐕ 4 ᦬㧘ᮮᵿ㧘ࠨࡉࠬࡍࠪࡖ࡝࠹ࠖࠨࡦ࠺ࠗ‫✛ޟ‬ౝ㓚⸻ᢿߩࠦ࠷ߣ⪭ߣߒⓣ‫ޠ‬ᐳ㐳)35㧕 2008 Japan-Sino Glaucoma(2008.06, Hong Kong, Long-term management of open-angle
glaucoma in Japan. Symposium.; Invited speaker)
36㧕 World Ophthalmology Congress 2008(2008.07, Hong Kong, Symposium̌Practical Strategies in
the Management of Open-angle Glaucoma̍course instructor)
37㧕 ╙ 19 ࿁ᣣᧄ✛ౝ㓚ቇળ(ᐔᚑ 20 ᐕ 9 ᦬㧘ᄢ㒋㧘࠺࡯࠲⸃ᨆᆔຬળ․೎࠮࠶࡚ࠪࡦ㧚ᣣᧄ✛ౝ㓚ቇળỹㆊ⢩ᗵᨴ⺞ᩏ⎇ⓥߩ⃻⁁ႎ๔ Ṷ⠪)38㧕 ╙ 19 ࿁ᣣᧄ✛ౝ㓚ቇળ(ᐔᚑ 20 ᐕ 9 ᦬㧘ᄢ㒋㧘ࠪࡦࡐࠫ࠙ࡓ 5‫ߩ⾰ޟ‬㜞޿⌒࿶ᴦ≮ࠍ⋡ᜰߒߡ‫ޠ‬ᐳ㐳)39㧕 2008 SEAGIG/AACGC(2008.09, Seoul Korea, Joint Congress. Symposium 3 ̌ Medical
Treatment̍ course instructor)
40㧕 2008 SEAGIG/AACGC Joint Congress(2008.09, Seoul Korea, Is the role of surgical treatmentchanging? ;Invited speaker)
41㧕 2008 SEAGIG/AACGC Joint Congress(2008.09, Seoul Korea, PAS detection by indentation
gonioscopy. ; Invited speaker)
42㧕 2008 SEAGIG/AACGC Joint Congress.(2008.09, Seoul Korea, Symposium ̌Epidemiology andTretmant of Primary Angle-closure̍ course instructor)
43㧕 ╙ 62 ࿁ᣣᧄ⥃ᐥ⌒⑼ቇળ(ᐔᚑ 20 ᐕ 10 ᦬㧘᧲੩㧘ࠪࡦࡐࠫ࠙ࡓ 17‫ޟ‬㐽Ⴇ㓈ⷺ✛ౝ㓚ߩᣂߒ޿⠨߃ᣇߣᴦ≮ᚢ⇛‫ޠ‬ᐳ㐳)44㧕 The Asian Oceanic Glaucoma Society Meeting2008(2008.12, Guangzhou China Relationship㧙㧙between central corneal thickness and visual field in glaucoma; Iinvited speaker)
45㧕 The Asian Oceanic Glaucoma Society Meeting 2008(2008.12, Guangzhou China Symposium 3
̌Imaging/Visual Field̍course instructor)
Ꮉἑ๺⑲㧦
1㧕 ੩ṑ✛ౝ㓚ࠞࡦࡈࠔ࡟ࡦࠬ(ᐔᚑ 18 ᐕ 3 ᦬㧘੩ㇺ㧘᜗ᓙ⻠Ṷ‫ޟ‬ၮ␆㧦✛ౝ㓚ߣㆮવሶ‫ޠ‬Ṷ⠪)
2㧕 ᧲ᶏ✛ౝ㓚ቇⴚ⻠Ṷળ(ᐔᚑ 18 ᐕ 3 ᦬㧘ฬฎደ㧘∝଀ឭ␜‫ޟ‬SSOH‫ޠ‬Ṷ⠪)3㧕 ጘ㒂✛ౝ㓚ߩળ(ᐔᚑ 18 ᐕ 5 ᦬㧘ጘ㒂㧘᜗ᓙ⻠Ṷ‫ⷞޟ‬㊁▤ℂ࠰ࡈ࠻ߦࠃࠆⷞ㊁ߩⷰኤ㧙㔚ሶࠞ࡞࠹ൻߣ✛ౝ㓚ߩ∛⸻ㅪ៤㧙‫ޠ‬Ṷ⠪)
4㧕 ╙ 17 ࿁ᣣᧄ✛ౝ㓚ቇળ(ᐔᚑ 18 ᐕ 9 ᦬㧘␹ᚭ㧘‫ޟ‬ỹㆊ⢩ᒻ⁁‫ޠ‬ᐳ㐳)
5㧕 ╙ 18 ࿁ᣣᧄ✛ౝ㓚ቇળ(ᐔᚑ 19 ᐕ 9 ᦬㧘ጘ㒂‫✛ޟ‬ౝ㓚ᬌᩏ 㧙߅㗿޿ߔࠆ஥ߣ߅㗿޿ߐࠇࠆ஥㧙‫ޠ‬ࠝ࡯ࠟ࠽ࠗࠩ࡯)6㧕 ╙ 112 ࿁ᣣᧄ⌒⑼ቇળ✚ળ(ᐔᚑ 20 ᐕ 4 ᦬㧘ᮮᵿ㧘ࠪࡦࡐࠫ࠙ࡓ‫⌒ޟ‬࿶ࠍ⑼ቇߔࠆ㧙⌒࿶㑐ㅪ࿃ሶߩൻቇ‫ޠ‬Ṷ⠪)7㧕 ᧲ᶏ✛ౝ㓚ߩળ(ᐔᚑ 20 ᐕ 7 ᦬㧘ฬฎደ㧘᜗ᓙ⻠Ṷ‫✛ޟ‬ౝ㓚ᴦ≮⮎ߩᣂߒ޿ዷᦸ‫ޠ‬Ṷ⠪)8㧕 ╙ 19 ࿁ᣣᧄ✛ౝ㓚ቇળ(ᐔᚑ 20 ᐕ 9 ᦬㧘ᄢ㒋㧘৻⥸⻠Ṷ ỹㆊᚻⴚ 3 ᐳ㐳)
9㧕 ⌒⮎ℂቇળ ࠪࡦࡐࠫ࠙ࡓ(ᐔᚑ 20 ᐕ 9 ᦬㧘ጟጊ㧘‫ࡦࠫࡦ࡜ࠣ࠲ࠬࡠࡊޟ‬ὐ⌒⮎ߩ⌒⴫㕙ߦ෸߷ߔᓇ
㗀‫ޠ‬Ṷ⠪)
8㧚ቇⴚ⾨╬ߩฃ⾨⁁ᴫ1㧕 ጊᧄື਽㧦ᣣᧄ⌒⑼ቇળ⹏⼏ຬળ⾨(ᐔᚑ 19 ᐕᐲ)
9㧚␠ળᵴേጊᧄື਽㧦
1㧕 ᣣᧄᄬ᣿੍㒐දળ⎇ⓥഥᚑㆬ⠨ᆔຬળᆔຬ(ᐔᚑ 19 ᐕᐲ㨪⃻࿷)2㧕 ᣣᧄቇⴚᝄ⥝ળ⑼ቇ⎇ⓥ⾌ᆔຬળኾ㐷ᆔຬ(ᐔᚑ 19 ᐕᐲ㨪⃻࿷)
3㧕 ᣣᧄቇⴚᝄ⥝ળ⑼ቇ⎇ⓥ⾌ᆔຬળኾ㐷ᆔຬ(ᐔᚑ 19 ᐕᐲ㨪⃻࿷)4㧕 ጘ㒂⋵␠ળ⑔␩ክ⼏ળᆔຬ(ᐔᚑ 18 ᐕᐲ㨪⃻࿷)5㧕 ጘ㒂Ꮢ␠ળ⑔␩ክ⼏ળᆔຬ(ᐔᚑ 18 ᐕᐲ㨪⃻࿷)
6㧕 ࿖᳃ᐕ㊄㓚ኂክᩏᆔຬ(ᐔᚑ 18 ᐕᐲ㨪⃻࿷)10㧚ႎ๔ᦠ
1㧕 ጊᧄື਽㧦✛ౝ㓚േ‛ࡕ࠺࡞ߦࠃࠆᣂⷙ⮎‛ᴦ≮ߩ㐿⊒ߣ⃻࿷ߩ✛ౝ㓚⸻≮ߩวℂᕈߩᬌ⸛㧦ᐔᚑ
17 ᐕᐲ㧙19 ᐕᐲ⑼ቇ⎇ⓥ⾌⵬ഥ㊄⎇ⓥᚑᨐႎ๔ᦠ(2008 ᐕ 3 ᦬)
2㧕 ጊᧄື਽㧦ᱜᏱ⌒࿶✛ౝ㓚ߩ࡝ࠬࠢࠕ࠮ࠬࡔࡦ࠻㧦ᐔᚑ 17 ᐕᐲ㧙19 ᐕᐲෘ↢ഭ௛⑼ቇ⵬ഥ㊄ᗵེⷡ㓚ኂ⎇ⓥ੐ᬺ ✚᜝࡮ಽᜂ⎇ⓥႎ๔ᦠ(⼱ේ⃰)㧦7㧙14(2008 ᐕ 4 ᦬)11㧚ႎ㆏ߥߒ12㧚⥄Ꮖ⹏ଔ
⹏ଔᤓ੹ߩකዪຬߩᷫዋߦࠃࠅ⥃ᐥᬺോߩ⽶ᜂ߇ฦකᏧߦჇ߃ࠆਛ㧘ቇળ⊒⴫㧘⺰ᢥ૞ᚑߥߤ♖ജ⊛ߦᵴേߒߡ޿ࠆߣᕁࠊࠇࠆ‫ࠄ߇ߥߒ߆ߒޕ‬㧘⎇ⓥᵴേߩߐࠄߥࠆዷ㐿ࠍᮨ⚝ߔࠆᔅⷐ߇޽ࠆ‫ޕ‬⃻⁁ߩ໧㗴ὐ෸߮ߘߩኻᔕ╷ᣂ⥃ᐥ⎇ୃක೙ᐲዉ౉ߦࠃࠆᣂߒ޿කዪ౉ዪ⠪ߩᷫዋߦ઻޿㧘කຬᢙ߇ᷫዋߔࠆ௑ะߦ޽ࠆ‫⚿ߩߎޕ‬ᨐ㧘⥃ᐥᬺോᤨ㑆ߩ⋧ኻ⊛Ⴧടߦࠃࠅ㧘⎇ⓥߦలߡࠆᤨ㑆߇ᷫዋߒߚ‫߼ߚߩߎޕ‬ᒰ⑼ߢߪ㧘⥃ᐥᬺോߦ೙㒢ࠍ⸳ߌ㧘⋧ኻ⊛ߦ⎇ⓥᤨ㑆ߩჇടߦߟ޿ߡᮨ⚝ߒߡ޿ࠆ‫ߚ߹ޕ‬㧘ጘ㒂ᄢቇߩ߶߆ߩၮ␆⻠ᐳ߿ઁ⎇ⓥᯏ㑐ߣ౒ห⎇ⓥߩଦㅴߥߤࠍⴕߞߡ޿ࠆ‫ޕ‬੹ᓟߩዷᦸࠃࠅࠃ޿⎇ⓥᚑᨐࠍ᳞߼ࠆ਄ߢ㧘කᏧ߭ߣࠅ߭ߣࠅߩ⥃ᐥᬺോߦࠁߣࠅࠍᜬߚߖࠆߎߣߪᔅⷐߢ޽ࠆ‫ޕ‬㧙㧙ߒߚ߇ߞߡᣂ౉කዪຬߩ⺃⥌߇ߘࠇࠍ㆐ᚑߔࠆ਄ߢᔅⷐਇนᰳߢ޽ࠆߣ⠨߃ࠆ‫߇ࠇߘޕ‬ᡷༀߐࠇߥ޿㒢ࠅ㧘⃻⁁ࠍᛂ⎕ߔࠆߎߣߪ㔍ߒ޿‫ޕ‬㧙㧙